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 Telomeres, the protein-DNA complexes found at the chromosome terminus of 
eukaryotic organisms, and telomerase, the enzyme complex that replicates telomeric 
DNA, work together to ensure proper chromosome maintenance by distinguishing the 
normal chromosome end from a double-stranded DNA break and preventing 
chromosome end-to-end fusions. Telomerase functions by adding a T/G rich repetitive 
sequence to telomeric DNA. There are a number of mechanisms that regulate the action 
of telomerase at the telomere. Some of these mechanisms include: temporally regulating 
the assembly of telomerase, inhibiting access of telomerase to the telomere by changes in 
DNA structure and competitive exclusion of the enzyme. Improper maintenance of the 
telomere can lead to chromosomal abnormalities and has been connected to both human 
aging and cancer. Therefore, understanding the mechanisms that regulate telomerase and 
telomere maintenance are important to a complete knowledge of these maladies.  
 The work presented in this thesis focuses on a how the telomerase complex 
assembles both in vivo and in vitro and begins to explore how one member of the 
telomerase enzyme in the budding yeast, Saccharomyces cerevisiae, termed Est3, 
functions within the complex. This chapter begins with a historical overview of the 
telomere/telomerase field, then moves into an introduction of our current understanding 
of the importance of the telomere and the telomerase holoenzyme, and concludes with a 
summary of telomere maintenance in both humans and yeast.  
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A History: The Beginnings of the Chromosome End From the Discovery of the 
Telomere to Telomerase 
 
 
The Telomere: 1920’s-1940’s 
 In the 1920’s and 1930’s two scientists, Hermann Muller and Barbara 
McClintock, used X-rays to gain insight into the nature of the chromosome and the 
hereditary unit, the gene. Dr. Muller, a geneticist and former student of Thomas Hunt 
Morgan, the renowned fly geneticist, mutagenized flies with X-rays and recorded 
chromosomal abnormalities, classified as inversions, translocations and deficiencies 
(deletions). He noted that these abnormalities rarely involved the chromosome terminus 
and that the rejoining of broken ends never occurred between “originally free ends” [1]. It 
was in this 1938 paper that he termed the “free ends” telomere, from the greek nouns 
telos-meaning “end” and meros-meaning “part.” Simultaneously, Dr. McClintock, a 
cytogeneticist, was developing maize as a system to study chromosomal inheritance. She 
too used X-rays to cause alterations within the chromosome and like Dr. Muller noted 
that never did she observe the natural end of the chromosome being attached to a broken 
end [2]. Both of these observations revealed that there must be something unique about 
the telomere because it appeared to be providing a protective “cap” for the chromosome. 
 In 1939 Dr. McClintock made another important observation regarding the 
telomere; when she applied X-rays to embryonic maize cells soon after the first zygotic 
division she found that the broken ends could be “healed” permanently [3]. This was the 
first evidence to hint that there might be a controlled process specific to maintaining the 
chromosome end. She also, prophetically, hypothesized that the healing occurred “during 
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the reproductive cycle of the chromosome,” now known as S phase, the phase of telomere 
elongation. 
 
The Telomere: 1971-1978 
 Little else was revealed or speculated about the telomere until the early 1970’s. In 
1971 Dr. Alexey Olovinkov authored a theoretical paper entitled Principles of 
marginotomy in template synthesis of polynucleotides. Here he postulated that the end of 
the DNA molecule could not be completely replicated (the so called “end-replication [or 
end-underreplication] problem”) because DNA polymerases cannot initiate de novo 
synthesis at the end of the chromosome. DNA synthesis requires a free 3’-hydroxyl (3’-
OH) group, which for lagging strand polymerization is accomplished by the synthesis of 
a complementary RNA primer that primes DNA polymerization. When the terminal RNA 
primer is removed from the chromosome a 5’-gap or a 3’-overhang is established and 
DNA polymerase cannot fill-in this gap. (Figure 1.1) [4]. The predicted consequence is 
that the telomere would become shorter during every cell division eventually resulting in 
loss “of a critical portion of the telomeric DNA.” Dr. James Watson independently 
suggested a similar hypothesis in 1972 through his work with linear phage DNA [5]. In 
addition, Dr. Olovinkov also speculated that the end-replication problem might cause the 
cellular senescence phenotype observed by Drs. Leonard Hayflick and Paul Moorhead in 
primary cell strains [4, 6, 7].  
 Since it had become plausible that telomeric shortening could be the cause of 






































Figure 1.1 The End-(Under)Replication Problem. (A) Diagram of the original concept 
of the End-Replication problem hypothesis. Lagging strand synthesis results in an 
unreplicated 3’-overhang that through multiple rounds of replication becomes shorter and 
shorter as evidenced by comparing the original chromosome length (denoted by the 
bracket at the bottom) and the chromosome length after two rounds of replication. The 
teal and pink lines represent the first and second rounds of replication, respectively. The 
red-spotted rectangle represents the 5’-RNA primer that is removed at the end of 
replication. (B) Diagram of an updated understanding of the End-Replication problem 
that includes the role of exonucleases (represented by the red “pac-man”). Since 
telomeres require a 3’-overhang to establish appropriate capping, both the products of 
leading and lagging strand synthesis end in a 3’-overhang. This occurs at least in part by 
removal of the 5’-RNA primer (lagging strand) and by the exonuclease activity of Mre11 
and Exo1 (leading strand). As a consequence, the parent strand involved in leading strand 
synthesis is continually attacked by exonucleases to re-establish a 3’-overhang in each 
cell cycle. This outcome is in stark contrast to the original hypothesis where the DNA 
strands involved in leading strand synthesis do not contribute to the End-Replication 
problem. The dashed line represents the length of the chromosome before 5’-resection by 
exonucleases. 
 6 
proposed. Most common among them was that the telomere contained a palindromic or 
inverted repeat sequence that could fold on itself and thereby “self-prime” [8]. This 
would allow the conventional DNA polymerase to use the 3’-OH located at the 3’-end to 
initiate synthesis in the 5’-3’ direction. This structure would be resolved by sequence 
specific endonuclease and/or recombination within the telomere. Because these models 
relied on palindromic or inverted repeat sequences, determining the sequence of 
chromosome ends became a high priority. 
 
The Telomere and Telomerase: 1978-1985 
 The largest challenge that stood before the field at this point was isolating the 
relatively small amount of telomeric DNA from the rest of the chromosome. The 
macronucleus of the ciliated protozoan, Tetrahymena thermophila, provided a solution to 
this problem. Ciliated protozoans maintain two functionally distinct nuclei: a 
micronucleus and a macronucleus. The micronucleus is a transcriptionally inert nucleus 
important for meiotic exchange and maintenance of the germ line DNA. Alternatively, 
the macronucleus chromosomes are fragmented into minichromosomes ranging in size 
from ~21 kilobases (kb) to 1,500 kb (compare to an average chromosome length of 
~44,000 kb in the micronucleus) (reviewed in [9]). The smaller minichromosomes (~21 
kb) belong to the rDNA, which are maintained at ~10,000 copies/cell. The telomeres 
constitute ~ 0.0013% of the total DNA in the micronucleus, while they compose ~ 2.85% 
of the rDNA minichromosomes. Therefore isolation of rDNA minichromosomes more 
readily permitted purification of telomeres. In 1978, Drs. Elizabeth Blackburn and Joseph 
Gall reported the tandemly repeated hexanucleotide sequence (CCCCAA/TTGGGG) of 
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the rDNA minichromosome terminus [10]. The 3`-end of the chromosome bore the 5’-
TTGGGG-3’ sequence, while the 5’-end bore the 3’-CCCCAA-5’ sequence. They 
observed that this sequence was repeated anywhere from 20-70 times at different 
chromosome ends. In the following few years, similar types of tandemly repeated 
sequences were discovered in other ciliates; each time the G-rich sequence being located 
at the 3’-end [11]. Collectively, these data began to argue against the prevailing 
hypotheses of a palindromic end or an inverted repeat that “self-primes,” and the quest 
was on to determine if this sequence was specific to ciliates or if it was conserved in 
other eukaryotic organisms and to elucidate how this sequence was being maintained. 
 In 1982, Dr. Blackburn along with her colleague Dr. Jack Szostak discovered that 
the terminal sequence of T. thermophila chromosomes could function in a yeast 
(Saccharomyces cerevisiae) cell [12]. Typically when a linear piece of DNA is 
transformed into yeast, it is not stably maintained unless it integrates into the 
chromosome. They took advantage of this property to test whether a linear yeast plasmid 
(one that would normally be lost during cell division) could be maintained if the ends of 
this plasmid consisted of telomere sequence from T. thermophila. They discovered that in 
14 out of 15 clones the plasmid was maintained as a linear molecule (the other clone had 
integrated into the chromosome, presumably by homologous recombination). 
Interestingly, the 14 linear clones that were maintained had become longer by ~100-300 
basepairs (bp) within the terminal restriction fragments, suggesting that the T. 
thermophila telomere sequences were being maintained as telomeres in yeast. Then in 
1984, Dr. Janis Shampay, a graduate student of Dr. Blackburn, cloned and sequenced 
yeast telomeres and found them to be a discontinuous sequence of G1-3T (~300 bp long) 
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[13]. Over the next few years, the sequences of telomeres from various species were 
determined and again, they contained a strand bias in which the 5`-strand was the G/T 
rich strand (reviewed in [14]). Together these data revealed that the maintenance of 
telomeres was (1) an evolutionarily conserved process and (2) began to argue for a 
specialized enzymatic process, specifically hypothesized by Blackburn and colleagues to 
be a terminal transferase [13]. 
 Dr. Blackburn has written that in addition to the above evidence, a letter she 
received from Dr. McClintock solidified her belief that there was a unique enzyme that 
acted on telomeres [15]. In this letter Dr. McClintock revealed that during her work on 
maize she found one mutant (unpublished) that could not “heal” broken ends even in the 
early zygotic stages. This observation suggested that there was a gene responsible for the 
healing process [15]. In 1985, Dr. Blackburn and her graduate student Carol Greider 
published their discovery of the telomere field’s “holy grail,” an enzymatic activity 
specific to the telomeric sequence [16]. They found, using a primer extension assay and 
cell-free protein extract from T. thermophila, that the enzyme would processively add 
nucleotides, with a six-base periodicity, to a primer containing TTGGGG repeats. The 
enzyme required only dGTP and dTTP to extend the primer, was sensitive to proteinase 
K treatment and heat denaturation; it was not dependent upon endogenous double 
stranded (ds) DNA or alpha-polymerase, as pre-treatment of the extract with micrococcal 
nuclease or aphidicolin did not disrupt activity. In addition, it was noted that the 
enzymatic activity was present both in newly mated cells and those growing vegetatively, 
suggesting that telomere maintenance is an important function in both states. This 
enzyme was eventually termed telomerase (from Telomere Terminal Transferase). 
 9 
 Over the past 25 years a growing body of knowledge has been uncovered in the 
telomere and telomerase field. The telomeric sequence and the telomerase enzyme have 
been identified in many organisms (reviewed in [17]). As a result, many proteins that 
both positively and negatively regulate telomere maintenance have been discovered and 
unique roles for DNA replication and repair machinery, uncovered. The following section 
will provide a general overview of the function of both the telomere and telomerase and 
touch on some of the unique roles that telomeres play in the cell. 
 
An Overview of the Function of the Telomere and Telomerase 
 
The Telomere 
 The telomere is the protein/DNA complex found at the ends of linear eukaryotic 
chromosomes. Its primary functions are to cap and protect the chromosome from 
nucleolytic attack by nucleases and to distinguish the natural end from an internal DNA 
break, to regulate gene expression, to help facilitate organization of chromosomes in the 
nucleus and to limit the replicative capacity of the cell by serving as a “mitotic clock” 
(reviewed in [18-21]). Most telomeres have a unique repetitive sequence. For instance, in 
humans, an array of other metazoans and some plants the telomere consists of a 
TTAGGG repeat (reviewed in [17, 22]) while in budding yeast, a less well defined, G1-3T 
repeat is found [13]. Additionally, all telomeres discovered to date end with a single-
stranded 3’-overhang important for telomere capping, suggesting it is an important, 
evolutionarily conserved structure. The 3’-overhang is established either by removal of 
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the 5’-primer left by lagging strand synthesis or by exonuclease activity to create an 
overhang on the blunt-ended product of leading strand synthesis (Figure 1.1b) [23-26]. 
 The 3’-overhang is important for proper maintenance of the telomere, but these 
resulting sticky ends must be capped to provide end-protection from nucleases and to 
signal to the cell that the normal chromosome end is not a double-strand break in need of 
repair. The proteins involved in capping vary in number and complexity in different 
species, but are found in all eukaryotes (see Figure 1.2 for reference). For example, the 
primary capping proteins in the ciliated protozoans are TEBPα and TEBPβ, which cap 
the telomere by forming a heterodimeric clamp around the chromosome end [27]. In 
budding yeast Cdc13, Stn1 and Ten1 (CST complex) are the primary telomeric capping 
proteins [28]. Recent data have revealed that mammals and the evolutionarily distant 
fission yeast, Schizosaccharomyces pombe, have both a CST complex and a hexameric 
“shelterin” complex that functions as the telomeric cap by promoting the formation of 
large telomere-loops (t-loops) (reviewed in [29]). Even Drosophila melanogaster, an 
organism that maintains telomeres without telomerase, has capping proteins, collectively 
termed “terminin” (HOAP, HP1, Moi and Ver) [30, 31]. In addition to having 
Oligonucleotide/oligosaccharide-Binding (OB) folds, which are important for binding the 
ssDNA overhang and protein-protein interactions, some of these end-binding proteins 
may be evolutionarily related. For instance, the TEBPα and TEBPβ proteins in ciliates 
are thought to be homologous to the POT1 and TPP1 proteins in mammals, respectively 







































Figure 1.2 Telomere capping proteins in different eukaryotes. Analogous or 
homologous subunits between different species are the same color to denote either 
functional similarity or evolutionary relationship. Though the end structure for different 
species may consist of different proteins, the essential roles of protecting the telomere 
from nucleolytic degradation or recognition by DNA repair proteins are conserved. 
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  The primary roles of the telomeric cap are to inhibit the telomere from being 
recognized as a broken DNA end and thereby, to inhibit DNA repair pathways from 
attempting to “heal” the telomere. The ATM kinase (Ataxia Telangiectasia Mutated) and 
ATR kinase (Ataxia Telangiectasia and Rad3 related) pathways respond to dsDNA 
breaks and activate signaling pathways to recruit factors that repair the DNA (reviewed in 
[34]). Briefly, ATM kinase directly recognizes dsDNA breaks, whereas ATR kinase is 
activated when the 5’-end becomes resected and subsequently bound by RPA 
(Replication Protein A). After recognition of a dsDNA break, the chromosome can be 
repaired by two main DNA repair mechanisms: Homology Directed Repair (HDR) or 
Non-Homologous End Joining (NHEJ).  
 The mammalian model systems have contributed extensively to understanding 
how the cap inhibits both the detection and repair of dsDNA breaks. Figure 1.2 illustrates 
the mammalian end-protection complex, termed shelterin. TRF1 and TRF2 bind as 
homodimers to the double-stranded telomere sequence TTAGGG through their respective 
Myb-type domains [35]. TRF2 can generate higher order DNA structures called t-loops 
in vitro that are speculated to help “hide” the 3’-overhang in vivo [36]. Rap1 interacts 
with TRF2. TIN2 binds to both TRF1 and TRF2 and acts as a bridge to connect them to 
TPP1, which associates with POT1 [37]. POT1 binds the single-stranded telomeric 
overhang [32]. 
 How do these proteins inhibit the telomere from recognition as dsDNA breaks? In 
mammals, TRF2 appears to inhibit activation of the ATM kinase, NHEJ and HDR as 
evidenced by an increase in Chk2 phosphorylation (specific to ATM activation) and 
telomere fusions upon TRF2 knocked-down [38-40]. Such inhibition is likely achieved 
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indirectly to its role in t-loop formation. Since TRF2 is important in “hiding” the 3’-
overhang, ATM kinase cannot be activated if it cannot detect ssDNA, thereby reducing 
the ability to activate NHEJ or HDR. When RAP1 is depleted from cells or unable to 
bind TRF2, there is no phosphorylation of Chk2 or Chk1 (specific to ATR activation) and 
no telomere fusions occur. However there is a dramatic increase in telomere-sister 
chromatid exchanges (T-SCEs), a measure of HDR [41-43]. Because RAP1 has both a 
BRCT and Myb-type domain, it is speculated that it may interact with other proteins that 
signal the inhibition of telomere recombination [44]. Loss of POT1 in mammalian cells 
activates ATR kinase and HDR is upregulated as evidenced by phosphorylation of Chk1 
and an increase in T-SCEs, respectively [45-47]. The POT1 binding partner, TPP1, 
inhibits ATR kinase activation, through its recruitment of POT1 to the telomere [46, 47]. 
Since POT1 binds the long single-stranded overhang, depletion of POT1 could cause an 
increase in RPA binding at the telomere and subsequently activate the ATR kinase 
pathway. Intriguingly, this is supported by two recent publications that show that there is 
a dynamic interplay between POT1 and RPA for telomere binding [48, 49]. In addition to 
preventing ATR and HDR signaling, POT1 also inhibits NHEJ in G2 phase of the cell 
cycle [45, 50]. 
 As well as its role in capping the chromosome end, the telomere is important for 
the proper localization of chromosomes in meiosis. In the latter part of the 19th Century, 
biologists were attempting to understand the biology of the chromosome in different 
phases of the cell cycle. One unique observation was that in some meiotic cells 
chromosome ends were clustered at their ends to one side of the nucleus (e.g. [51]). In 
1900, Gustav Eisen, who was studying meiosis in salamanders, termed the structure 
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“chromosomal bouquet” due to its similarity to bundled flower stems [52]. The 
polarization of chromosomes to a restricted section of the Nuclear Envelope (NE) is 
conserved among most eukaryotes, suggesting that this is an important cellular 
mechanism (reviewed in [53]). 
 Telomeric clustering is important for proper progression through meiosis, as 
telomere dysfunction caused by reduced telomerase activity results in an inability for 
yeast and mice to complete meiosis [54-57]. Telomeres are anchored to the NE by 
telomere end-binding proteins. For example, if Taz1 or Rap1’s (S. pombe shelterin 
proteins-Figure 1.2) ability to bind the telomere is disrupted, then telomere clustering and 
attachment at the NE are disrupted as well [58-61]. In budding yeast when the telomere 
sequence is altered so that Rap1 (a telomere-binding protein) can no longer bind 
efficiently, cells do not pass through meiosis [62]. In addition, a budding yeast meiotic-
telomere specific protein, Ndj1/Tam1, interacts with the Spindle Pole Body (SPB) 
component Msp3 and is important for crossing-over and telomere clustering [63-65]. 
Interestingly, when nuclear envelopes are purified from frog oocytes, TRF2 has also been 
purified, suggesting that telomere binding proteins may also be important for telomere 
anchoring in higher eukaryotes [66]. 
 Why is it important for telomeres to be attached to the NE in meiosis? During 
meiosis, it is critical that homologous chromosomes locate one another (termed 
homology search) and undergo recombination to ensure proper chromosomal segregation. 
Homologous recombination cannot occur if the homologous chromosomes do not first 
locate each other. It is hypothesized that attachment of the telomere to the NE during 
meiosis simplifies the homology search by clustering chromosome ends in one place 
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(reviewed in [53]). This idea is supported by several observations: S. pombe taz1- or rap1- 
cells have significantly lower recombination rates than WT (wild type) and ndj1Δ cells in 
S. cerevisiae have delayed kinetics of homologue pairing [58-61, 63-65]. Additionally, 
telomeric clustering is generally limited to the leptotene to zygotene (sometimes 
pachytene) phases of meiosis but once the synaptonemal complex is formed, the bouquet 
does not persist, perhaps because the chromosome pairing is complete (reviewed in [53]). 
Interestingly, in species that do not form a synaptonemal complex, as in S. pombe or T. 
thermophila, the bouquet is present until the end of prophase I, when recombination is 
complete [67, 68]. This apparent correlation between the completion of homologous 
chromosome pairing and of the dissolution of chromosome bouquets also supports that 
telomeric clustering is important for homology search. 
 Telomeres also play an important role in gene silencing. The role of telomeres in 
gene silencing is best understood in S. cerevisiae where many of the proteins involved 
and some of the mechanisms have been elucidated. Silencing at the end of the 
chromosome involves both the telomere and subtelomeric regions, which consist of 
special DNA structures termed X-elements and Y`-elements. Proteins that bind within the 
telomeric and subtelomeric DNA nucleate the formation of a specific chromatin structure 
that can spread inward from the telomere and is thought to sterically hinder the 
transcription machinery’s access to genes within this region (reviewed in [69]). This 
phenomenon is called the Telomere Position Effect (TPE). 
 The chief proteins involved in TPE in S. cerevisiae are Rap1 and the Ku70/80 
heterodimer, which bind directly to the yeast telomeric repeat, and the Sir family proteins 
(Sir2, Sir3 and Sir4). Rap1 binds, in a sequence-specific manner, to the double-stranded 
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portion of telomeric DNA. Rap1 then recruits either the Rif1/2 proteins, which regulate 
telomere length (discussed below) or the Sir proteins (Sir2/3/4), which are involved in 
chromatin silencing. Sir4 binds to Rap1 and in turn recruits Sir2 and Sir3 (See Figure 1.3) 
[70-73]. Sir2, an NAD+-dependent histone deacetylase, deacetylates lysines in the histone 
tails of neighboring histone 3 (H3) and histone 4 (H4). The resulting hypoacetylated 
histones can be bound by Sir3, independent of the Sir4-Rap1 interaction [74], which then, 
in turn, recruits more Sir complexes to the DNA to spread chromatin silencing. The 
extent of silencing is dependent upon the pool of Sir3 as overexpression of Sir3 increases 
the range of the TPE [75].  
 Interestingly, Sir4 and Ku70/80 are also important for tethering telomeres to the 
nuclear envelope (NE). Specifically, Sir4 interacts with Esc1, an NE integral membrane 
protein, to anchor telomeres in S phase of the cell cycle. The Ku70/80 interacts with both 
Esc1 and Mps3, another NE integral membrane protein, to tether telomeres to the NE in 
G1 phase [76, 77]. Mutations in both Sir4 and Ku80 that separate telomeric anchoring 
from silencing, demonstrate that these two functions are independent of each other [77]. 
However, there is likely and important functional interplay between telomeric silencing 
and telomeric tethering since the same proteins accomplish these functions. Indeed, it has 
been hypothesized that clustering telomeres at the NE helps to create a sub-nuclear 
compartment to facilitate concentration of silencing factors that are important for gene 
silencing (reviewed in [21]). For example, both mating-type loci are located near the 
terminal regions of the opposite arms of Chromosome III in budding yeast. Silencing of 
































Figure 1.3 Telomere Position Effect (TPE) in Saccharomyces cerevisiae. TPE has 
been most extensively studied in budding yeast. Rap1 binds to the telomere in a sequence 
specific manner and recruits both Rif1 and Rif2, which bind to the C-terminus of Rap1. 
Sir4 competes with Rif1 and Rif2 for Rap1 binding at the telomere. Once Sir4 binds, it 
recruits Sir2 and Sir3. Sir2 then deacetylates histones which can recruit more Sir3 and 
Sir4 in a Rap1-independent manner. The telomeric region of the DNA that is bound by 
Rap1 is called the telosome while the region proximal to the centromere is comprised of 
nucleosomal chromatin. This figure was adapted from Ottaviani et al., 2008 [21]. 
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telomeres and subsequently the silencing factors, these genes can be transcriptionally 
silenced even if they are not located directly in silenced chromatin [78]. 
 TPE plays a role in DNA replication, recombination and repair. Origins of 
replication that are located in the heterochromatic sub-telomeric regions of DNA are fired 
later during S-phase than those more internal and their firing time is dependent upon Sir3. 
When Sir3 is inactivated, late origins are prematurely fired earlier in S-phase, and 
conversely, when Sir3 is tethered to an early-firing origin, it becomes a late-firing origin 
[79, 80]. TPE is responsible for decreasing rates of recombination within the telomere, 
which could result in non-homologous chromosome exchange and interestingly, 
anchoring of telomeres near the nuclear pore is important for proper repair of dsDNA 
breaks located in the sub-telomere [81, 82].  
 TPE is not a phenomenon restricted to yeast; when a luciferase reporter gene is 
integrated directly adjacent to telomeres in mammalian cells the expression of this gene is 
decreased 2 to 10-fold compared to integration more internal in the genome. [83]. Forced 
telomere elongation in this context caused further repression of the reporter, while 
addition of trichostatin A, a histone deacetylase inhibitor, restored expression [83]. Since 
the expression of a reporter gene can be modulated by changes at the telomere in a 
manner similar to that seen in yeast, these data support the existence of TPE in mammals. 
The telomere and subtelomere in humans vary significantly among each other in both 
size and arrangement (reviewed in [21]). This variability makes it difficult to understand 
what importance, if any, there maybe in differential expression of sub-telomeric genes in 
humans. One potential way that TPE may affect human disease is if a normally active 
gene(s) is rearranged, perhaps via translocation or terminal deletion, to be located 
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adjacent to the telomere. This situation might down-regulate gene expression resulting in 
a human disease phenotype (reviewed in [21]). Indeed, approximately 5-10% of patients 
with idiopathic mental retardation have small karyotypic changes in subtelomeric regions 
of their chromosomes, suggesting that deletions or rearrangements near the telomere can 
influence human disease (reviewed in [21]). 
 
Telomerase 
 Eukaryotic species, excepting Dipterans, maintain telomeres using telomerase, a 
ribonucleoprotein complex, consisting minimally of the Telomerase Reverse 
Transcriptase protein (TERT) and the Telomerase RNA (TR). TERT, as the name 
implies, is a specialized DNA polymerase that adds nucleotides to the telomere using 
reverse transcription (RT). The RT domain of TERT is functionally and structurally 
homologous to viral RNA polymerases and reverse transciptases and the B-type family of 
polymerases [84, 85]. TR is the RNA template for the telomerase complex as it contains a 
sequence that is complementary to the telomere DNA [86, 87]. In Euplotes the RNA 
template contains the sequence 5`-CAAAACCCCAAA-3`, which is complementary to 
the telomere sequence TTTTGGGG, found at the Euplotes telomere [87]. Though the 
existence of an RNA subunit and some aspects of tertiary structure have been conserved 
through evolution the size and sequence of the RNA has not. For example, in ciliates the 
RNA is ~150 nucleotides long, while in vertebrates it is ~500 nucleotides and in yeast it 
is much larger, ~1,300 nucleotides [86-90]. The divergence is attributed to the fact that in 
different species, different factors bind to the RNA and aid in its maturation and stability 
in the cell [91]. In vitro TERT and TR (along with the chaperones Hsp90 and p23) are the 
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only two telomerase components required for telomerase activity, as production of TERT 
and TR from humans in rabbit reticulocyte lysate can reconstitute telomerase activity 
[92]. In vivo telomerase activity is regulated by different, often species specific, 
accessory factors that are necessary for both proper association of telomerase with the 
telomere and elongation of the telomere. 
 Telomerase adds to G/T rich 3’-overhangs, specifically the 3’-overhang of the 
telomere [93]. Telomerase binds with the DNA (as assessed in vitro) in at least two 
independent mechanisms: TERT binds to DNA upstream of the terminal 3’-nucleotide 
using the “anchor site” and through base pairing between TR and the end of the telomeric 
DNA (see Figure 1.4) [94-96]. To ensure proper telomeric sequence replication, the RNA 
has both a 3’ and 5’-template boundary. The 3’-boundary is defined by its 
complementarity to the telomeric sequence, whereas the 5’-boundary of the template 
RNA is often restricted by secondary structural elements within the RNA (reviewed in 
[97]). Once anchored and base paired to the DNA, telomerase elongates the telomere by 
adding nucleotides to the 3’-overhang one nucleotide at a time until it reaches the end of 
the RNA template. Then telomerase translocates to reposition the DNA and continues to 
add more nucleotides (Figure 1.4). Other protein interactions with the telomere and 
interactions between lagging strand DNA replication machinery and telomerase are 
important for regulating the extent of telomere elongation (discussed below). 
 TERT consists of three distinct domains: an N-terminal extension (NTE), the RT 
domain and a C-terminal extension (CTE) (Figure 1.5) [98]. The NTE is specific to 









Figure 1.4 Telomerase catalyzes the addition of nucleotides to the end of the 
telomere. First telomerase must associate with the DNA template. This is accomplished 
minimally by two interactions within the telomerase complex: (1) the TERT protein binds 
to the template through its N-terminus in a region termed the anchor site and (2) the TR 
(telomerase RNA) base pairs with complementary residues at the extreme 3’-end of the 
telomere (the black lines denote base pairing). Next telomerase adds nucleotides to the 
telomere using the template region of the RNA until the template boundary is reached or 
telomerase dissociates from the telomere (the hot pink lines denote new addition). 
Finally, telomerase translocates and adds another repeat or dissociates completely and 
telomere elongation is complete (the light pink lines denote an additional round of 
telomere addition). 
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eukaryotes, but is absent in some insects [85, 97]. The NTE is comprised of four 
evolutionarily conserved regions, the most amino-terminal domain is called the 
Telomerase Essential N-terminus (TEN) followed by Region II, Region III, and the T-
motif [98, 99]. The NTE is important for interacting with TR, nucleolar localization, and 
multimerization in some species [100-107]. In addition, there is a small motif defined 
within the TEN domain of human TERT that can dissociate activities of telomerase 
(DAT). Mutations within this motif of both the human and budding yeast TERT disrupt 
in vivo function but not in vitro function, implying that TERT has a function in the cell 
other than catalysis [98, 102]. Interestingly, direct fusion of hPOT1 to hTERTDAT 
mutants rescues the in vivo phenotype in a manner dependent upon hPOT1 association 
with telomeric chromatin, suggesting that the DAT motif is important for assembly of 
TERT with the telomere [108]. 
 The RT domain is the catalytic center of the protein and has the same conserved 
motifs as all other reverse transcriptases (1, 2, A, B`, C, D and E) (reviewed in [109]). 
Recently, the structure of full-length TERT from the flour beetle, Tribolium castaneum, 
was published and revealed that TERT retains important structural features also found in 
the HIV RTs [85]. The RT domain and the CTE form a ring configuration that has a 
groove hypothesized to bind an RNA/DNA duplex. The RT domain is organized into 
“finger” and “palm” subdomains. The “finger” subdomain is created by motifs 1 and 2, 
while the “palm” is created by motifs A-E [85]. There are three absolutely conserved 
aspartate residues in motifs A and C that function together in the tertiary structure to 
coordinate two magnesium ions important for positioning the incoming dNTP and the 3`-



































Figure 1.5 Schematic of the TERT domains. Most TERT genes have a highly conserved 
N-terminal extension that is important for interacting with TR and accessory proteins. 
The Telomerase Essential N-terminal (TEN) domain is important for associating with the 
DNA template via the anchor site. Additionally, mutations within a region of the TEN 
domain in higher eukaryotes specifically disrupts telomerase activity in vivo but not in 
vitro this is termed the DAT (dissociate activities of telomerase) domain. In budding 
yeast the TEN domain is important for assembling two accessory proteins (Est1 and 
Est3). The central portion of TERT consists of the reverse transcriptase domain, which 
contains both the finger and palm subdomains. TERT also has a C-terminal extension that 
is important in stabilizing DNA/RNA interactions, facilitating interactions with accessory 




residues results in a catalytically dead TERT [84, 110]. Mutations in both motifs C and E 
can either positively or negatively affect telomerase processivity [111].   
 The CTE is considered the “thumb” domain in TERT; this domain is mostly 
dispensable in yeast [98, 101, 103, 104, 111-113]. In the T. castaneum structure, the CTE 
appears to stabilize a modeled RNA/DNA duplex through interactions between lysines in 
the “thumb” domain and the DNA backbone [85]. Mutations within the CTE also affect 
telomerase processivity and hTERT multimerization [107, 111-115]. The CTE in hTERT 
also has binding sites for 14-3-3 and CRM1 proteins, which aid in proper intracellular 
localization and export of TERT, respectively [116]. 
 
Maintenance of Human Telomeres 
 Some of the main questions in the human telomere research area are: (1) What are 
the components of the active telomerase holoenzyme in vivo? (2) What mechanisms 
regulate telomerase activity? (3) How is the complex trafficked in the cell to become 
competent to extend telomeres? In the past several years there have been many advances 
in the understanding of each of these questions using a variety of techniques from 
bioinformatics and human genomics to cellular biology and biochemistry. These 
advances have identified homologous genes between yeasts and humans related to 
telomere maintenance and have aided in understanding the cellular localization of 
telomerase components and interaction partners [89, 117-123]. 
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Components of Active Telomerase 
 The primary method used to determine if a protein is complexed with active 
telomerase is to determine if the proteins can immunoprecipitate telomerase activity. 
hEST1A and hEST1B both purify telomerase activity [117, 118]. These proteins were 
identified as homologues to the telomerase complex EST1 gene from yeast. hEST1A is 
important in both telomere capping and telomere elongation as overexpression of this 
protein results in telomere uncapping and anaphase bridge formation [118]. The role of 
hEST1B at the telomere has yet to be uncovered, though binding to HDAC8 does protect 
hEST1B from being targeted to the proteosome by the ubiquitin E3 ligase, CHIP (C-
terminal heat shock protein interacting factor). Depletion of HDAC8 affects telomerase 
activity in vivo presumably due to loss of hEST1B [124]. 
 The RNA component in humans, hTR, is transcribed by RNA polymerase II and 
is subsequently bound at its 3’- H/ACA box by a complex of proteins composed of 
dyskerin, NHP2, NOP10 and GAR1. This dyskerin complex remains associated with the 
active telomerase complex and is important in processing, localizing and stabilizing the 
RNA [125-128]. hTR is also bound by TCAB1, a recently identified telomerase complex 
component that is also important for its localization in the cell [121]. 
 Human telomerase also requires two chaperones, Hsp90 and Hsp23, for 
appropriate assembly both in vivo and in vitro. Inhibition of Hsp90 by geldanamycin 
inhibits the assembly of an active telomerase complex [129, 130]. hTERT complexes 
with nucleolin, SMN, and 14-3-3 to regulate its localization in the cell [116, 131, 132]. 
Only nucleolin has been shown to associate with the active telomerase complex. 
Additionally, other proteins associate with telomerase activity, though their function and 
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contribution to the complex remains enigmatic; these are: Ku, La and hnRNP D [133-
136].  
 
Regulation of hTERT  
 Telomerase is active in stem cells, germ cells, some highly proliferative cells and 
in ~85% of cancer cell lines, but is inactive in the vast majority of human somatic cells 
[137]. This inactivity is due primarily to the transcriptional repression of hTERT in these 
differentiated cells [123]. The hTERT promoter does not have a TATA or CAAT box, but 
instead is highly GC rich [138]. This sequence may form a CpG island near the ATG to 
regulate gene transcription. The promoter also contains an array of motifs that can bind 
different transcriptional repressors and/or activators. In addition, the methylation and 
acetylation status of nucleosomes in the promoter is regulated to alter the chromatin 
structure and subsequently modify the transcriptional state of hTERT (reviewed in [139]).   
 Transcription of hTERT can be activated by a number of transcription factors. The 
oncogene c-Myc heterodimerizes with its binding partner, Max, and binds to E-boxes 
located within the promoter of hTERT to activate transcription [140, 141]. There are also 
GC boxes within the promoter that can recruit SP1, a transcription factor that interacts 
with TATA-box binding protein-associated factors that are important in initiating 
transcription in TATA-less promoters [139]. Mutation of these GC boxes decreased 
transcription of telomerase in vivo [142]. The estrogen receptor and the human papilloma 
virus 16 E6 protein also activates hTERT expression. Estrogen binds to the estrogen 
receptor protein which then binds the estrogen responsive elements found in the hTERT 
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promoter, while the E6 protein interacts with Myc to bind the E-box within the promoter 
to increases transcription [139, 143, 144]. 
 There are a number of factors that repress hTERT expression. As is true at other 
genes, the Mad1/Max heterodimer competes for binding at the E-boxes with the 
Myc/Max heterodimer to repress transcription [145]. Cells that are exiting the cell cycle 
or undergoing differentiation up-regulate Mad1 expression and down-regulate Myc 
expression resulting in a decrease in hTERT mRNA, explaining, at least in part, why 
most differentiated cells have silenced hTERT [139]. p53 inhibits expression of hTERT 
by binding SP1 and preventing it from binding to the promoter [146]. In 2003, Lin and 
Elledge screened for repressors of hTERT expression and discovered a number of factors: 
a tumor suppressor termed Menin; the transcriptional target of TGF-β, SIP1; Rak, a 
protein kinase that interacts with the tumor suppressor Rb; and a novel protein called 
Brit1 were all found to repress hTERT expression [147]. Another tumor suppressor, 
Wilms’ tumor 1 (WT1), binds to the promoter in a sequence specific manner. Mutation of 
WT1 binding sites in the promoter results in increased hTERT (reviewed in [139]).  
 It is interesting to note that the vast majority of genes found to regulate hTERT are 
often categorized as either tumor suppressors or oncogenes, suggesting that these 
pathways are important in hTERT regulation. Additionally, this observation suggests that 
mutation within these genes may directly result in the dysregulation of hTERT in cancers. 
 Epigenetic changes to chromatin, such as methylation and acetylation of histones 
are important in regulating gene expression [148]. Acetylation does seem to play an 
important role in hTERT silencing. As observed elsewhere, an increase in acetylation 
results in an increase in hTERT expression. For example, addition of trichostatin A, an 
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inhibitor of histone deacetylases, to cell culture increases hTERT expression [149]. This 
result is consistent with the fact that Mad1, an hTERT silencer, associates with a histone 
deacetylase [150]. Methylation also modifies hTERT expression. Methylation of histone 
H3 on lysine 9 (H3K9) and histone H4 on lysine 20 (H4K20) are associated with hTERT 
repression, while methylation of histone H3 at lysine 4 (H3K4) is associated with hTERT 
expression [151]. Interestingly, depletion of SMYD3, a histone methyltransferase, 
decreases H3K4 methylation which reduces hTERT mRNA and telomerase activity 
[152]. Conversely, inhibition of LSD1, a lysine-specific demethylase, increases H3K4 
methylation in human fibroblasts resulting in increased hTERT transcription [153]. The 
CpG islands of the hTERT promoter are also methylated (reviewed in [154]). To date 
there have been no recognizable differences between the hTERT promoter methylation 
profile of normal cells versus cancer cell lines or even within different cancer cell lines, 
suggesting that methylation of the DNA may not be a critical regulator of hTERT 
expression [154].  
 In addition to transcriptional regulation, hTERT is post-translationally modified to 
regulate its activity. Phosphorylation of hTERT both positively and negatively regulates 
its activity. Akt kinase and PKC phosphorylate hTERT to activate telomerase activity in 
vitro, while c-Abl, a tyrosine kinase, negatively regulates telomerase activity (reviewed in 
[139]). Overexpression of c-Abl decreases telomerase activity in vivo and cells that lack 
c-Abl not only have increased telomerase activity but also increased telomere length 
[155]. hTERT is ubiquitinated by MKRN1 and targeted to the proteasome for 
degradation when its chaperone, Hsp90, is inhibited from associating with hTERT, 
suggesting that ubiquitination is another level of post-translational control [156]. 
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Trafficking of Telomerase 
 Exactly how hTR and hTERT are localized to the telomere during S phase, the 
phase of telomere extension, remains enigmatic, but recent discoveries have elucidated 
how these components are trafficked in the cell differentially during the cell cycle [157]. 
Both the nucleolus and Cajal bodies are important subnuclear compartments of 
telomerase assembly and maturation. The nucleolus is most notably the site of ribosome 
assembly and RNAs that traffic to nucleoli are termed small nucleolar RNAs (snoRNAs). 
Cajal bodies are important in maturation of spliceosomal components and RNAs that 
traffic here are termed small Cajal body RNAs (scaRNAs) (reviewed in [158, 159]). 
 hTERT is most likely trafficked into the nucleus once it is phosphorylated via the 
PI3K/Akt pathway [160]. Once in the nucleus during G1 and G2 phases of the cell cycle, 
hTERT is found in foci in the nucleoplasm, but not associated with the nucleolus or Cajal 
bodies [157]. As the cell progresses into early-S phase, hTERT localizes to the nucleolus 
and during mid-S phase it is found in foci adjacent to Cajal bodies and no longer co-
localizes with the nucleolus or Cajal bodies [157]. hTR is primarily associated with Cajal 
bodies throughout the cell cycle, though it can also associate with the nucleolus [161]. 
hTR has two specific domains within its 3’-end that regulate its nuclear localization, the 
H/ACA box domain and the CAB domain. The dyskerin complex (dyskerin, GAR1 
NOP10, and NHP2) binds the H/ACA box while TCAB1 binds the CAB domain. 
TCAB1 is a Cajal body specific protein and is thought to be responsible for shuttling hTR 
to the Cajal body [121]. Interestingly hTERT, hTR/Cajal bodies, and a subset of 
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telomeres co-localize during S-phase, suggesting that only a fraction of telomeres are 
elongated each cell cycle [157, 162]. 
 
Telomeres, Telomerase and Human Disease 
 In 1961, Drs. Leonard Hayflick and Paul Moorehead elegantly showed that 
karyotypically normal primary cells, from 25 different cell strains, derived from fetal 
tissues, stopped dividing (or senesced and then died) in culture after ~40-50 generations 
[6]. When the cells were removed from culture and frozen at different generations and 
subsequently thawed and re-initiated to grow, the culture stopped dividing at what would 
have been a total of ~40-50 generations. Drs. Hayflick and Moorehead were never able to 
maintain these cells indefinitely in culture and this result caused a paradigm shift in the 
field of cellular biology. It had previously, albeit erroneously, shown that cells given the 
correct milieu of serum could grow indefinitely in culture. (It has since been 
hypothesized that in this earlier experiment cells were unknowingly contaminated with 
stem cells when harvested). It was Hayflick and Moorehead’s observation that cells have 
a finite number of cell divisions that originally stirred the end-replication hypothesis 
proposed by Olovnikov in 1971. Three decades after Hayflick’s finding, Harley et al. 
found that as mitotically differentiated cells divide, their telomeres become progressively 
shorter (acting as a “mitotic clock”) [163]. The following year Allsopp et al. 
demonstrated that telomere length was a predictor of cellular senescence [164]. These 
three seminal pieces of work established a strong association between telomere length 
and cellular senescence. The following section is dedicated to examining how telomere 
length and telomerase activity may contribute to human disease. 
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Telomere Length of Cultured Cells 
 Telomeres of most differentiated cells shorten with each cell division because the 
transcriptional repression of TERT expression leaves no active mechanism to combat the 
end-replication problem (Figure 1.6) [165]. Consequently, these cells have a limited 
replicative capacity before they undergo cellular senescence. Alternatively, 
undifferentiated human stem cells express low levels of telomerase, which helps maintain 
the telomere, but this regulated expression of telomerase is insufficient to counteract 
telomere attrition, ultimately leading to a decline in tissue renewal (an aging phenotype) 
(reviewed in [166]). Interestingly, germ cells and >85% of cancer cells maintain high 
TERT expression and can maintain telomeres (reviewed in [139]). In germ cells, telomere 
maintenance ensures that progeny begin with sufficiently long telomeres. In cancer cells, 
telomere maintenance is required to induce cellular immortality, a hallmark of cancer. 
The telomere length in cancer cells is generally held at a short, stable length. In the other 
~15% of cancer cells, telomeres are maintained by an alternative method that is 
dependent upon telomere recombination (reviewed in [139]). It is important to note that 
the maintenance or lack thereof, of the telomere, unlike any other DNA structure, is 
linked both to normal cellular aging and cancer formation. As a result, the telomere sits at 
the forefront of understanding some of the molecular mechanisms related to human aging 




















































Figure 1.6 The relationship of telomere length to cellular senescence and aging 
phenotypes. (A) Telomere length (y-axis) changes as cells divide (x-axis) depending on 
telomerase activity. Germ cells (black line) express sufficient levels of telomerase to 
maintain their telomere length through out population doublings. Stem cells (blue line) do 
not maintain sufficient levels of telomerase causing a modest decrease in telomere length 
over the lifetime of the cell. Most somatic cells (red line) are telomerase negative and 
lose telomere length as they divide. In culture, most somatic cells will eventually reach 
the Hayflick limit and trigger a cell-cycle checkpoint arrest, leading to cellular 
senescence. Cells with mutations in p53 or pRb can bypass the Hayflick limit allowing 
them to continue to divide until they reach crisis. Crisis is the point at which telomeres 
are so short that the capping function is lost. This loss ultimately results in chromosome 
fragmentation, vast genomic instability and cell death. A small number of these cells will 
gain the ability to maintain telomeres by either activating telomerase or up-regulating a 
recombination-based pathway of telomere maintenance. These cells are now immortal 
and have the propensity, given that they have undergone such dramatic mutagenesis, to 
become cancerous. Adapted from Shay and Wright, 2006 [167]. (B) Telomere length (y-
axis) decreases as age (x-axis) increases. The telomere length of stem cells (blue lines) 
and somatic cells (red lines) are influenced by defects in telomerase function. Telomeres 
from stem cell populations will decrease more slowly than somatic cells due to greater 
telomerase expression. The lower colored-lines represents the lower telomere-length 
boundary of each cell type due to compromised telomerase expression. The large 
decrease in telomere length diagramed early in life is due to the rapid cellular division 
and turnover that occurs in childhood. As adulthood is reached, cell division reaches a 
more steady state and the slope of telomere attrition is less steep. Individuals who have 
defects in telomerase activity are more likely to reach age-related phenotypes earlier in 
life (the lower boundaries) compared to individuals with wild-type telomerase 
expression. Adapted from Kappei and Londono-Vallejo, 2008 [168]. 
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The Link Between in vivo Telomere Length and Human Disease 
 Once the link between telomere length and cellular senescence (aging) was 
established in cell culture, there was great interest in elucidating if this correlation existed 
in vivo. Large population-based studies in the late 1990’s and early 2000’s established a 
negative (or inverse) correlation between age and telomere length, suggesting that the 
same phenomenon (telomeres shorten with cellular age) also exists within the organism 
(reviewed in [169]). This correlation alone does not mean that telomere shortening causes 
cellular aging or age-related phenotypes. To determine if it is causative, researchers have 
developed mouse models and used human genomics to determine genes involved in 
diseases that greatly perturb telomere maintenance. 
 Laboratory mice begin with extraordinarily long telomeres compared to humans 
or even wild mice, therefore when using them as a model it is important to note that aging 
phenotypes will be delayed a few generations. In TR knockout mice (TR-/-), mice grow 
normally for the first 3-4 generations, revealing that telomerase activity is not required 
for viability. As the mice reach the 5th and 6th generations they show age-related 
phenotypes such as graying fur, skin lesions, decreased tissue renewal in intestine, testes, 
and bone marrow (these are highly proliferating tissues), as well as a shorter life span and 
an increased propensity for precancerous lesions [170]. Reintroduction of TR into TR-/- 
mice rescues these aging phenotypes. Introduction of the TR-/- mutation into wild mouse 
strains with naturally shorter telomeres results in earlier expression of phenotypes, 
suggesting that short telomeres do influence aging phenotypes [170]. In this same study, 
telomere maintenance in mice heterozygous for TR (TR+/-) was also compromised and 
had phenotypic consequences, although those phenotypes were delayed by several 
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generations compared to the TR-/- mice. This result suggests that loss of one TR allele 
causes haploinsufficiency. The strongest evidence in this system that telomere shortening 
alone can cause disease is that genotypically wild-type progeny that are offspring from 
later generation heterozygotes (and thus start with short telomeres) also develop disease 
phenotypes. Since these mice have normal telomerase expression but very short 
telomeres, the authors convincingly argue that it is the short telomere and not the lack of 
telomerase activity per se that gives rise to the disease state [170]. 
 Dyskeratosis Congenita (DC), Aquired Aplastic Anemia (AAA) and Idiopathic 
Pulmonary Fibrosis (IPF) are three telomerase spectrum diseases recently discovered to 
be caused, at least in some cases, by mutations in telomerase components or telomere 
capping genes (reviewed in [171]). The telomere lengths in these patients are generally 
(though not always-as in some AAA patients) much shorter than their age-matched-
control subjects. DC is the more severe telomerase-deficiency related disease compared 
to AAA or IPF and patients tend to present symptoms earlier in life. Population studies of 
DC patients have identified mutations in dyskerin, NOP10, NHP2, TIN2, TR and TERT, 
all genes involved in telomere maintenance (reviewed in [171]). DC has a spectrum of 
phenotypes related to it that may include, but are not limited to: bone marrow failure, nail 
dystrophy, oral leukoplasia (a precursor for oral carcinomas) and predisposition to cancer 
[171]. Additionally, families with DC show genetic anticipation, an associated 
phenomenon in which disease symptoms appear earlier in each subsequent generation. 
This phenomenon is expected in DC as each generation begins with shorter telomeres. 
 AAA is a less severe telomerase spectrum disease that can be genetically inherited 
or induced through exposure to environmental agents or drugs such as benzene or 
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chloramphenicol that give rise to an immune-mediated bone marrow failure. Patients with 
AAA typically present symptoms later in life compared to DC patients. Mutations in 
TERT have been found to be associated with AAA in some patients [172]. 
Approximately 33% of patients with AAA have short telomeres and those with short 
telomeres do not respond well to the typical immunosuppressive treatment (reviewed in 
[171]). 
 IPF is also a less severe telomerase spectrum disease compared to DC that 
presents later in life. It can be inherited in families or occur sporadically by mutation in 
either TR or TERT. Pedigrees affected by IPF often show phenotypes similar to DC and 
patients have short telomeres. The development of IPF is influenced by environmental 
factors such as smoking, which might explain why the disease shows variable penetrance 
(reviewed in [171]). 
 Werner’s Syndrome (WS) is a premature-aging disease that also affects telomere 
length, though the mechanism affecting telomeres is unknown. WS is caused by 
mutations in the WRN gene, which encodes a RecQ Family DNA helicase that plays a 
role in DNA replication, repair, and recombination and is particularly important in the 
restart of stalled replication forks (reviewed in [168]). The main phenotypes associated 
with WS are: short stature, early graying, formation of early cataracts and early death 
(40-50 years old) resulting from cancer or heart disease. Interestingly, studies have 
demonstrated a strong inverse correlation between telomere length and cardiovascular 
complications in this disease (reviewed in [168]). 
 These are the diseases in which changes in telomere length are most directly 
linked with aging or disease-phenotypes. Intriguingly, TERT mutations have been 
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reported for DC, IPF and AAA, but there does not appear to be any correlation between 
either the site of mutation within the protein or the extent to which telomerase activity is 
affected in these patients. Furthermore, different diagnoses can occur in the same family 
where the same mutation of TERT is segregating, suggesting that there must be other 
factors influencing the disease phenotype. Additionally, it is interesting that these 
diseases share some phenotypes but are also extremely varied, begging the question of 
why diseases that negatively affect telomere length give rise to such variation in disease 
presentation? The answer is likely due to multiple reasons: (1) Mutations within some 
proteins such as dyskerin, NOP10, NHP2, and WRN most likely disrupt multiple 
pathways in the cell in addition to telomere maintenance, which could instigate variable 
phenotypes. (2) The genetic environment may influence how a particular mutation affects 
the phenotype. (3) Environmental differences may explain a considerable amount of the 
variation, as smoking, obesity, stress and sex-hormones, exercise, diet and even marriage 
status have all been shown to influence telomere length [173-179]. Therefore, 
environmental pressures may negatively or positively impact telomere length, resulting in 
differential disease states. 
 It is and will be challenging to concretely establish that telomere shortening 
causes normal aging and its related diseases, as it is difficult to distinguish between cause 
and effect. However, given the above spectrum of premature aging diseases, the genetic 
anticipation in DC patients, and the data observed from mouse models, it does seem 
certain that telomere length is an important factor influencing health and longevity. 
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 Telomere Maintenance in Yeast 
 The budding yeast, Saccharomyces cerevisiae, is an excellent model system for 
the study of telomeres and telomerase as yeast maintain their telomeres similarly to 
mammals and telomerase actively elongates telomeres during every S-phase of the cell 
cycle. Because telomerase is active in yeast, the yeast cell, at least at the level of 
telomerase assembly and function, is somewhat analogous to a cancer cell. These 
characteristics allow investigators to address fundamental questions regarding telomere 
structure and maintenance and telomerase assembly and function in a tractable system 
that can directly impact the research in the human cancer and telomerase fields.  
 
The Cell Cycle Regulated Assembly of Telomerase Components 
 Telomerase activity is confined to late S phase and G2/M, implying that there is a 
mechanism(s) restricting activity to these phases [180, 181]. Interestingly the telomere 
structure in yeast changes during the cell cycle. In G1 and G2/M phases, the telomeric 
overhang is ~12-14 nucleotides long, whereas the overhang in S phase is > 30 nucleotides 
[25, 182]. The length of the overhang is not determined by telomerase since deletion of 
Est2 does not alter the single-stranded telomere segment in the cell cycle [24]. It is 
instead regulated by the yin-yang relationship between capping proteins, Cdc13-Stn1-
Ten1 (CST complex), Rap1 and Ku70/80 and exonucleases, Exo1 and Mre11 (reviewed 
in [183]). In G1, capping by both Ku70/80 and Rap1 are important in limiting nucleolytic 
cleavage of the 5’-strand, while the CST complex is essential in S phase for the same 
function [184, 185]. 
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 In the early 2000’s, Dr. Virginia Zakian’s group began detailing the temporal 
association of telomerase components with the telomere using chromatin 
immunoprecipitation (ChIP). Cdc13, though not an integral member of the complex, is an 
essential single-stranded telomeric binding protein and is important in recruiting 
telomerase to the telomere [186-189]. It associates with the telomere in S-phase, 
coincident with the increase in the single-stranded 3’-overhang [190]. In G1, both Est2 
and TLC1 (the catalytic core of yeast telomerase) are bound to the telomere through an 
interaction with the double-stranded DNA binding protein, Ku70/80 [191]. As cells move 
into S phase, the association of Est2 and TLC1 with the telomere is decreased and peaks 
again in late-S phase, the time of telomere replication [190]. The Est1 protein (a 
telomerase accessory protein) levels are very low in G1 precluding it from telomere 
association, but as the cell moves into late-S phase, Est1 protein levels are higher and it 
can be detected at the telomere by ChIP, presumably due to its interaction with Cdc13p 
[190, 192]. Importantly, low Est1 protein levels alone do not restrict telomerase activity 
at the telomere in G1, since stabilization of Est1 in G1 using MG132 is not sufficient to 
promote telomere elongation, even though Est1 associates with Est2 under these 
conditions in G1 [192]. This finding supports the idea that there is a mechanism 
restricting telomere elongation to S phase. The association of Est3 (another telomerase 
accessory protein) with the telomere throughout the cell cycle has recently been 
elucidated and it generally mimics the Est1 profile [193]. In addition to having a peak of 
telomere association in late-S phase it also has a very small peak in G1, suggesting that 
Est3 can assemble with the telomere, at a low level, in the absence of Est1 [193]. This 
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Est3 assembly is presumably through Est2 as it is not thought that Est3 binds to telomeric 
DNA independent of the other telomerase components [194, 195]. 
 
Telomere Length Regulation 
 There are a number of positive and negative regulators of telomere length whose 
interactions are dynamically orchestrated to ensure that telomeres in yeast are maintained 
within a set average length. Telomere length homeostasis is ultimately a balance between 
activities that deplete telomeric DNA (incomplete replication and nucleolytic processing 
of the telomere) and addition of telomeric DNA by telomerase. Interestingly, the actual 
length of each individual telomere is important in regulating telomere addition in cis. A 
long telomere restricts telomere addition (unextendible), while telomerase generally acts 
upon a shorter telomere (extendible) [196]. This phenomenon is due to a telomere length 
“counting” mechanism regulated by Rap1 and its interacting partners Rif1 and Rif2 
(discussed below) [197]. 
 Maintenance of the telomere can be broken down into four general steps: (1) 
replication of the telomere, (2) nucleolytic processing the 3’-end, (3) telomerase-
mediated elongation and (4) “fill-in” synthesis by the lagging strand replication 
machinery. DNA replication is important for proper telomere processing and telomere 
elongation [181, 198]. Deletion of the DNA replication origin on a linear yeast plasmid 
inhibited processing of the 3’-end of the telomere [198]. In 2000 Marcand et al. observed 
that removal of an origin on a yeast minichromosome disrupted telomere elongation, 
while strains that retained the origin maintained and elongated their telomeres, suggesting 
that DNA replication and telomere elongation are linked [181]. A recent publication from 
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the Shore lab elegantly showed that the timing of origin firing is strongly correlated with 
the extent of telomere elongation [199]. When a late firing origin located near (~1 
kilobase upstream) the telomere is replaced with an early firing origin, telomere length is 
increased over wild type (on that chromosome only). Inversely, if an origin many 
kilobases upstream (~20) of the telomere is used to replicate the telomere, telomere 
length is significantly shorter than wild type. These data strongly support the idea that 
replication of the telomere is important for telomere elongation. Why might DNA 
replication and telomere elongation be strongly linked? One possibility is that the 
heterochromatic state of the telomere needs to be disrupted to allow telomere elongation. 
It is also conceivable that as the replication fork passes through the telomeric DNA, 
Cdc13p binds to the single-stranded DNA (similar to RPA in other regions of DNA), 
increasing the pool of Cdc13p near or at the telomere thereby stimulating telomerase 
recruitment [200]. 
 Telomerase can only extend a 3’-single-stranded telomeric DNA substrate [93]. 
Therefore the telomere product of leading-strand synthesis (a blunt end) must be resected 
or processed before telomerase can act. Not all of the nucleases involved in telomere 
processing are known, but Exo1 and Mre11 (a member of the MRX complex: Mre11-
Rad50-Xrs2; analogous to MRN in higher eukaryotes) are key players. Deletion of Exo1 
suppresses the temperature sensitive phenotype in yeast strains with elongated ssDNA 
overhangs resulting from defective telomere capping, suggesting that in the absence of 
Exo1 the telomere is not degraded as readily [201]. Deletion of Mre11 in yeast cells 
decreases the telomeric overhang throughout the cell cycle and inhibits telomerase 
activity in vivo, revealing an important role for Mre11 in telomere processing [25, 202]. 
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While nucleolytic processing of the telomere is required, it also could be detrimental 
since a large amount of single-stranded DNA triggers a cell-cycle checkpoint arrest. As a 
result, telomere resection must be highly regulated. Proteins involved in telomere capping 
are important in regulating the extent of resection, although the mechanism of this 
inhibition is poorly understood (reviewed in [183]). 
 As mentioned above, passage of the replication fork and telomere processing are 
important for telomere elongation, but once these processes are completed, how is 
telomerase recruited to the telomere? Once the telomere is processed, Cdc13 and its 
associated proteins, Stn1 and Ten1, most likely bind the long G/T rich 3’-overhang to 
protect the telomere from extensive nucleolytic degradation (Figure 1.7). The Cdc13 
protein may be post-translationally modified (perhaps phosphorylation by the cyclin 
dependent kinase) to recruit the telomerase complex (reviewed in [183]). Interestingly, 
the initiation of telomere elongation appears to be dependent, at least in part, on the Rif1 
and Rif2 proteins (Figure 1.7). Deletion of either protein increases the frequency but not 
the extent of telomere elongation events, suggesting that their normal role is to restrict 
telomerase association with the telomere [196]. In vivo, yeast telomerase appears to add 
repeats in a non-processive manner [203]. As a result, after telomerase replicates the 
RNA template region, it dissociates from the telomere and either the same or a different 
complex may re-associate. The lagging-strand polymerase machinery may regulate the 
extent of telomere elongation. The catalytic subunit of polymerase alpha, Pol1, and an 
accessory protein Pol12 interact with Cdc13 and Stn1, respectively [204, 205]. These 
interactions have been hypothesized to limit telomerase access to the telomere since Stn1 







































Figure 1.7 The telomere is processed to recruit telomerase. Briefly, the 
Mre11/Rad50/Xrs2 (MRX) complex along with Tel1p processes short telomeres. Cdc13p 
binds to the overhang and recruits the capping proteins Stn1 and Ten1 (together the CST 
complex). Cdc13p is phosphorylated by the Cyclin Dependent Kinase (CDK) to enhance 
recruitment of telomerase to the telomere through its interaction with Est1. Telomerase 
extends the 3’-overhang by catalyzing the addition of nucleotides. Polymerase alpha-
primase competes with telomerase for binding to Cdc13p and inhibits telomerase action 
at the 3’-end. This figure was modified slightly from Shore and Bianchi, 2009 [183]. 
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exact mechanism for how the CST complex and telomerase complex compete for 
telomere binding is unclear, but may be regulated by post-translational modifications to 
the Cdc13 protein (reviewed in [183]). 
 Telomere length in yeast is maintained between ~250-300 base pairs and 
interestingly, only ~6-8% of wild-type telomeres each cell cycle are elongated, most 
being short telomeres [196]. This begs the question; how does telomerase recognize short 
telomeres? There are a number of different protein complexes at the telomere, one such 
complex is the Rap1/Rif1/Rif2 complex. Rap1 binds the double-stranded portion of the 
telomere and dictates the extendibility of the telomere [197]. When the number of Rap1 
molecules is artificially increased at the telomere there is a concomitant and dose-
dependent decrease in the length of that telomere, revealing that Rap1 acts in cis to 
negatively regulate telomere length [197]. A C-terminal region of Rap1 interacts with 
Rif1 and Rif2, to negatively regulate telomere elongation, in part, through the Tel1 
protein (reviewed in [183]). It is thought that the amount of Rif2 (low at a short telomere 
and high at a long telomere) dictates whether Tel1 can bind to the telomere. Indeed, Tel1 
preferentially binds short telomeres, as assessed using chromatin immunoprecipitation 
(ChIP) and this preference is eliminated upon deletion of RIF2 [206]. This result suggests 
that Tel1 can discriminate between the levels of Rif2 at the telomere. Tel1 may sense 
Rif2 levels through its interaction with Xrs2, a member of the MRX complex [207]. The 
Xrs2 protein can also interact with Rif2 but how this interaction may regulate the 
association of Tel1p with the telomere is not understood. Additionally, the Rif1 and Rap1 
proteins can negatively regulate Tel1 and the MRX complex, respectively, but again the 
exact inhibitory relationships have not yet been well described [207]. Overall, it appears 
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that low levels of Rif2 at the telomere may bias Tel1 binding to short telomeres. 
Interestingly, the telomerase proteins Est1 and Est2 also preferentially bind short 
telomeres and this preference is dependent upon Tel1 [208]. Therefore, though the exact 
mechanism of telomere length control is not completely understood, it does appear that 
the Tel1 protein along with Rap1, Rif1, Rif2 and the MRX complex are playing very 
important roles. 
  
Yeast Telomerase Components 
 Drs. Greider and Blackburn first measured the enzymatic function of telomerase 
in 1985 in the ciliate Tetrahymena thermophila [16]. Then in 1989 the first gene involved 
in telomerase function was identified; it was termed EST1 for the Ever Shorter Telomere 
phenotype it elicited when deleted or mutated [209]. Three other EST genes, EST2-EST4, 
were identified in 1996 and the RNA template (Telomerase Component 1 or TLC1) was 
characterized in 1994 in budding yeast, establishing S. cerevisiae as a leading genetic 
model system for telomere and telomerase research [90, 210]. 
 As with humans, the TERT subunit, EST2, and the RNA template subunit, TLC1, 
are sufficient for in vitro telomerase activity in yeast [211, 212]. Both Est1 and Est3 co-
purify with telomerase from yeast extract but deletion of either gene from yeast strains 
does not prevent telomerase activity in vitro, therefore, EST1 and EST3 are thought to 
play accessory or regulatory roles in vivo [211, 213]. EST4 was later determined to be a 
separation-of-function allele of CDC13 [214]. The Cdc13 protein is not considered a 
member of the telomerase complex as it does not co-purify with telomerase activity from 
yeast extract and Cdc13p cannot co-purify subunits of the telomerase complex from yeast 
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[213]. The essential function of Cdc13p is to cap the 3’-overhang of the telomere and 
protect it from nucleolytic degradation [189, 215]. A mutation of CDC13 was isolated in 
the EST genetic screen due to its other role in telomerase recruitment via an interaction 
with Est1 [186, 200]. 
 Est2 is the evolutionarily conserved telomerase reverse transcriptase subunit. In 
yeast, Est2 has a conserved N-terminus that consists of four regions. The most N-terminal 
is termed the TEN (Telomerase Essential N-terminus) domain and is thought to 
contribute to the assembly of the accessory components Est1 and Est3. Alanine-block 
mutations within this domain phenocopy deletions of either EST1 or EST3 [98]. The TEN 
domain is also important for anchoring telomerase to the DNA substrate by the so-called 
anchor site and regulating telomere length, as some mutations within this domain result in 
longer-than-normal telomeres [95, 216-218]. The other three regions are termed Region 
II, Region III and the T-motif; the latter two are critical for proper TLC1 binding, but the 
function of Region II is unknown (See Figure 1.5 for graphical representation) [98, 100]. 
The canonical reverse transcriptase domain is located centrally in Est2 (immediately C-
terminal to the T-motif) and there is a C-Terminal Extension (CTE) that is thought to be 
the “thumb” domain of the reverse transcriptase. In yeast, this region is non-essential 
since the cells can survive, albeit with short telomeres, without most of the CTE [85, 98]. 
 TLC1 contains the RNA template for the telomerase complex [90]. It is 
transcribed in yeast by RNA polymerase II and it has both a 5’-2,2,7 trimethyl-guanosine 
(TMG) cap and polyadenosine tail. At least two forms of the RNA exist in cells: a 
precursor, telomerase-unbound, polyadenylated form and a mature, telomerase-bound, 
depolyadenylated form [219]. The RNA has non-overlapping binding sites for Est1 and 
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Est2 in the central region of the RNA. As with components of the splicing machinery, 
TLC1 is considered a small nuclear RNA (snRNA) because the heptameric Sm protein 
complex binds to the 3’-end of TLC1 and is important for its maturation [219, 220]. The 
Sm proteins are retained in the active telomerase holoenzyme since immunoprecipitation 
of Sm proteins co-purifies telomerase activity. Because the heptameric Sm protein 
complex binds TLC1 it is considered an snRNA. TLC1 also has a binding site for the 
Ku70/80 heterodimer that is required for localization of telomerase to the telomere in G1 
phase [191, 221]. The RNA in yeast is much longer than the template RNA in human 
(~1,300 bp versus ~500 bp, respectively) (reviewed in [97]). The variation in size 
between different organisms may be due, in part, to variability in the number and identity 
of protein interaction partners. Interestingly, a mini-TLC1 (500 bp) that has been 
modified to remove RNA regions that are not involved in protein interactions retains 
enzymatic function. However, cells expressing mini-TLC1 have reduced fitness 
compared to cells with wild-type TLC1. This result suggests that the intervening regions 
of TLC1, though not essential, do contribute to function, perhaps by providing structural 
support or appropriate spacing and/or flexibility between protein-binding molecules 
[212]. 
 Est1 is an accessory protein that recruits telomerase to the telomere through an 
interaction with the ssDNA binding protein Cdc13p. When Cdc13p is fused to Est2 (the 
catalytic subunit) yeast cells can survive without Est1, but die in the absence of Est3. 
This genetic result strongly suggests that the normal function of Est1 is to recruit 
telomerase to the telomere [188]. Interestingly, in wild-type yeast cells when Cdc13 and 
Est2 are fused, telomeres become hyper-elongated due to increased telomerase 
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recruitment at the telomere. If the only function of Est1 is to recruit telomerase to the 
telomere then deletion of EST1 should not appreciably affect telomere maintenance. 
Strikingly, deletion of EST1 from these cells results in a shorter than wild-type telomere 
phenotype, suggesting that Est1 has, at minimum, two functions at the telomere and that 
the second function is only partially rescued by the Cdc13-Est2 fusion. Our lab suggests 
that this function is stimulating the recruitment of Est3 to the complex. The observation 
that over-production of Est1 results in a concomitant increase in the association of Est3 
with telomerase supports this hypothesis [192]. Not only is Est1 sufficient for Est3 
recruitment, it is also necessary because deletion of EST1 precludes Est3 assembly with 
the complex [192]. Est1 assembles with TLC1 independent of Est2 via a specific 
interaction with a bulge stem structure within the central region of TLC1 [220, 222]. It 
can also bind single-stranded RNA or DNA telomeric substrates in vitro and was recently 
shown to stimulate telomerase activity in vitro [223, 224]. Since the telomere is rich in 
guanosine, higher-order DNA structures, such as G-quadraplexes are hypothesized to 
form in vivo. The Est1 protein has been shown to stimulate G-quadraplex formation in 
vitro and mutations that disrupt this activity result in cellular senescence in vivo [225]. 
This result suggests that Est1 may function to stimulate telomere addition by modifying 
the structure of telomeric DNA. 
 Est3 is a 21kDa protein that has structural similarity to the mammalian shelterin 
protein TPP1, which is important in capping the telomere and is a processivity factor for 
telomerase activity [33, 226, 227]. Indeed, it has very recently been demonstrated that the 
Est3 protein in a closely related yeast species, Saccharomyces castelli, influences the 
processivity of telomerase in vitro, suggesting that it might be functionally related to 
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TPP1 [194]. Est3 has been suggested to have non-sequence specific helicase activity in 
vitro, although the possibility of a contaminating function remains since no mutation 
tested disrupted the unwinding activity [228]. More recent data using Nuclear Magnetic 
Resonance (NMR) uncovered no Est3 peak shifts upon titration of DNA oligos, raising 
doubt about the ability of the S. cerevisiae protein to bind DNA [194, 228]. Est3 can 
multimerize in vitro and addition of magnesium appears to stimulate multimerization 
[229-231]. However, the significance of potential Est3 multimerization for its function in 
vivo is unknown. Indeed, immunoprecipitation using differential tagged alleles of EST3 
was unable to detect Est3 multimerization in cell extract (Robin Bairley, unpublished 
data). 
 Two forms of Est3 are translated in vivo: a small 92 amino acid protein resulting 
from an in-frame stop codon and the telomerase-bound, full-length Est3 protein (181 
amino acids) that results from a programmed +1 translational frameshift at a rare serine 
codon [232]. At steady-state, the smaller form constitutes ~75% of the total Est3 protein 
in the cell [232]. To date, there is no known function for the truncated Est3 protein. 
Deletion of the rare codon, to ensure only the full-length protein is made in vivo, yields 
no measurable mutant phenotype associated with telomere maintenance or cellular 
viability [232]. 
 
Significance of This Study 
 Striving to gain greater knowledge of natural processes is a method of seeking 
truth, while working toward understanding the fundamental mechanisms underlying 
cellular processes is important for appreciating and respecting the environment and life. 
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Often these discoveries can improve the length and quality of life for individuals. 
Specifically the study of telomeres and telomerase is proving to be critical in 
understanding the finite nature of tissue renewal (aging) and the establishment and 
persistence of cancer and other age-related diseases. 
 Studying fundamental processes is often more simply accomplished and less 
expensive in lower eukaryotes. Due, in part, to evolutionary constraint, many of the 
cellular mechanisms discovered in more simple organisms are frequently conserved in 
humans. Consequently, our lab studies telomere biology in the genetic model system, 
Saccharomyces cerevisiae. In Chapter II, I demonstrate that the telomerase accessory 
protein Est1 is degraded in G1 phase of the cell cycle in a manner dependent upon the 
proteasome. This finding has contributed significantly to our understanding of telomerase 
assembly and activity in the cell cycle. Chapter III focuses on elucidating an interaction 
that is important for the assembly of Est3 with telomerase and finally in Chapter IV, I 
uncover a function for Est3 in telomerase activity. Both of these findings regarding the 
Est3 protein are the first to establish an in vitro assay for determining how Est3 
assembles with components of telomerase and show that Est3 does contribute to 
telomerase activity in S. cerevisiae. 
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 CHAPTER II 
 
THE EST1 PROTEIN IS DEGRADED IN G1 PHASE OF THE CELL CYCLE IN 
A PROTEASOME-DEPENDENT MANNER1 
 
Introduction 
 The action of telomerase in Saccharomyces cerevisiae is regulated in the cell 
cycle. The enzyme does not extend telomeres in G1 phase, but acquires that capability in 
late S phase and G2 phase of the cell cycle [180, 181]. The catalytic core of the complex 
(Est2 and TLC1 RNA) is bound to the telomere in G1 through an interaction of the TLC1 
RNA with the yKu70/80 heterodimer [191]. Its association with the telomere dips in early 
S phase and then peaks again in late S/G2 phase [190]. The accessory protein Est1 is not 
detected at the telomere in G1, but does peak in late S/G2 phase, concurrent with both the 
presence of the catalytic core and telomere elongation [190]. The association of Est3 with 
the telomere was recently shown to also be regulated in the cell cycle, with a very minor 
peak in G1 and a strong peak of association in late S/G2 phase, concomitant with both the 
Est1 and Est2 peaks [193]. 
 The assembly of the telomerase complex is also cell cycle regulated. Both Est1 
and Est3 co-purify with Est2 in G2/M-blocked cells, but neither protein co-purifies with 
Est2 in G1 [192]. Interestingly, the modest association of Est3 with the telomere during 
G1 phase suggests that there may be some residual interaction between the catalytic 
                                                
1 This chapter represents my contribution to the published work: [192] Osterhage, J.L., 
J.M. Talley, and K.L. Friedman, Proteasome-dependent degradation of Est1 regulates 
the cell cycle-restricted assembly of telomerase in Saccharomyces cerevisiae. Nat Struct 
Mol Biol, 2006. 13(8): p. 720-8. 
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subunit and Est3 [193]. Overall, these data suggest that the Est1 and Est3 proteins are 
primarily precluded from telomerase assembly in G1, but are competent for assembly in 
S phase, begging the question: what is precluding these components from assembly in 
G1? The EST3 RNA does not appear to vary during the cell cycle and Est3 protein levels 
are constant throughout [192, 233]. In contrast, the levels of EST1 RNA are modestly 
reduced in G1 phase when compared to G2 phase (~ three-fold reduction), but the protein 
levels are reduced by greater than four-fold, suggesting that in addition to modest 
transcriptional regulation, the Est1 protein may also be degraded more rapidly during G1 
phase [192, 234]. Interestingly, over-expression of Est1 stimulates the association of Est1 
with Est2 in G1 phase, implying that Est1 protein levels account, at least in part, for 
regulated assembly [192]. In addition, Est3 assembly with telomerase is dependent upon 
Est1 as deletion of EST1 reduces Est3 association with the catalytic core while over-
production of Est1 stimulates Est3 binding to the complex [192]. These results suggest 
that Est1 is a critical determinant of telomerase assembly in G1 phase and further suggest 
that Est1 stability during G1 phase may play an important role in the regulation of 
telomerase assembly and/or activity.  
There are two major pathways of protein degradation in yeast cells: the lysosome 
and its associated proteases and the ubiquitin-proteasome system. The proteasome is an 
important regulator of protein stability and is often involved in cell cycle regulation of 
protein abundance (reviewed in [235, 236]). Ubiquitin is a 76 amino acid protein moiety 
that is covalently attached to one or more lysine residues of proteins targeted for protein 
trafficking, cell signaling, or proteolysis [236]. There are a number of steps involved in 
marking a protein with ubiquitin. First, ubiquitin is activated by the E1 activating 
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enzyme. Second, the ubiquitin moiety is transferred to the E2 ubiquitin-conjugating 
enzyme and finally, an E3 ligase covalently attaches ubiquitin to the targeted lysine 
residue on the protein of interest. There are two types of ubiquitination: mono-
ubiquitylation and poly-ubiquitination.  Mono-ubiquitylation is typically involved in cell 
signaling and protein trafficking, while poly-ubiquitination usually results in the 
proteasome-dependent degradation of proteins (reviewed in [237]). 
Because Est1 is not at the telomere or associated with the catalytic core in G1 
phase and because its protein abundance is extremely low in G1 phase relative to other 
phases of the cell cycle, I hypothesized that the Est1 protein is specifically degraded in 
G1 phase of the cell cycle. To test this hypothesis, I monitored the half-life of the Est1 
protein in G1-blocked cells. Consistent with a role for protein degradation, the half-life of 
Est1 during G1 phase is markedly shorter than during G2/M. Finally, I determined that 





The half-life of Est1 is lower in G1-blocked cells compared to G2/M-blocked cells 
 To analyze Est1 stability in the cell cycle, I used cells deleted for EST1 at the 
endogenous locus and complemented by a plasmid-borne HA3-EST1 allele under control 
of the galactose-inducible GAL1 promoter. Use of an inducible-promoter system 
facilitates the determination of protein half-life by allowing gene expression to be turned 











Figure 2.1 HA3-Est1 stability is decreased during G1 phase. (A) The half-life of Est1 
is decreased in G1-arrested cells. Cultures of strain YKF332 (Myc9-EST2 EST3-HA3 
bar1::URA3) containing plasmid pVL242 (GAL1-HA3-EST1 LEU2) were arrested with 
alpha factor (G1; lanes 3-5) or nocodazole (G2/M; lanes 6-8) in medium containing 
galactose. Glucose was added at time 0 to repress EST1 transcription. Protein extracts 
were prepared from cells harvested at the indicated times after glucose addition and 
analyzed by Western blotting with anti-HA and anti-Arf1p antibodies. Extracts prepared 
from asynchronous cultures of AVL78 (untagged; lane 1) and TVL288 (HA3-EST1; lane 
2) are included as negative controls. Note that expression of endogenous HA3-Est1 (lane 
2) is below the detection limit of this experiment. (B) EST1 mRNA shows increased 
stability in G1-arrested cells compared to G2/M-arrested cells. RNA was isolated from 
the identical extracts shown in (A) (lanes 3-8) and analyzed by Northern blotting with 
EST1 and U1 radiolabeled probes (shown in lanes 3-8). RNAs isolated from strain 
YKF332 (Myc9-EST2 EST3-HA3 bar1::URA3) containing plasmid pVL242 (GAL1-HA3-
EST1 LEU2) grown with (lane 1) or without (lane 2) induction are included as controls.  
The upper band is of the size expected for HA3-EST1 expression. At this exposure, 
endogenous EST1 transcript is not detected (lane 2). Results shown in (A) and (B) are 
representative of two independent experiments. 
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arrested with alpha factor (G1-block) or nocodazole (G2/M-block). Glucose was added 
(time zero) to repress HA3-EST1 expression once greater than 95% of the cells were 
arrested in the appropriate cell-cycle phase. Markedly, HA3-Est1 is virtually undetectable 
two hours after the addition of glucose in G1-arrested cells (Figure 2.1a, lanes 3-5), while 
the Est1 protein persists for at least four hours (the length of the experiment) in G2/M-
arrested cells (Figure 2.1a, lanes 6-8).  Interestingly, as expected if the protein is rapidly 
degraded in G1 phase, the steady-state levels of HA3-Est1 were lower at time zero in cells 
arrested in G1 phase with alpha factor than in those arrested in G2/M with nocodazole 
(Figure 2.1a, lanes 3 and 6). 
 Since it had previously been demonstrated that EST1 RNA levels are modestly 
reduced (~ 3 fold) in G1 phase compared to G2/M phase, I wanted to ensure that the 
differences in protein levels were not due to differences in the persistence of the EST1 
mRNA following inhibition of transcription by glucose addition [192, 234]. Therefore, 
the identical samples used in Figure 2.1a were monitored for levels of EST1 mRNA by 
Northern blot. Intriguingly, the EST1 mRNA is more stable in G1-blocked cells than in 
cells arrested in G2/M, opposite to the trend observed for the HA3-Est1 protein (Figure 
2.1b).  Together, these data support the hypothesis that the Est1 protein is turned over 
more rapidly during G1 phase compared to G2/M. 
 
Degradation of Est1 in G1 phase of the cell cycle is dependent upon the proteasome 
 
 During the course of analysis, it was discovered that a consensus destruction box 
sequence (D-box: RxxLxxxxN) was created when the HA-epitope tag and was cloned at 
the N-terminus of Est1 [238]. D-boxes are known to target proteins to the proteasome in a 
 57 
cell-cycle dependent manner via recognition by the anaphase promoting complex (APC), 
an E3 ubiquitin ligase [239]. To eliminate concerns that this sequence was contributing to 
Est1 protein degradation, I mutated the highly conserved arginine residue to alanine and 
found no obvious change in Est1 stability using an assay similar to that shown in Figure 
2.1 (data not shown). This version of HA3-Est1 was used in future experiments. 
 To obtain an accurate estimate the half-life of the Est1 protein and to eliminate 
any confounding effects of mRNA stability, I modified the above promoter shut-off 
assay. Cells were initially grown to mid-log phase in media containing 2% raffinose to 
ensure that the GAL1 promoter was neither stimulated (galactose) nor repressed 
(glucose). Cultures were arrested in G1 or G2/M phases as described previously. Once 
the cells were arrested, 2% galactose was added to induce transcription of HA3-EST1 for 
one hour. After the one-hour incubation, glucose and cycloheximide were added (time 
zero) to prevent both transcription of EST1 mRNA and new protein synthesis. In G1-
arrested cells, HA3-Est1 has a half-life of 15-30 minutes and is not detected by 60 
minutes (Figure 2.2a, lanes 2-7). In contrast, cells blocked in G2/M phase maintain a 
detectable level of HA3-Est1 for at least 120 minutes (Figure 2.2a, lanes 9-14).  I 
conclude that Est1 degradation is accelerated during G1 phase when compared to G2/M. 
 The yeast strain used in these experiments is deficient in vacuolar proteases. 
Therefore, I hypothesized that the ubiquitin-proteasome system could be responsible for 
Est1 protein degradation in G1 phase. MG132 is a drug that reversibly binds to and 


















Figure 2.2 Inhibition of the proteasome by MG132 stabilizes HA3-Est1 in G1. 
(A) Half-life of HA3-Est1 monitored in the presence of cycloheximide. Cultures of strain 
YKF333 (Myc9-EST2 EST3-HA3 bar1::URA3 erg6::kanMX6) containing plasmid 
pVL242RtoA (GAL-HA3-EST1RtoA LEU2) were arrested with alpha factor (G1; lanes 2-
7) or nocodazole (G2/M; lanes 9-14). Following galactose induction, glucose and 
cycloheximide were added (time 0), and cells were harvested at the indicated times.  
Samples were analyzed by Western blotting with antibodies against the HA epitope tag 
and actin. Lanes 1 and 8 contain extract from an uninduced control strain. (B) 
Stabilization of HA-Est1 in G1 phase after the addition of MG132. Identical to (A), 
except that MG132 was added at time 0 in addition to glucose and cycloheximide. All 






degradation [240]. To assess the contribution of the proteasome to Est1 protein 
degradation, the promoter shut-off strategy described above was used. MG132 was added 
at time zero in addition to glucose and cycloheximide to inhibit the proteasome. Because 
yeast cell walls are not normally permeable to MG132 (a cation), ERG6 was deleted to 
increase cell permeability [240]. Strikingly, addition of MG132 to G1-arrested cells 
stabilizes HA3-Est1 abundance out to 120 minutes (Figure 2.2b, lanes 2-7), while 
treatment of G2/M-arrested cells with MG132 had little effect (Figure 2.2b, lanes 9-14). 
These results demonstrate that proteasome function is required for HA3-Est1 degradation 
during G1 phase of the cell cycle. 
 
Discussion 
 These data support the hypothesis that Est1 protein levels are reduced during G1 
phase due to regulated degradation. How and why the Est1 protein is degraded is unclear. 
It could be targeted to the proteasome directly by ubiquitination, or alternatively, it might 
be targeted indirectly. If Est1 is a direct target of the proteasome, it is most likely 
ubiquitinated. To date our lab has not been able to demonstrate that Est1 is itself 
ubiquitinated, thus it is possible that the effect on Est1 stability is indirect. For example, a 
protein that is itself a direct proteasome target during G1 phase may normally be required 
to stabilize Est1 throughout the cell cycle. I favor the hypothesis that Est1 is targeted to 
the proteasome by ubiquitination, potentially by the Anaphase Promoting Complex 
(APC). The APC is a large, cell cycle regulated, E3 ubiquitin ligase that targets specific 
proteins such as S/M phase cyclins for degradation during a period from anaphase to the 
following G1 phase [239]. The APC is activated by two separate proteins, Cdc20, an 
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early APC activator (anaphase to the completion of mitosis), and Cdh1, the G1 activator 
(reviewed in [241]). Jenifer Ferguson, a graduate student in our lab, has demonstrated 
that the steady-state levels of endogenous Est1 protein mimic the profile of known APC-
target proteins. Furthermore, Est1 is stabilized in G1 phase by a temperature-sensitive 
mutation of Cdc16, an essential APC component (J. Ferguson, unpublished data). Finally, 
overexpressed HA3-Est1 protein becomes stabilized in G1 phase in cells disrupted for 
APC function (J. Ferguson, unpublished data). Taken together, these data argue strongly 
that the APC influences Est1 stability. However, Jenifer has been unable to demonstrate 
that recombinant Est1, made by in vitro transcription/translation, is degraded in an in 
vitro APC assay utilizing Xenopus egg extract. One interpretation is that the degradation 
of Est1 is more complex than previously thought (J. Ferguson, unpublished data). 
Alternatively, since the APC components used in this assay are from the evolutionarily 
distant Xenopus lavis (APC core complex) and human (Cdh1) and not budding yeast, the 
specificity of the APC/Est1 interaction could be weakened or completely disrupted. 
 What is the physiological importance of Est1 degradation during G1 phase? One 
hypothesis is that low levels of Est1 ensure that telomerase remains inactive in G1. 
Jennifer Osterhage, a previous graduate student in the Friedman lab, demonstrated that 
stabilization of the endogenous Est1 protein in G1 phase using MG132 resulted in 
association of both Est1 and Est3 with Est2, an interaction that does not normally occur 
in G1 phase [192]. This result suggested that Est1 could be the limiting factor for active 
telomere elongation in G1 phase. However, even though the complex was able to 
assemble and this “G1-telomerase” was active in vitro, it was not competent to extend 
telomeres in vivo [192]. It is not known if the G1-telomerase complex is present at the 
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telomere, the site of elongation. If it is localized but unable to extend the telomere, then 
there must be an additional mechanism that restricts telomerase action in G1 phase. 
Alternatively, if it is not localized to the telomere, then the telomere structure (perhaps an 
open vs. closed conformation) may be critical for the regulation of telomerase action. No 
matter what the answer may be regarding the location of the fully complexed telomerase 
in G1 phase, the fact that Est1 stabilization in G1 is insufficient for telomere elongation 





THE EST3 PROTEIN BINDS DIRECTLY TO AN ESSENTIAL N-TERMINAL 
DOMAIN OF THE CATALYTIC SUBUNIT OF TELOMERASE (EST2)2 
 
Introduction 
 Telomeres are protein-DNA complexes that protect chromosome termini from 
nucleolytic digestion and distinguish natural chromosome ends from internal DNA 
breaks. While the majority of telomeric DNA is double stranded, the G/T-rich strand 
forms a protruding 3’-overhang. In the absence of a counteracting mechanism, telomeres 
shorten during each cell division, ultimately activating cell-cycle checkpoints and cellular 
senescence [165]. If these checkpoints are disrupted or bypassed, end-to-end fusions and 
bridge-breakage cycles can ensue. Telomerase, a ribonucleoprotein complex, promotes 
telomere maintenance and genomic stability by elongating the 3’-overhang by reverse 
transcription [84].  
In budding yeast, telomerase consists minimally of four dedicated subunits: TLC1 
RNA, the template RNA [90]; Est1, an accessory protein important for recruiting and 
activating telomerase at the telomere [188, 224]; Est2, the reverse transcriptase [84]; and 
Est3, an additional accessory protein necessary for proper activity in vivo [213]. Deletion 
of any of these components eliminates telomerase function in vivo, yielding the EST 
(Ever Shorter Telomere) phenotype [90, 209, 210].  
                                                
2 The work presented in this chapter are published in: [242]  Talley, J.M., et al., 
Stimulation of yeast telomerase activity by the Ever Shorter Telomeres 3 (Est3) subunit is 
dependent on direct interaction with the catalytic protein Est2. J Biol Chem, 2011. In 
Press. 
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Although these and other telomerase components have been known for well over a 
decade, few details of their assembly into the ribonucleoprotein complex are understood. 
Described interactions are largely confined to protein associations with the RNA 
template. Est1 and Est2 independently bind distinct regions within the central portion of 
TLC1 RNA [220, 222, 243]. Sm proteins facilitate RNA stability through interaction with 
a site near the 3’ end of the RNA and association of the catalytic core of telomerase with 
the telomere in G1 phase is mediated by interaction of the yKu heterodimer with TLC1 
RNA [191, 219]. Protein-protein interactions are less well understood. Est1 and Est2 may 
interact in an RNA-independent manner. When Est1 is tethered to an internal 
chromosomal site via fusion with the Gal4 DNA binding domain, Est2 is recruited to that 
site in the absence of TLC1 RNA [244]. Furthermore, recombinant Est1 and Est2 can 
bind directly, although TLC1 RNA enhances this interaction [224]. 
 Both the function of Est3 and the mechanism of its assembly into the telomerase 
complex are unknown. Est1 stimulates the association of Est3 with telomerase in a cell-
cycle dependent manner that requires Est2 [192]. Very recently, Est1 protein purified 
from yeast was shown to bind recombinant Est3 protein, yielding strong evidence for a 
direct interaction between these two proteins [193]. Genetic evidence suggests that Est3 
interacts with an N-terminal (Telomerase Essential N-terminus: TEN) domain of Est2, 
but no direct protein/protein or protein/RNA interactions have been reported [213, 245, 
246]. It has been suggested that Est3 binds nucleic acid and possesses helicase activity 
[228]. However, sensitive analysis by NMR spectroscopy of Est3 in the presence and 
absence of DNA failed to detect an interaction [246]. 
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  Here I show the first biochemical evidence that Est3 binds directly to the TEN 
domain of Est2 in Saccharomyces cerevisiae and additionally reveal amino acids within 




Est2TEN and Est3 interact directly in vitro 
 The previously reported allele-specific suppression of temperature-sensitive (ts) 
mutations within the Est2 TEN domain by over-production of Est3 [245] may reflect a 
direct interaction between the two proteins. To test this hypothesis, EST3 was fused with 
an N-terminal His6 tag and the TEN domain of EST2 (EST2TEN; residues 1-162) was 
fused to the C-terminus of maltose binding protein (Mbp). Tagged proteins were 
individually expressed in Escherichia coli and purified to greater than 95% apparent 
homogeneity (Figure 3.1). An 1H-15N heteronuclear single quantum correlation (HSQC) 
experiment was used to assess His6-Est3 tertiary structure. If the protein were unfolded, 
there would be a collapse of crosspeaks in the region near 8 ppm. Instead, the HSQC of 
Est3 revealed excellent spectral dispersion with backbone amide peaks that range from 
~6.1 to 9.9 ppm in the proton dimension (Figure 3.2).  
The individually purified proteins were mixed and their co-purification was 
monitored. His6-Est3 did not detectably associate with amylose resin alone (Figure 3.3c, 
lane 6) or when co-incubated with Mbp (Figure 3.3a, lane 7). In contrast, His6-Est3 
robustly co-purified with Mbp-Est2TEN (Figure 3.3a, lane 10), indicating that His6-Est3 





































Figure 3.1 Coomassie-stained protein gel of recombinant proteins. Mbp-Est2TEN and 
His6-Est3 were individually expressed and purified from E.coli. Marker sizes (M) are 
shown in Kilo Daltons (KDa). Mbp, Mbp-Est2TEN and His6-Est3 are 42KDa, 62KDa, and 
21KDa, respectively. The proteins were estimated to be >95% pure. Mbp was purchased 










































Figure 3.2 1H-15N Heteronuclear Single Quantum Correlation (HSQC) of His6-Est3 
purified from E. coli. NMR spectra were recorded at 15°C on a 500 MHz Bruker 
Avance spectrometer equipped with cryoprobe. Data were processed and visualized using 
Topspin 2.1 software. The intensity of the crosspeaks and relatively robust spectral 
dispersion suggest that Est3 retains tertiary structure. 
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 To examine the specificity of the interaction between Est3 and Est2TEN, I created 
and characterized EST3 mutants known or suspected to influence telomerase assembly 
and/or function. Based on structural modeling, these mutations are predicted to affect 
surface-exposed residues and to have minor effects on protein stability [227]. Est3K71A 
(lysine 71 mutated to alanine) has been shown to disrupt telomere maintenance but retain 
assembly with telomerase in vivo, as assessed by co-purification of the mutant protein 
with TLC1 RNA [227]. In contrast, individual mutations in residues glutamate 114, 
threonine 115 or asparagine 117 were shown to shorten telomeres and reduce Est3 
association with TLC1 RNA [227]. To completely disrupt this charged region, I 
simultaneously mutated all three residues to create Est3ETN114,115,117AAK (Est3ETN). 
Aspartate 166 also contributes to the association of Est3 with TLC1 RNA [227]. Because 
glutamine 167 is conserved in related fungal species, I mutated both residues to create 
Est3DQ166,167AA (Est3DQ). 
 These mutant proteins were purified as His6 fusion proteins from E. coli and their 
secondary structure characterized by circular dichroism. Both the wild-type Est3 and each 
of the altered Est3 proteins displayed strong evidence of secondary structure, suggesting 
that the amino acid changes did not strongly perturb protein folding (Figure 3.4). 
Compared with the interaction observed for wild-type His6-Est3, co-purification of His6-
Est3ETN with Mbp-Est2TEN was greatly decreased (Figure 3.3a and b; 17 fold, p=0.0007).  
In contrast, the interaction between recombinant Mbp-Est2TEN and His6-Est3DQ was only 
slightly decreased compared to wild type (Figure 3.3a and b; 1.5 fold, p=0.0002). The 
identification of point mutations that disrupt the Est3-Est2TEN interaction in vitro suggests 
































Figure 3.3 His6-Est3 interacts directly with Mbp-Est2TEN. (A) 200 pmol Mbp or Mbp-
Est2TEN were incubated as indicated (+) with 1 nmol His6-Est3, His6-Est3DQ or His6-
Est3ETN and captured on amylose resin. Input (1% of total; left panel) and amylose-bound 
proteins (right panel) were analyzed by Western blotting using anti-Mbp and anti-His 
antibodies. Data shown are representative of four independent experiments. (B) 
Quantification of data shown in (A). Fold reduction in recovery of His6-Est3DQ and His6-
Est3ETN compared to WT was averaged over four independent experiments. Bars are 
standard error. Both His6-Est3DQ and His6-Est3ETN binding are statistically different from 
His6-Est3 by one-tailed paired t-test (p-values 0.0002 and 0.0007, respectively) as 
denoted by *. (C) 200 pmol Mbp or Mbp-Est2TEN were incubated as indicated (+) with 1 
nmol His6-Est3 or His6-Est3K71A and captured on amylose resin. Input (1% of total; left 
panel) and amylose-bound proteins (right panel) were analyzed by Western blotting using 












































Figure 3.4 Circular Dichroism (CD) of His6-Est3 proteins and Mbp-Est2TEN. Circular 
dichroism (CD) was used to determine if the recombinant proteins used in this study 
retained substantial secondary structure characteristics. Secondary structural elements 
such as α-helix, β-sheet, and random coil exhibit distinctive CD signals in the far-UV 
region (180nm-260nm), while unfolded proteins do not. Circular dichroism spectrum of 
each native protein was collected at 20°C, shown in blue. The temperature of the identical 
protein sample was gradually increased from 20°C to 80°C over the course of an hour. 
The sample was returned to 20°C after heat denaturation and an additional CD spectrum 




and specific.  Furthermore, residues near E114 contribute to the association of Est3 with 
the TEN domain of Est2.  
Surprisingly, no association between His6-Est3K71A and Mbp-Est2TEN could be 
detected in the pull-down assay (Figure 3.3c, lane 10), even though this mutant can 
assemble with the telomerase complex in vivo ([227] and Figure 3.5). This result 
may suggest that multiple interactions are required for the association of Est3 with 
Est2TEN in vitro, but that additional redundancy exists in vivo. However, I cannot dismiss 
the possibility that mutation of lysine 71 to alanine disrupts the integrity of the 
recombinant protein in a manner not detected by circular dichroism. 
 
EST3 mutant alleles alter telomerase assembly and function in vivo 
 
 Since the est3ETN and est3DQ alleles evaluated in this study are different from 
those previously investigated, I characterized their in vivo phenotype. Telomerase 
assembly was monitored by co-immunoprecipitation of HA-tagged Est3 with TLC1 RNA 
and with Myc18-tagged Est2 (Figure 3.5a and b). EST2 was epitope-tagged at its N-
terminus by two-step integration of eighteen copies of the Myc epitope at the endogenous 
locus. To avoid complications that might arise from measuring telomerase assembly in 
senescent strains, the epitope-tagged EST3 variants were expressed from a plasmid in the 
presence of the endogenous, untagged EST3 gene. Previous work has shown that the 
untagged Est3 protein does not appreciably interfere with the ability of epitope-tagged 
Est3 to co-immunoprecipitate with its binding partners [227].  
 I first verified that TLC1 RNA levels are not affected by the EST3 mutations. As 























Figure 3.5 EST3ETN reduces association with telomerase in vivo. (A) Whole-cell RNA 
(lanes 1-6) or anti-HA immunoprecipitations (lanes 7-12) were generated from yeast 
strains AVL78 (untagged; lanes 1 and 7) or YKF126 (EST2-MYC18 est3::KANR) with 
pKF441 (CEN EST3 URA3) and pKF448HA (CEN EST3-HA3 LEU2), or pKF449HA (2 µm 
est3K71A, ETN or DQ-HA3 LEU2) as indicated. TLC1 and U1 RNA were detected by Northern 
blot (top panel); (M) is marker in base pairs (bp). The amount of TLC1 retained in each 
co-immunoprecipitation (normalized to the wild-type value) is notated under lanes 9-12. 
This value was determined by first subtracting the amount of TLC1 bound non-
specifically (untagged Est3; lane 8) from the amount of TLC1 observed in each lane and 
then dividing by the wild-type value (lane 9). Est3-HA3 recovery was measured by 
Western blot (bottom panel; lanes 13-18) in the identical immunoprecipitation. Results 
are representative of two independent biological replicates. (B) Protein extracts were 
isolated from strains AVL78 (lanes 1 & 8), YKF126 containing plasmid pKF441 (lanes 2 
& 9), YKF122 (est3::KANR) containing pKF442HA (CEN EST3-HA3 URA3; lanes 3 & 
10), or YKF126 containing plasmids pKF441 and  pKF448HA or pKF449HA mutants, as 
indicated. Anti-Myc immunoprecipitations were analyzed by Western blot with 
monoclonal anti-Myc and anti-HA antibodies (lanes 8-14). Input (1% of total) was 
probed with anti-HA and anti-Rap1p antibodies as a loading control (lanes 1-7). Results 
are representative of two biologically independent experiments.  
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cellular RNA are equivalent across strains. Est3 was immunoprecipitated from whole-cell 
extract and an aliquot was analyzed by Western blot (Figure 3.5a, bottom panel). Each of 
the mutant proteins was purified at a level equivalent to or slightly higher than wild-type 
Est3 (mutants are expressed from a high copy number 2 um plasmid). TLC1 RNA was 
detected by Northern blot in the identical immunoprecipitates (Figure 3.5a, lanes 7-12). 
After correcting for minor nonspecific recovery of TLC1 RNA from control extract 
lacking the HA tag on Est3 (Figure 3.5a, lane 8), the amount of TLC1 RNA 
immunoprecipitated with each mutant protein was expressed as a fraction of the 
association observed for wild-type Est3. Highly congruent results were obtained in two 
independent biological replicates (Figure 3.5a and data not shown). Est3ETN-HA3 and 
Est3DQ-HA3 showed very little if any residual association with TLC1, in agreement with 
the effects previously observed for the corresponding single amino acid mutations in 
EST3. Est3K71A-HA3 consistently retained higher levels of association with TLC1 than the 
other mutants, but was reduced to approximately 10% of the wild-type level (Figure 
3.5a). 
 As an alternate measure of telomerase complex assembly, I monitored the co-
immunoprecipitation of each Est3 variant with Myc18-Est2. In agreement with the effects 
on TLC1 association, Est3ETN-HA3 and Est3DQ-HA3 were reduced in their ability to co-
immunoprecipitate with Myc18-Est2 (Fig. 2B). Interestingly, Est3K71A-HA3 
immunoprecipitated with Myc18-Est2 at a similar level to wild type.  The discordance 
between the ability of Est3K71A-HA3 to immunoprecipitate with TLC1 and Myc18-Est2 
suggests that the interaction between TLC1 RNA and Est3 (likely indirect) is more easily 
disrupted by the wash conditions than the interaction between Est2 and Est3. In 
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agreement with previous results [227], I conclude that the residues near glutamate 114 
and aspartate 166 are important for Est3 assembly with telomerase, whereas residue 
lysine 71 plays a less critical role in vivo. 
 
est3ETN does not complement an EST3 delete strain 
 To address the ability of the EST3 variants to support telomere replication, each 
allele was expressed from a low-copy number centromere plasmid in yeast lacking 
endogenous EST3. The resulting strains were monitored for the ability to support growth 
over three consecutive restreaks on solid medium. As expected, the yeast expressing 
wild-type EST3 maintained robust cellular growth (Figure 3.6a), while the empty vector 
control senesced after three restreaks. Interestingly, the strain expressing est3ETN 
resembled the empty vector control for growth (Figure 3.6a), while est3K71A and est3DQ 
looked similar to wild type. As a more sensitive measure of telomerase function, the 
telomere length of cells taken from the final restreak was measured by Southern blot. 
XhoI releases a terminal fragment from chromosomes containing one or more 
subtelomeric Y’ elements, generating a heterogeneous DNA band of 1.2 to 1.3 kilobases. 
In comparison with the telomere length of cells expressing wild-type EST3, cells 
containing either the empty vector control or expressing est3ETN displayed severe 
telomere shortening (Figure 3.6b, compare lanes 1, 6 and 7). In the absence of telomerase 
function, these cells were unable to maintain telomeres and instead utilized a RAD52-
dependent recombination pathway to maintain telomeres, manifested on the Southern blot 
as stochastic lengthening of the TG-rich telomeric repeats or amplification of Y` elements 
































Figure 3.6 est3ETN does not complement an est3∆ strain even when overexpressed. 
(A) Yeast strain YKF122 complemented with pKF441 was transformed with pRS315 
(CEN LEU2 empty vector), pKF448 (CEN EST3 LEU2) or pKF448 mutants (CEN 
est3K71A, ETN or DQ LEU2) and loss of the URA3 complementing plasmid was selected on 
plates containing 5-FOA. Cells were restreaked four times; numbers represent restreaks 
following loss of the complementing plasmid. (B) DNA was extracted from cells grown 
in liquid culture from the 3rd restreak of strains shown in (A). DNA was digested with 
XhoI, Southern blotted, and probed with a randomly labeled telomeric probe. (-) indicates 
the empty vector control. Y’-elements are bracketed. Two independent transformants are 
shown. (M) is marker in kilobases. (C) YKF122 (est3::KANR) complemented with 
pKF441 (CEN EST3 URA3) was transformed with pRS425 alone (2 µm LEU2), lane 1; 
pKF449 (2 µm EST3 LEU2), lane 2 or pKF449ETN, lane 3. After selection for loss of the 
complementing plasmid on plates containing 5-FOA, cells were restreaked three times on 
plates lacking leucine (–leu). Telomere blots were performed as described in (B). Y’-
elements are bracketed. 
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Expression of est3ETN from a high-copy number 2 um plasmid allowed the protein to 
accumulate at wild-type levels (Figure 3.5b compare lanes 4 and 6) but did not improve 
complementation for either growth (data not shown) or telomere length (Figure 3.6c), 
indicating that low protein levels alone do not account for the lack of telomere 
maintenance.  
Although both est3DQ and est3K71A supported normal cellular growth (Figure 
3.6a), the telomeres in cells expressing these EST3 alleles were maintained at a length 
shorter than wild type (Figure 3.6b), similar to a previous report [227]. All of the est3 
alleles were dominant-negative when overexpressed in the presence of wild-type Est3, 
suggesting that they are expressed and retain some function (Figure 3.7). Together, these 
data reveal that residues E114, T115, and N117 are critically important for telomerase 
assembly both in vivo and in vitro, while D166 and Q167 appear to have a lesser role in 
vitro. As previously described [227], K71 has a modest influence on telomerase assembly 
in vivo, though mutation of this residue to alanine disrupts the interaction between Est3 
and the TEN domain of Est2 in vitro. 
 
Discussion 
Although the major components of yeast telomerase have been known for more 
than a decade, it has been difficult to determine the details of subunit interactions within 
the complex. Here I provide the first evidence of a direct Est2/Est3 interaction. 
Recombinant Est3 binds the purified N-terminal (TEN) domain of Est2 in vitro and this 
interaction is largely dependent upon several predicted surface residues of Est3 including 









































Figure 3.7 All of the EST3 alleles are dominant negative. AVL78 was transformed 
with pKF449 (2 µm EST3 LEU2) expressing the indicated EST3 alleles. After three 
successive restreaks –leu, genomic DNA was digested with XhoI, blotted, and probed 
with a randomly labeled telomeric probe. (M) is marker in kilobases. Two biological 
replicates are shown. The parental wild-type strain (AVL78) is shown for reference. 
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showed that Est1 stimulates the assembly of Est3 with telomerase [192]. However, our 
failure to detect an Est1/Est3 interaction in the absence of Est2 suggested that Est1 might 
not be the primary binding site for Est3. Additionally, EST1 function is bypassed in a 
strain expressing a Cdc13-Est2 fusion protein, while EST3 remains essential [188]. This 
result implies that Est3 can, in some circumstances, assemble and contribute to 
telomerase function in the absence of Est1. Prior to work presented here, genetic results 
revealed that overexpression of Est3 suppresses mutations located in the Est2 TEN 
domain, but evidence for a direct interaction between these components was lacking 
[245].  
 Here I have combined an in vitro co-purification assay using recombinant proteins 
with experiments that assess both RNA and protein interactions in the native telomerase 
complex to gain a more clear understanding of telomerase complex assembly. Using 
these assays I have demonstrated that the Est2 TEN domain (residues 1 to 161) interacts 
directly with Est3 in vitro (Figure 3.3). Mutation of three predicted surface-exposed 
residues (E114, T115, and N117) of Est3 significantly perturbs this interaction in vitro, 
while also disrupting the assembly of Est3 with telomerase in vivo (Figures 3.3 and 3.5).  
 Interestingly, the est3DQ mutation decreases the co-immunoprecipitation of Est3 
with both TLC1 RNA and Myc18-Est2 in vivo (Figure 3.5), but has a fairly minor (less 
than two-fold) effect on Est2 TEN binding in vitro (Figure 3.3a and b). One interpretation 
of these data is that the interaction between Est3 and Est2TEN is insufficient for the 
assembly of Est3 with the telomerase complex in vivo, consistent with a model in which 
Est3 makes multiple contacts with telomerase components. This proposal is consistent 
with the recent report that Est3 interacts directly with Est1 [193]. However, because 
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telomere length is only moderately affected by the DQ mutation, it is also possible that 
the co-immunoprecipitation experiment overemphasizes the defect of Est3 association in 
vivo. Indeed, even though the general trends are the same for Est3ETN-HA3 and Est3DQ-
HA3, each mutation has an apparently more severe effect on TLC1 RNA association than 
on the ability to co-immunoprecipitate with Myc18-Est2 (compare Figure 3.5a, lanes 11 
and 12 to Figure 3.5b, lanes 13 and 14), suggesting that TLC1 RNA might be more 
sensitive to co-immunoprecipitation conditions than Est2. This effect is even more 
pronounced with the Est3K71A-HA3 mutation. While the co-immunoprecipitation of TLC1 
is reduced to approximately 10% of wild-type levels, the association of Est3K71A-HA3 
with Myc18-Est2 is equivalent to that of wild-type Est3. This difference may arise 
because Est3 and Est2 interact directly, while Est3 and TLC1 do not. 
 Although Est3K71A-HA3 and Myc18-Est2 co-immunoprecipitate from cellular 
extract, the est3K71A mutation abolishes the in vitro interaction between Mbp-Est2TEN and 
His6-Est3 (Figure 3.3c). This result may suggest that a second site of interaction between 
Est3 and telomerase, such as the interaction with Est1 [193], can mediate Est3 assembly 
when the TEN domain interaction is compromised. If true, the est3ETN mutation must 
disrupt both contacts. However, I cannot eliminate the possibility that the Est3K71A 
protein has defects in vitro (such as a minor disruption in tertiary structure) that are not 








 The function of Est3 in Saccharomyces cerevisiae is unknown, even though it was 
identified in a genetic screen fifteen years ago. Until recently there were no clues to any 
structural or functional homologues in higher eukaryotes. Based on modeling algorithms, 
both the Lundblad and Lue groups published in 2008 that the Est3 protein from S. 
cerevisiae and Candida albicans, respectively, may be structurally similar to the 
characterized oligosaccharide/oligonucleotide-binding fold domain (OB fold) of TPP1, a 
telomere binding protein in mammals [37, 226, 227]. Interestingly, mutations in Est3 that 
were predicted to disrupt tertiary folding resulted in dramatic decreases in Est3 protein 
abundance while mutations in predicted surface residues disrupted telomerase function 
and or assembly in vivo, suggesting that their structural models were functionally relevant 
[226, 227].  
 One role of TPP1 at the telomere is to positively affect telomerase processivity 
through an interaction with POT1 [33].  Additionally, although Est3 has been reported to 
be dispensable for the catalytic activity of S. cerevisiae telomerase [211], recent work in a 
related species, Saccharomyces castelli, implicates the Est3 homologue in the stimulation 
                                                
3 Work from this chapter (Figure 4.1) has been published in: [242]  Talley, J.M., et al., 
Stimulation of yeast telomerase activity by the Ever Shorter Telomeres 3 (Est3) subunit is 
dependent on direct interaction with the catalytic protein Est2. J Biol Chem, 2011. In 
Press. 
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of nucleotide addition processivity [246]. Moreover, Est3 from C. albicans is required for 
robust telomerase activity in vitro with specific primers [248]. These data raise the 
possibility that Est3 affects the enzymatic activity in S. cerevisiae, but that technical 
limitations have, to date, precluded the detection of such effects.  
 I show that recombinant Est3 stimulates telomerase activity during in vitro primer 
extension and that telomerase immunopurified from yeast extracts lacking EST3 or 
containing an est3 mutant allele (est3ETN) are modestly reduced in overall telomerase 
activity. These data suggest that Est3 from S. cerevisiae, like its closely related fungal 
homologues, can stimulate telomerase function. This observation further strengthens the 
similarities between Est3 and its hypothesized TPP1 homologue. Interestingly, the 
interaction of Est3 with the Est2 TEN domain appears to be required for this function 




Est3 stimulates telomerase activity in vitro 
 The function of Est3 in S. cerevisiae has remained elusive since its discovery as a 
telomerase complex component [213]. While early studies did not detect an obvious 
effect on the catalytic activity of telomerase upon EST3 deletion in S. cerevisiae [211], 
more recent studies of S. castelli and C. albicans have demonstrated roles for these Est3 
homologues during primer extension in vitro [246, 248]. These observations raise the 
possibility that S. cerevisiae Est3 may have a similar function, but that the particular 
assay conditions utilized either minimize or mask that effect. 
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To address this issue, I collaborated with Brian Freeman’s lab at the University of 
Illinois to measure the ability of recombinant Est3 to stimulate the primer extension 
activity of partially purified yeast telomerase. It is thought that proteins that stimulate 
telomerase activity above basal levels (like Est1; ref. 10) may induce a more functional 
confirmation for the telomerase complex in the primer extension assay, thereby 
increasing the overall activity on the enzyme (B. Freeman, personal communication). The 
Freeman lab has extensive knowledge in assaying the effects of exogenous protein factors 
in an in vitro telomerase activity assay [224, 249-251]. Diane DeZwaan performed the 
experiments in Figure 4.1 with recombinant protein that I generated at Vanderbilt 
University. Briefly, a biotin-labeled yeast telomeric primer was bound to streptavidin 
beads and incubated in the presence of radio-labeled nucleotides and wild-type 
telomerase extract that was partially purified over DEAE and Mono Q resins [224, 250]. 
As previously demonstrated (ref. 10), yeast telomerase adds seven nucleotides (5’-
GGTGTGG) to the end of the primer and then terminates elongation. Strikingly, titration 
of His6-Est3 into this reaction increased overall telomerase activity in a dose-dependent 
manner, whereas a bovine serum albumin (BSA) control did not (Figure 4.1a). 
Importantly, Est3 does not appear to affect the processivity of telomerase in this assay 
since neither the maximal length of the extended product nor the relative intensity of each 
band is altered. I conclude that Est3 (like Est1; ref. 9) stimulates telomerase activity by 
increasing the fraction of extended primers.  
 Having established that recombinant Est3 stimulates primer extension by 
telomerase, I next determined the effect of each previously characterized (Chapter III) 
mutant Est3 protein in this assay. Both Est3K71A and Est3ETN were significantly reduced 
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in their ability to stimulate telomerase activity compared with wild-type Est3 (Figure 4.1b 
and c; p = 0.0018 and 0.03, respectively). Because the association of Est3K71A and 
Est3ETN with the Est2 TEN domain was dramatically reduced in vitro (Chapter III), this 
result suggests that the interaction between Est3 and Est2TEN is required for telomerase 
stimulation. Consistent with its ability to bind Est2TEN in vitro, Est3DQ retained the 
capacity to stimulate telomerase (Figure 4.1b and c; p=0.87). Given the reduced assembly 
and activity of this mutant in vivo, this result suggests that Est3DQ affects a different, yet 
uncharacterized function of Est3. Overall, these data show that S. cerevisiae Est3 can 
stimulate telomerase activity in a manner dependent on direct interaction with Est2TEN. 
 
Telomerase activity is reduced in the absence of EST3 
 
 The observation that recombinant Est3 stimulates primer extension activity by 
telomerase suggests that telomerase isolated from strains lacking Est3 should have 
reduced activity in comparison to telomerase from EST3 strains. While previous work 
demonstrated that neither EST1 nor EST3 is required for S. cerevisiae telomerase activity 
in a primer extension assay [211], in both cases a modest reduction in nucleotide 
incorporation was noted, although this reduction was not quantified. Given my results 
and the observations in related yeast species that Est3 is required for optimal telomerase 
activity [246, 248], I revisited the question of whether loss of S. cerevisiae Est3 has 
consequences for in vitro telomerase catalytic activity.  
 I addressed this question by using yeast strains containing tagged Est2 (Myc18-








 Figure 4.1 Recombinant Est3 stimulates telomerase activity in vitro in a manner 
dependent on the Est3/Est2TEN interaction. A. Partially purified telomerase extracts 
were prepared from YPH499 cells and incubated with a 7-base 3’-overhang immobilized 
DNA primer in the presence of dTTP and [α-32P] dGTP. In lane (R) RNase A was added 
to telomerase prior to addition of the primer BSA or recombinant His6-Est3 (0.5, 1, 2.5, 5 
or 10 µM) was titrated into DNA extension reactions as indicated. (-) indicates basal 
telomerase activity. (◊) indicates a 27-mer loading control added prior to DNA 
precipitation. B. Recombinant His6-Est3 (wild type or indicated mutant; 0.25, 0.5, 1, 2.5, 
and 5 µM) was titrated into DNA extension reactions as described above. (-) indicates 
basal telomerase activity. (◊) indicates a 27-mer loading control added prior to DNA 
precipitation. C. Recombinant His6-Est3 (wild type or mutant) was added at 2.5uM to 
DNA extension reactions. Signal intensity of three replicates was determined using 
ImageQuant software and its significance was assessed using an analysis of variance 
(ANOVA) post hoc Dunnett’s (Control= His6-Est3). The stimulatory activities of His6-
Est3K71A and His6-Est3ETN were lower than wild-type His6-Est3 (p=0.0018 and 0.03, 
respectively), while His6-Est3DQ activity was similar to wild type (p=0.87). Bars 

















copy vector. I partially purified telomerase from these yeast cells by immunopurifying 
Myc18-Est2 and assessing telomerase activity using primer extension. Telomerase 
purified from either the Myc18-EST2 est3∆ or Myc18-EST2 EST3-HA3 strains showed no 
statistical difference in overall telomerase activity (Figure 4.2c; p=0.224). 
 Since it is difficult to know what percentage of the active telomerase that I 
immunopurified has Est3 associated with it, I became concerned the association of Est3 
with telomerase might be sensitive to the wash conditions of the immunoprecipitation. If 
Est3 is present at substoichiometric levels in telomerase isolated from the EST3 strain, 
any reduction in activity upon deletion of EST3 would be underestimated. To circumvent 
this concern, I used Est3 as the “handle” for immunoprecipitation of telomerase (anti-HA 
immunoprecipitation from an Myc18-EST2 EST3-HA3 extract), to ensure that the catalytic 
core (Est2/TLC1) was associated with Est3 in the primer extension assay. Telomerase 
lacking Est3 was obtained as before, by immunoprecipitation from a Myc18-EST2 est3∆ 
extract using antibodies against the Myc epitope. Isolation of telomerase via Est3-HA3 
gives consistently lower yield than when Myc18-Est2 is used (in the est3Δ background), 
as measured by co-immunoprecipitation of the TLC1 RNA (data not shown). I cannot 
distinguish whether this discrepancy reflects differences in the efficiency of 
immunoprecipitation, differences in enzyme stoichiometry, or both. To account for this 
difference, standard primer extension assays were adjusted to contain approximately 
equal amounts of telomerase RNA and the telomerase activity measurements were 
normalized to the amount of TLC1 RNA present in each sample. Using this approach in 
three independent experiments (each representing the average of three independent 





















Figure 4.2 The activity of telomerase isolated by immunoprecipitation of Myc18-Est2 
is similar in the presence and absence of Est3. A. Co-immunoprecipitation of TLC1 
RNA from strains YKF126 (MYC18-EST2 est3∆) complemented with pKF442 (CEN 
EST3-HA3 URA3) or YKF126 alone was monitored by Northern blot. 10µL of 
immunoprecipitation beads were analyzed for both strains. B. Telomerase activity assay. 
Telomerase was immunoprecipitated using antibodies against the Myc epitope from 
extracts derived from strains YKF126 complemented with pKF442 or from YKF126 
alone. Extension of a 14-nt telomeric primer was assessed by addition of dTTP and [α32-
P] dGTP to the identical immunoprecipitations shown in (A). All the numbered lanes in 
(A) correspond directly to the numbered lanes in (B). A labeled oligonucleotide was 
added to each sample prior to DNA precipitation (◊). Lane (M) contains the 14-nt primer 
used in the telomerase assay extended by terminal transferase in the presence of [α-32P] 
dTTP to mark the +1 position. Lane 1 is addition of RNaseA prior to addition of the 
telomeric primer. In Lane 2 (dTTP), only [α-32P] dTTP was added to the extension 
reaction to allow addition of a single nucleotide (+1). Both lane 1 (RNaseA) and lane 2 
(dTTP) show that activity is specific to telomerase. Each lane represents an independent 
biological replicate. C. Bar graph representation of quantification of three independent 
telomerase assay experiments. For each experiment telomerase activity was measured in 
two anti-Myc immunoprecipitations from either MYC18-EST2 est3∆ extract or from 
MYC18-EST2 EST3-HA3 extract. After correction for precipitation and loading, 
telomerase activity values were adjusted for the amount of TLC1 RNA in each sample as 
measured by Northern blot (A). Significance was assessed using a randomized block 
design with gel number as the block. There is no statistical difference in telomerase 
activity between the two yeast strains; p=0.224, but there was a significant contribution 
for gel number; p=0.0001, showing that there is significant variation between gels (or 
experiments). This is most likely due to variation in the specific activity of 
radionucleotides between experiments. 
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(Figure 4.3c; p=0.0046). These results are consistent with my observation that addition of 
recombinant Est3 stimulates telomerase activity. These data also support the idea that 
Est3 may be at substoichiometric levels when purified from wild-type extract using Est2. 
 Given that Est3ETN was both unable to assemble with Est2 in vivo (Chapter III) 
and has reduced capacity for stimulation in vitro (Figure 4.1b and c), I predicted that 
telomerase activity should be reduced in the presence of this allele. I have previously 
shown (Chapter III-Figure 3.5) that Est3ETN-HA3 was unable to co-immunoprecipitate 
either TLC1 or Est2. Therefore the only way to isolate telomerase from Myc18-EST2 
est3ETN yeast extract is by immunoprecipitation of Myc18-Est2. Since immunopurification 
of Myc18-Est2 from an est3∆ did not show a significant change in telomerase activity 
from wild-type extracts (Figure 4.2), I did not expect to see any differences, in this assay, 
between the wild-type and est3ETN extracts. Unexpectedly, extracts made from yeast 
expressing only Est3ETN-HA3 displayed a significant reduction in telomerase activity 
(Figure 4.4c; p=0.03). Since est3ETN has a dominant negative phenotype the reduction in 
telomerase activity detected in this assay may be due to this phenomenon (perhaps 
competitively binding other telomerase factors) instead of the lack of Est3. 
 
Discussion 
 Two recent papers demonstrated that the Est3 homologues in C. albicans and S. 
castelli influence telomerase activity in vitro [211, 246, 248]. I report here that S. 
cerevisiae Est3 also stimulates basal telomerase activity (Figure 4.1). Interestingly, His6-
Est3DQ, the mutant that retains assembly with the Est2 TEN domain, stimulates 




Figure 4.3 Telomerase activity is decreased in est3Δ  strains compared to wild-type 
extract enriched for Est3. A. Representative co-immunoprecipitation of TLC1 RNA 
from strains YKF126 (MYC18-EST2 est3∆) with or without pKF442 (CEN EST3-HA3 
URA3) was monitored by Northern blot. 20µL or 2.5µL of immunoprecipitation beads 
were added for the MYC18-EST2 EST3-HA3 and MYC18-EST2 est3∆ strains, respectively. 
B. Representative data used to measure telomerase activity. Extension of a 14-nt 
telomeric primer was assessed by addition of dTTP and [α32-P] dGTP to the identical 
immunoprecipitations shown in (A). All the numbered lanes in (A) correspond directly to 
the numbered lanes in (B). A labeled oligonucleotide was added to each sample prior to 
DNA precipitation (◊). (M) contains the 14-nt primer extended by terminal transferase in 
the presence of [α-32P] dTTP to mark the +1 position. In lane 2 (dTTP), only [α-32P] 
dTTP was added to the extension reaction to allow addition of a single nucleotide (+1). 
Both lane 1 [IP beads treated with RNaseA (R)] and lane 2 (dTTP) show that activity is 
specific to telomerase. Extracts were derived from three independent extracts of each 
strain. C. Bar graph representation of quantification of three independent telomerase 
assay experiments. For each experiment telomerase activity was measured in three anti-
Myc immunoprecipitations from MYC18-EST2 est3∆ extract or in three anti-HA 
immunoprecipitations from MYC18-EST2 EST3-HA3 extract. After correction for 
precipitation and loading, telomerase activity values were adjusted for the amount of 
TLC1 RNA in each sample as measured by Northern blot (A). Significance was assessed 
using a randomized block design with gel number as the block. There is a statistical 
difference in telomerase activity between the two yeast strains; p=0.0046 and a 
significant contribution for gel number; p <0.0001, showing that there is significant 
variation between gels (or experiments). This is most likely due to variation in the 
specific activity of radionucleotides between experiments. 
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(est3ETN and est3K71A) do not (Figure 4.1). These results suggest that Est3 requires 
interaction with the Est2 TEN domain to mediate its stimulatory effect. The requirement 
for this interaction in the stimulation assay may simply reflect a defect in the recruitment 
of recombinant Est3 to the telomerase complex in vitro.  However, it is also plausible that 
the stimulatory effect of Est3 requires a specific interaction with the TEN domain that is 
separable from complex assembly.  
 Although previous work demonstrated that Est3 is not required for in vitro S. 
cerevisiae catalytic activity, these initial experiments hinted at a modest reduction in 
activity when telomerase was isolated from est3∆ or est1∆ strains [211]. I have revisited 
this issue by measuring telomerase activity in a manner that ensures the presence of Est3 
in telomerase samples purified from wild-type yeast and that corrects for the efficiency 
with which TLC1 RNA is co-immunoprecipitated. Using this method, I detect a 
reproducible decrease in primer extension activity when telomerase is immunopurified 
from an est3Δ strain under conditions that ensure the presence of Est3 in the wild-type 
sample (Figure 4.3). Notably, there is not a significant difference between telomerase 
activity from est3∆ strains immunopurified using Myc18-Est2 (Figure 4.2; p=0.224). This 
could be due to the small sample size (n=6), inherent variability between experiments 
(p=0.0001), and/or depletion of Est3 from the telomerase complex during 
immunoprecipitation washes. Though it is difficult to increase the concentration of Est3 
co-immunoprecipitated from the wild-type yeast extract, repeating this experiment using 
a larger sample size and analyzing as many data points as possible on one gel could help 






Figure 4.4. Telomerase activity from yeast expressing Est3ETN is reduced compared 
to wild type. A. Representative co-immunoprecipitation of TLC1 RNA from strains 
YKF126 (MYC18-EST2 est3∆) with or pKF442 (CEN EST3-HA3 URA3) or 
pKF449ETN(2micron est3ETN-HA3 LEU2) was monitored by Northern blot. 10µL of 
immunoprecipitation beads were processed. B. Representative data used to measure 
telomerase activity. Extension of a 14-nt telomeric primer was assessed by addition of 
dTTP and [α32-P] dGTP to the identical immunoprecipitations shown in (A). All the 
numbered lanes in (A) correspond directly to the numbered lanes in (B). A labeled 
oligonucleotide was added to each sample prior to DNA precipitation (◊). (M) contains 
the 14-nt primer extended by terminal transferase in the presence of [α-32P] dTTP to 
mark the +1 position. In lane 2 (dTTP), only [α-32P] dTTP was added to the extension 
reaction to allow addition of a single nucleotide (+1). Both lane 1 [IP beads treated with 
RNaseA (R)] and lane 2 (dTTP) show that activity is specific to telomerase. Extracts 
were derived from three independent extracts of each strain. C. Bar graph representation 
of quantification of three independent telomerase assay experiments. For each experiment 
telomerase activity was measured in two to three anti-Myc immunoprecipitations either 
extract. After correction for precipitation and loading, telomerase activity values were 
adjusted for the amount of TLC1 RNA in each sample as measured by Northern blot (A). 
Significance was assessed using a randomized block design with gel number as the block. 
There is a statistical difference in telomerase activity between the two yeast strains; 
p=0.03 and a significant contribution for gel number; p=0.009, showing that there is 
significant variation between gels (or experiments). This is most likely due to variation in 
the specific activity of radionucleotides between experiments. 
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  Telomerase isolated from a strain expressing est3ETN shows reduced catalytic 
activity compared to wild type (Figure 4.4). This result was not entirely expected because 
to assess telomerase activity in the est3ETN strain I had to immunopurify telomerase using 
Myc18-Est2 (caveats discussed above). Therefore, the observed decrease in the est3ETN 
strain may reflect the dominant negative phenotype of Est3, rather than its lack of 
assembly into the complex. For example, it is possible that Est3ETN disrupts formation of 
the telomerase complex in a manner that greatly perturbs the conformation and/or 
function of telomerase in vivo. If the Est3ETN protein retains the ability to bind some 
telomerase components, both known (Est1) and/or unknown (other unidentified 
subunits), it may alter the telomerase complex stoichiometry through competition for 
association with those subunits. In support of this idea, it has recently been shown that 
Est1 and Est3 interact directly in vitro, though the site of interaction remains enigmatic 
[193]. 
 Why is the effect of Est3 on in vitro telomerase activity greater in the 
“stimulation” assay compared to the “conventional” primer extension assay? I suggest 
that technical differences between the protocols may influence the effect of Est3. 
Specifically, our conventional assay immobilizes telomerase on a bead (possibly 
restricting important conformational changes) while the primer is free in solution. In 
contrast, the stimulation assay anchors the primer to a streptavidin bead, perhaps better 
mimicking the situation at a chromosome terminus and telomerase is free in solution. 
Therefore, the stimulation assay may allow a more dynamic examination of telomerase 
activity than the conventional assay. Exactly how Est3 aids in telomerase activity is 
unknown, but it is plausible that it could affect the position of telomerase at the 3`-
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overhang, allowing it to initiate synthesis more efficiently. Alternatively, Est3 may 
enhance the ability of telomerase to recognize the substrate. Both of these possibilities are 
consistent with an increase in overall telomerase activity and no increase in telomerase 
processivity. 
 TPP1 is a member of the telomere-binding shelterin complex in mammals and 
influences the processivity of telomerase in vitro [33, 37]. Based on prediction 
algorithms, fungal Est3 has a similar structure to the oligonucleotide/oligosaccharide-
binding (OB) fold domain of TPP1, although this observation alone does not imply an 
evolutionary relationship between the two proteins [226, 227]. Intriguingly, deletion of 
the TPP1 OB fold disrupts telomerase localization to the telomere in human cells [252]. 
Additionally, a sequence-specific interaction between TPP1 and the human TEN domain 
of TERT is important for telomerase processivity [253]. My observation that the Est2 
TEN domain mediates a critical interaction with Est3 that influences both telomerase 
assembly in vivo and stimulation of telomerase activity in vitro provides an intriguing 
parallel between the two proteins. The glutamate 114, threonine 115, and asparagine, 117 
of the Est3 primary structure align near some surface-exposed residues within a small 
alpha helix of the OB fold of TPP1: arginine 159, glutamate 160, aspartate 163 and 
threonine 164. Determining if these residues influence telomerase function in higher 





MATERIALS AND METHODS 
 
Plasmids for protein expression 
 The plasmid pET Duet EST3 (for expression of His6-EST3) was made by moving 
EST3 from YCPlac33 EST3 using primers M090 and M091 (Table 5.1) into pET Duet-1 
(Novagen) using restriction sites BamHI and SalI. EST3 mutants K71A (lysine 71 to 
alanine), ETN (glutamate 114, threonine 115, and asparagine 117) and DQ (aspartate 166 
and glutamine 167) were introduced into pET Duet EST3 by Quikchange™ (Stratagene) 
using primer pairs: K71A For and K71A Rev; ETN114AAK F and ETN114AAK R; DQ 
For and DQ Rev, respectively. A vector for expression of Mbp-EST2TEN was made by 
cloning EST2TEN (residues 1-161) from pKF404 [98] using primer pair LM204.1 For and 
LM204.1 Rev into pLM204a (gift of L. Mizoue) using restriction sites EcoRI and PstI. 
The Mbp-EST2TEN fusion gene was then moved into the EcoRV and KpnI sites of pET 
Duet-1 using primer pair EcoRV Mbp F and KpnI Est2RI R to create pET Duet Mbp-
EST2TEN. Mbp alone was cloned into the EcoRV and KpnI restriction sites of pET Duet-1 
from pLM204a using primer pair EcoRV Mbp F and KpnI Mbp R to create pET Duet 
Mbp. 
 
Plasmids for in vivo characterization 
 A consensus destruction box (D-box) motif in plasmid pVL242 (GAL-HA3-EST1; 
gift of V. Lundblad) was mutated by PCR  using primers M086 and M087 [254]. The 
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resulting PCR product was cloned into the BamHI and HindIII sites of pVL242 to create 
pVL242RtoA and verified by sequencing. 
 pKF441 (CEN EST3 URA3) was created by PCR amplification of the EST3 
promoter and frameshift-corrected gene from pVL901 (gift of V. Lundblad) using primer 
pair UEprimer1 and UEprimer4 to create an EcoRI site upstream of the promoter and a 
KpnI site immediately before the EST3 stop codon.  The endogenous EST3 termination 
sequence was amplified using primer pairs UEprimer5 and UEprimer6 to create a HindIII 
site downstream of the terminator. UEprimer1 and UEprimer6 were then used to amplify 
the full-length insert using these two PCR products as template. The resulting fragment 
was cloned into YCplac33 (CEN URA3) using EcoRI and HindIII. pKF442 (CEN 
EST3HA URA3) was created by PCR amplification of the HA3 tag from pVL901 using 
primer pair KpnI For and XbaI Rev and ligation into pKF441 using KpnI and XbaI. EST3 
and EST3HA were subsequently moved into pRS315 or pRS425 (CEN LEU2 and 2µm 
LEU2, respectively; [255, 256]) using the PvuII sites of pKF441 or pKF442. The est3ETN 
and est3K71A alleles were subcloned from pET Duet-1 (see above) using restriction sites 
MscI and XhoI. est3DQ was created by Quikchange™ using the same primers as above 
and subcloned using SpeI and XmaI. All point mutations were verified by sequencing. 
 
Yeast strains 
 YKF122 (AVL78 est3::KANR) was created by standard one-step gene 
replacement by PCR amplifying the kanamycin resistance gene from pFA6a-kanMX6 
using primers Est3KanFor and Est3KanRev. The PCR product was cloned into the SacI 
and KpnI sites of pKF441 to create pKF441 est3::KAN. The deletion construct was 
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transformed into AVL78 using a standard lithium acetate protocol. YKF126 [AVL78 
est3::KANR EST2-G8-Myc18 (G: glycine)] was created by linearizing pRS304-Est2-G8-
Myc18 (Gift of V. Zakian) with SwaI and transforming it into YKF122 + pKF441. A list 
of yeast strains and plasmids can be found in Table 5.2. 
 
Complementation and growth assay 
 Functional complementation of the est3 mutant alleles was tested in YKF122 
(AVL78 est3::KANR) using mutant constructs created in pRS315 (CEN LEU2). YKF122 
was complemented with pKF442 (CEN EST3-HA URA3); loss of the complementing 
plasmid was selected on 5-fluoroorotic acid (5-FOA) plates and the WT or mutant 
pRS315 plasmids were subsequently transformed using the standard lithium acetate 
method. Resulting single colonies were restreaked three times on plates lacking leucine. 
Cell viability was assessed visually and telomere length was determined by Southern blot 
using XhoI as previously described [245].  
 
Protein Purification 
 BL21 cells containing pET Duet EST3 were grown in six liters of standard Luria 
broth (LB) with 50ug/mL ampicillin at 37°C to an OD600 0.3-0.4. After shifting the 
culture to 16°C for 1h, protein expression was induced with 500µM IPTG overnight with 
moderate shaking (110 rpm). Cells were harvested by centrifugation at 4°C and 
resuspended in 10 mL TG buffer (+ 100 mM NaCl) per liter of original culture (TG: 
50mM Tris pH 7.5, 10% glycerol and 3mM beta-mercaptoethanol [β-ME]). Cells were 
lysed using an EmulsiFlex (Avestin) by passing cells 3-4 times through the machine at 
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20,000 psi. The resulting extract (60mL) was incubated with 7.5mL Talon® resin 
(Clontech) for 1h at 4°C with gentle agitation and gravity packed into an empty glass 
EconColumn™ (BioRad). Resin was washed with 10 column volumes of TG + 300mM 
NaCl and 10mM imidazole. Protein was eluted with 5 column volumes TG + 100mM 
NaCl and 100mM imidazole. The elution was dialyzed (Spectra/Por® #7; 10,000KDa 
[Spectrum Laboratories]) at 4°C overnight into TG buffer, bound to a Source™ 15Q 
HR16/10 column (GE Healthcare) and eluted using a linear salt gradient (TG + 0mM 
NaCl to TG + 1M NaCl). The purest fractions were pooled and applied to a Superdex™ 
200 26/60 gel filtration column (GE Healthcare) using TG + 100mM NaCl buffer. Again, 
His6-Est3 fractions were pooled and concentrated to 3mL using a 15mL, 10KDa cutoff 
Amicon® Ultra concentrator (Millipore) and dialyzed into TG + 100 mM NaCl + 50% 
glycerol. The protein was stored at -20°C. Mutant proteins were purified in the same 
manner except that His6-Est3ETN and His6-Est3DQ were purified at pH 8.0. The Est3 
protein sequence was verified by mass spectrometry. 
 Three-liter cultures of BL21 cells containing pET Duet MBP-EST2TEN were 
grown and harvested as described above. Cells were lysed as above in 10mL TEG-200 
per liter of original culture (TEG-200: 20mM Tris-HCl pH 7.4, 200mM NaCl, 1mM 
EDTA, 10% glycerol). Extract was incubated with 10mL amylose resin for 2 hours at 
4°C and was packed similarly as above. Resin was washed with 15 column volumes TEG 
+ 500mM NaCl. Mbp-Est2TEN was eluted with TEG-200 + 5mM maltose. Fractions 
containing Mbp-Est2TEN were further purified over an S200 gel filtration column using 
TG + 100mM NaCl buffer. Mbp-Est2TEN was concentrated as described for His6-Est3 and 
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dialyzed into TG + 100mM NaCl, 50% glycerol. Protein was stored at -20°C. The 
Est2TEN protein sequence was verified by mass spectrometry. 
 All purified proteins were separated by 12% sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) to determine purity. All protein 
preparations used were judged by Bio-Safe™ Coomassie (BioRad) staining to be at least 
95% pure. Protein concentration was determined either by spectrophotometry or by 
comparison of a serial dilution to a known concentration of protein standard. 
 Maltose Binding Protein (Mbp) was purchased from New England Biolabs and 
diluted to 20µM in TG + 100mM NaCl + 50% glycerol. 
 
In vitro pulldown assay, immunoprecipitation and Western analysis 
 Mbp or Mbp-Est2TEN (200 picomol) were incubated with 25µL amylose resin in 
buffer I (20mM Tris-HCl pH 7.4, 200mM NaCl, 1mM EDTA, 0.05% Tween-20 and 10% 
glycerol) for 2h at 4°C with gentle agitation. 1 nmol His6-Est3 or mutant Est3 proteins 
were added and incubated 3h at 4°C. The resin was washed 3 times for 5 min. with 1mL 
buffer I, resuspended in 100µL buffer I, loaded into a 700µL spin cup (Pierce), and 
washed with 1.5mL buffer I. Retained resin was resuspended in 40µL buffer I and 20µL 
were separated by 12% SDS-PAGE. For detection of Mbp and Mbp-Est2TEN, proteins 
were blotted onto nitrocellulose (GE Healthcare) and blocked with 5% Milk/phosphate 
buffered saline pH 7.4 with 0.05% Tween (PBS-T). For detection of His6-Est3, proteins 
were blotted onto Hybond P membrane (GE Healthcare) and blocked with 5% BSA/PBS-
T. HRP-conjugated anti-Mbp (NEB) was used at a dilution of 1:50,000. Primary antibody 
for detection of His6 (Santa Cruz Biotechnology) was diluted 1:1,000. Secondary 
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antibody was peroxidase-conjugated mouse anti-rabbit at 1:10,000 (Chemicon). ECL plus 
Western Blotting Detection system (GE Healthcare) was used for detection. 
 Yeast protein extract was prepared as described [98]. Extracts were normalized to 
20mg/mL and incubated with antibodies as previously described [98, 192]. Either 20µL 
of anti-Myc immunoprecipitated material (1/3 of total) or 2.5 µL of anti-HA 
immunoprecipitated material (1/24 of total) was separated by 10%-12% step-gradient 
SDS-PAGE. Proteins were transferred to Hybond P membrane (GE Healthcare). The 
membrane was blocked with 5% Milk/PBS-T followed by incubation with primary 
antibodies (HA: 1:500 dilution murine monoclonal HA.11 [Covance] or Myc: 1:250 
dilution of murine monoclonal Myc Ab-1 [OP10L, EMD Biosciences]) in 5% Milk/PBS-
T. Secondary antibody was peroxidase-conjugated goat anti-mouse (Chemicon) used at a 
1:10,000 dilution in 5% Milk/PBS-T. Detection was done as described above. 
 
Est1 protein stability assays 
 100 mL cultures containing plasmid pVL242RtoA were grown overnight in 2% 
raffinose medium lacking leucine to an OD600 > 0.3 but < 0.45. Cells were arrested by 
incubation with 1 mM alpha factor or 10 mg/ml nocodazole for 4h. When >95% of the 
cells were of the expected morphology, galactose was added at a final concentration of 
2% for 60 minutes. At time zero, glucose (2% final concentration) and cycloheximide (10 
mg/ml) were added. For proteasome inhibition, MG132 (Peptides International) was 
added to a final concentration of 50 mM. 10 mL samples were collected at 0, 15, 30, 60, 
90 and 120 minutes. Protein was isolated by trichloroacetic acid (TCA) precipitation as 
described [257] and pellets were resuspended in 150 ml of 0.05 N NaOH. 10 µL of each 
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sample was immunoblotted as described above except anti-HA antibody was used at 
1:500 at room temperature for 2h or at 4°C overnight. 
 
Telomerase assays and Northern analysis 
 Telomerase was partially purified by immunoprecipitation from extracts of strains 
YKF126 [est3Δ::kanMX6 EST2-G8-MYC18], YKF126 + pKF442 (EST3-HA) or YKF126 
+ pKF449ETN (EST3ETN) using antibodies against Myc (A14, Santa Cruz Biotechnology) 
or HA (Y11, Santa Cruz Biotechnology), respectively, as previously described [98]. 
Telomerase activity was assessed using the Tel14 primer (Table 5.1) with either 2.5µL or 
20µL of immunoprecipitation beads (YKF126 or YKF126 + pKF442, respectively) as 
previously described [98]. For each immunoprecipitation, an identical aliquot was 
analyzed by Northern blot for TLC1 RNA, as described below. Total radioactive signal 
corresponding to extension of the Tel14 primer was quantified for each sample using 
ImageQuant and divided by the signal from an end-labeled 12-base oligonucleotide used 
as a precipitation and loading control. This corrected telomerase activity value was 
divided by the TLC1 RNA signal obtained by Northern blot from the corresponding 
sample and values of two to four independent reactions were averaged. To facilitate 
statistical analysis of five experiments, these average values were normalized to the 
activity obtained in the presence of EST3 (YKF126 + pKF442). 
 For Northern analysis, RNA was isolated from immunoprecipitation beads and 
detected by Northern blotting as previously described [98, 192]. Whole-cell RNA was 
prepared from 10mL mid-log phase cultures and hybridization was performed 
simultaneously with probes specific for TLC1 RNA ([32P]dCTP random-primed fragment 
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of TLC1) and U1 snRNA (32P-5’-end-labeled oligonucleotide 
5’CTACTATTGGAAGCGCATGTTTG) [258]. For analysis of EST1 mRNA stability, 
whole cell RNA was isolated from 50 ml cultures grown to mid-log phase and Northern 
blotting was performed as described [259].  Hybridization was performed with probes 
specific for EST1 RNA ([32P]dCTP random-primed fragment of EST1) and U1 snRNA as 
described above. 
 Telomerase was partially purified from wild-type yeast (YPH499) by 
chromatography over DEAE sepharose fast flow resin (GE Healthcare) and MonoQ resin 
(GE Healthcare) as previously described [224, 251] and used in telomerase DNA 
extension assays. Briefly, partially purified telomerase extract was incubated with 2 pmol 
of a 7-base 3’-overhang template (GTGTGTG) immobilized on streptavidin 
paramagnetic beads (Promega) and extension buffer (50 mM Tris [pH 8.0], 1 mM MgCl2, 
1 mM spermidine, 1 mM DTT, 0.5% glycerol, 50 µM dTTP, 10 µCi of [α- 32P]dGTP 
[3,000 ci mmol-1; Amersham]). The 7-base 3’-overhang template was generated by 
annealing biotin-conjugated Backbone1 primer (Table 1) to GTG7 base consensus 
primer. Reactions were incubated for 30 min at 30°C followed by magnetic collection of 
DNA-bound beads. The beads were washed twice with 1x EcoRI buffer (New England 
Biolabs). Beads were resuspended in 50 µL of 1x EcoRI buffer, 100 µg/mL bovine serum 
albumin (BSA) and 10U of EcoRI and incubated for 1 hour at 37°C. The beads and 
cleaved DNA fragments were separated magnetically. A PNK (T4 Polynucleotide Kinase 
[NEB]) end-labeled, 27-base oligonucleotide was added and the DNAs were ethanol 
precipitated. DNA was reconstituted in formamide-NaOH loading buffer and run in a 
14% acrylamide denaturing gel and subsequently visualized using a PhosphorImager. For 
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the experiments in Chapter IV, Figure 4.1, BSA or recombinant His6-Est3 was titrated 
into the extension buffer at varying concentrations before addition of telomerase extract 
[224].  
 106 
Table 5.1. Oligonucleotide primers 
 





K71A For CGCCAAAATTACAGCGTTTTATAACGTTTGCGAC 
K71A Rev GTCGCAAACGTTATAAAACGCTGTAATTTTGGCG 
ETN114AAK F GCAGGATCACATCTGCGGCGACGAAATGCTTAATGATCATTGGCG 
ETN114AAK R CGCCAATGATCATTAAGCATTTCGTCGCCGCAGATGTGATCCTGC 
DQ For CCAGGCCACGATATTTGATATTGCAGCTGTCGGATCGTTAAGTACTTTC 
DQ Rev GAAAGTACTTAACGATCCGACAGCTGCAATATCAAATATCGTGGCCTGG 
LM204.1 For CGAATTCGATGAAAATCTTATTCGAG 
LM204.1 Rev AACTGCAGTTAGACCCCATTTGGGC 
EcoRV Mbp F CGGATATCATGGGTATGAAAATCGAAG 
KpnI Est2RI R CGGTACCTTAGACCCATTTGGGCGGCAG 





KpnI For GTATATAAATATTTAGGTACCATGTACCCGTATG 





















Genotype Chapter Source 
AVL78 MATa leu2 trp1 ura3-52 prb1 prc1 pep4-3 II-IV V. Lundblad 
YPH499 MATa ura3-52 lys2-801_amber ade2-101_ochre 
trp1-∆63 his3-∆200 leu2∆1 
IV B. Freeman 
TVL288 HA3-EST1 II V. Lundblad 
YKF122 AVL78 est3Δ::kanMX6 III This study 
YKF126 AVL78 Myc18-EST2 [TRP] est3Δ::kanMX6 III & IV This study 
YKF332 AVL78 EST3-HA3 Myc9-EST2 [TRP] bar1:URA3 II J. Osterhage 
YKF333 AVL78 Myc9-EST2 EST3-HA3 bar1::URA3 
erg6::kanMX6 
II J. Osterhage 
pVL242 GAL1-HA3-EST1 LEU2 II V. Lundblad 
pVL242RtoA pVL242 RxxLxxxN to AxxLxxxN in linker 
between HA and  EST1 
II This study 
pLM204a MBP KAN III L. Mizoue 
pKF441 CEN EST3 URA3 III This study 
pKF442HA CEN EST3-HA3 URA3 III & IV This study 
pKF448 CEN EST3 LEU2 III This study 
pKF448K71A CEN EST3K71A LEU2 III This study 
pKF448ETN CEN EST3ETN114,115,117AAK LEU2 III This study 
pKF448DQ CEN EST3DQ166,167AA LEU2 III This study 
pKF448HA CEN EST3-HA3 LEU2 III This study 
pKF449 2 µm EST3 LEU2 III This study 
pKF449ETN 2 µm EST3ETN114,115,117AAK  LEU2 III This study 
pKF449HA 2 µm EST3-HA3 LEU2 III This study 
pKF449K71A- HA 2 µm EST3 K71A-HA3 LEU2 III This study 
pKF449ETN-HA 2 µm EST3ETN114,115,117AAK -HA3 LEU III & IV This study 
pKF449DQ-HA 2 µm EST3DQ166,167AA -HA3 LEU2 III This study 
pKF1201 pET Duet-1 MBP-EST2TEN AMP III This study 
pKF1301 pET Duet-1 EST3 AMP III This study 
pKF1302 pET Duet-1 EST3K71A AMP III This study 
pKF1303 pET Duet-1 EST3ETN114,115,117AAK AMP III This study 
pKF1304 pET Duet-1 EST3DQ166,167AA AMP III This study 





CONCLUSIONS AND FUTURE DIRECTIONS 
 
The potential roles for Est1 degradation in G1 phase of the cell cycle 
 The maintenance of the telomere is critical for faithful replication of DNA and 
proper cell division [165]. This thesis has focused on the regulation of telomerase 
complex assembly, defining interactions within the complex and elucidating an 
enzymatic contribution for the telomerase accessory protein, Est3. Understanding how 
members of the telomerase complex assemble is critical since the assembly of the 
complex is a prerequisite for activity in vivo [192, 226, 227, 248]. Telomerase is only 
active in S/G2 phases of the cell cycle, even though Est2 and TLC1 RNA are localized to 
telomeres in G1 phase via an interaction with the yKu70/80 heterodimer [180, 181, 191]. 
Interestingly, Est1 protein levels were found to be much lower in G1 compared to G2/M; 
this observation led Jennifer Osterhage to hypothesize that perhaps a decrease in Est1 
protein levels in G1 phase precludes telomerase assembly in this phase and results in an 
inactive complex in G1 [192]. Intrinsic to this hypothesis is the proposal that the EST1 
RNA or protein is regulated differentially in G1 phase as compared to other phases of the 
cell cycle. To address this possibility, I determined the half-life for the Est1 protein in G1 
and G2/M phases (Chapter II; [192]). I found that in G1 phase the stability of the Est1 
protein is decreased compared to G2/M phase. Furthermore, I demonstrated that Est1 is 
degraded in a proteasome-dependent manner [192]. This finding allowed Jennifer to 
stabilize endogenous Est1 in G1 phase and assess both complex assembly and telomerase 
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activity (through proteasome inhibition by MG132). Under these conditions, the 
telomerase complex assembles and interestingly, telomerase is active in vitro even when 
partially purified using Est3 (a phenomenon not seen in untreated cells) [192]. 
Intriguingly, Est1 stabilization in G1 phase was not capable of extending telomeres in 
vivo [192]. These somewhat unexpected results suggest that there are mechanisms in 
addition to telomerase assembly that must regulate telomerase activity in G1 phase [192]. 
 Arising from these findings are at least three additional questions: How is Est1 
targeted to the proteasome in G1 phase of the cell cycle? Why is Est1 degraded in G1 
phase? What other mechanisms regulate telomerase activity? The Anaphase Promoting 
Complex (APC), an E3 ubiquitin ligase, is an obvious candidate for what is targeting Est1 
to the proteasome in G1 phase.  Although, it is active during the time of Est1 degradation, 
the influence of the APC on Est1 stability remains in question (Chapter II-discussion). 
Another possibility is that there is a unique E3 ubiquitin ligase that recognizes Est1 in 
G1. There are a number of E3 ubiquitin ligases in yeast; therefore the most viable way to 
discover which E3 may target Est1 to the proteasome is a genetic screen. For example, 
EST1-3xGFP (Green Fluorescent Protein) could be integrating into yeast strains deleted 
for different E3 ligases. These cells could be blocked in G1 phase and assessed for 
increases in GFP expression over wild-type cells. Any yeast strains that show an increase 
would be considered candidates for the E3 ligase that targets Est1 to the proteasome. The 
candidate(s) should be verified using immunprecipitation assays to determine if the E3 
ligase and Est1 interact. In addition, showing that in G1 phase, in the absence of the 
candidate E3 ligase, Est1 stability is increased and the telomerase complex assembles 
would support its role as the targeting E3 ligase. 
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 Est1 degradation could serve at least two functions. It could serve a redundant 
mechanism for preventing telomere elongation in G1 phase. Telomerase requires both 
Est1 and Est3 to function properly in vivo and since Est1 stimulates Est3 assembly with 
the complex, degradation of Est1 ultimately ablates Est1 and reduces Est3 assembly with 
telomerase in G1 resulting in an inactive complex [192, 209, 210]. Given the above 
observation, the fact that stabilizing Est1 in G1 is insufficient for telomere elongation in 
vivo suggests that there must be another mechanism(s) restricting telomerase function to 
S phase. Two of the more prominent thoughts on what is regulating telomerase activity in 
the cell cycle are the structure of the telomere (telomerase must be able to recognize the 
telomere) and that DNA replication and telomere elongation are coupled. For example, 
the length of the telomeric overhang is short in G1 phase, ~12-14 nucleotides, and longer 
in S phase, >30 nucleotides [25, 182]. The longer 3’-overhang in S phase binds Cdc13 
molecules, which presumably permits telomerase recruitment, whereas the G1-telomere 
does not bind Cdc13p, as assessed by ChIP [190]. This finding predicts that a longer 
ssDNA telomeric overhang in G1 phase could recruit Cdc13 binding. Indeed, deletion of 
Ku70, a gene important both in NHEJ and protecting the telomere from resection, 
increases the length of the single-stranded 3’-overhang in G1 phase, resulting in 
increased Cdc13 binding in G1 [191]. Stabilizing the Est1 protein in G1 phase in this 
yeast strain, would address if the telomere structure in addition to telomerase assembly 
are the mechanisms restricting telomere elongation to S phase. 
 DNA replication must occur once, faithfully and completely during each cell 
cycle and as such is a tightly regulated process (reviewed in [260]). Prevention of 
telomere elongation in G1 phase might be due in part to an overall inhibition of DNA 
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replication in G1 phase. Interestingly, the Diffley group has generated a yeast strain that 
replicates its DNA in G1 phase [261]. Investigating whether or not telomeres are 
elongated during G1 phase in this strain could address if Est1 protein degradation is a 
redundant mechanism preventing telomere replication in G1. If telomeres are replicated 
in G1 phase in this strain background while Est1 levels are low, then Est1 protein 
degradation is not a critical mechanism preventing telomere replication. Alternatively if 
telomeres are not elongated in G1 phase in this strain then Est1 could be considered an 
important regulator of telomerase activity in G1. One caveat to this experiment is that 
replication in the Diffley yeast strain may not be occurring normally or completely; 
therefore it would be important to verify that the telomeres are actually being replicated 
in this yeast strain under asynchronous (or wild-type) growing conditions. 
 Why is it important to prevent telomere elongation in G1 phase of the cell cycle? 
After the T/G-rich 3’-overhang is extended by telomerase in late S phase, it is thought 
that lagging strand polymerase (pol α) fills-in the C/A strand (reviewed in [183]). 
Consequently, if telomeres are elongated in G1 phase the long single-stranded T/G tracts 
generated by telomerase addition could encourage spurious recombination events (a 
common phenomenon in yeast) (reviewed in [262]) or induce a DNA damage checkpoint 
response (reviewed in [263]). Both of these events threaten the genomic stability of the 
yeast cell; therefore, coordinating DNA replication and telomere elongation may ensure 
proper genome maintenance. 
 Est1 degradation in G1 phase could also serve to “unmark” a recently extended 
telomere. Interestingly, only 6-8% of wild-type telomeres are elongated in each cell cycle 
and those that are replicated tend to be the shortest telomeres [196]. This finding suggests 
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that telomeres are “marked” for elongation during the cell cycle, most likely before late S 
phase. Inherent in this “marked-telomere” concept is that each “marked” telomere must 
be “unmarked” during the subsequent cell cycle to ensure that other telomeres (that 
would have been shortened in preceding rounds of cell division) have the chance to be 
elongated. Removing or disassembling telomerase from the telomere after replication 
would ensure that the newly elongated telomere would start the next cell cycle telomerase 
free. Since Est1 is important in both recruiting telomerase to the telomere and activating 
the complex, Est1 degradation could be an event that ensures the disassembly of the 
telomerase complex at the completion of telomere elongation [188, 224]. This hypothesis 
predicts that the same telomere could be elongated in successive cell cycles if the Est1 
protein is not removed before the start of the subsequent S phase. Comparing WT cells to 
those constitutively overexpressing Est1 and assaying changes in the patterns of telomere 
addition in two consecutive cell cycles can begin to test this hypothesis. If cells 
overexpressing Est1 show a greater number of telomeric repeats added to a single 
telomere compared to WT cells then this would support the idea that degradation of Est1 
is important in regulating telomerase action at a single telomere. Importantly, association 
of Est1 with the telomere would need to be assessed using ChIP to ensure that the Est1 
protein is telomere-associated though out the cell cycle (Est1 is typically only associated 
in S phase). 
 
The assembly and function of Est3 in the telomerase complex 
 The Est3 protein is abundant throughout the cell cycle, suggesting that unlike 
Est1, Est3 is not regulated in abundance in the cell cycle [192, 193]. Est1 is both 
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necessary and sufficient to stimulate Est3 assembly with telomerase, therefore the 
relatively low Est1 levels during G1 phase is one mechanism that precludes Est3 from 
complex formation in G1 [192]. Additionally, Est2 is critical for Est3 assembly since 
deletion of EST2 prevents Est3 association with TLC1 RNA and Est1 [213]. 
Alternatively, deletion of EST3 does not inhibit Est1, Est2 and TLC1 RNA from 
assembling in vivo [213]. Since deletion of either EST1 or EST2 precludes Est3 assembly 
with TLC1 RNA, it is widely accepted that Est3 does not, itself, independently interact 
with the RNA [213]. All of these data together suggest that Est1, Est2 and TLC1 RNA 
must be in complex before Est3 assembles. It is reasonable to hypothesize that Est3 could 
interact directly with Est1, Est2 or both.  
 To begin to understand what interactions Est3 could have within the telomerase 
complex, I chose to look at a potential interaction between Est3 and Est2. Genetic 
evidence demonstrates that overexpression of EST3 specifically suppresses the 
temperature-sensitive phenotypes of alleles within a defined region of Est2 (termed the 
TEN domain; amino acids 1-162) [245]. After developing methods to purify recombinant 
Est3 and Est2TEN protein from Escherichia. coli and assessing a number of different 
mutants for both proteins (Chapter III and data not shown), I found that Est3 interacts 
directly with the TEN domain of Est2 in Saccharomyces cerevisiae and that this 
interaction depends upon at least three residues within the central region of Est3 
(glutamate 114, threonine 115, and asparagine 117) [242]. Interestingly, using 
complementary approaches (in vitro co-purification and in vivo co-immunoprecipitation 
assays) I determined that EST3 mutants that disrupt telomerase assembly in vivo do not 
necessarily have the same effects in a direct binding assay. For example, mutation of Est3 
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aspartate 166 and glutamine 167 (Est3DQ) resulted in a dramatic decrease in telomerase 
assembly in vivo, but only modestly reduced interaction with the Est2TEN domain in vitro 
(Chapter III-Figures 3.3 and 3.5). This result suggests that the assembly defect in vivo is 
due to perturbation of interactions that lie outside of the Est2 TEN domain [242]. These 
data also demonstrate that interaction with the TEN domain is insufficient for complex 
assembly in vivo. Mutation of lysine 71 to alanine resulted in the least severe assembly 
defect in vivo, but abrogated binding to the TEN domain in vitro (this could be due to a 
minor disruption in tertiary structure), suggesting that interaction with the Est2 TEN 
domain is not necessary for assembly in vivo and that additional interactions must exist 
[242]. Combining both in vivo and in vitro techniques, I have created assays to better 
determine the individual contributions of Est3 and Est2 to assembly of the telomerase 
complex. 
 Making more mutations within each protein and determining their binding 
phenotypes both in vitro and in vivo could further characterize the interaction(s) between 
Est3 and Est2TEN. I have attempted to purify other N-terminal regions of Est2 (Regions II 
and III). Neither of these proteins expresses well in E. coli, nor are they soluble in any 
conditions I have tried. Interestingly, although a small amount of the N-terminal half of 
Est2 (comprising the TEN domain and Regions II and III) can be expressed, it is rapidly 
degraded to generate a fragment corresponding to the TEN domain (Kanika Pulliam, 
unpublished data). This result suggests that Regions II and III may be unstable outside 
the context of the full-length protein. It is unlikely that either of these regions interacts 
directly with Est3 since the temperature-sensitive alleles within Regions II and III were 
not suppressed upon overexpression of Est3 (as was seen for the TEN domain) [245]. 
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Even so, assessing if these regions do have direct interactions with Est3 will be difficult if 
they cannot be purified. To determine their contribution, the full-length protein would 
need to be expressed and purified and point mutations made within either Region II or 
Region III. 
 Where within the TEN domain of the Est2 protein does Est3 interact? In an 
attempt to better understand the function of Est2’s N-terminus, large alanine block 
mutations of 10 consecutive amino acids changed to alanine were created within each 
region (TEN and Regions II and III) of Est2.  Est2ala1, which is in the TEN domain, 
retains its ability to extend a primer in vitro and bind RNA.  However, a strain expressing 
this allele at WT levels still senesces [98]. This mutant phenocopies strains that are 
deleted for EST1 and EST3.  Co-immunoprecipitation (coIP) experiments revealed that 
Est2ala1 failed to pull-down Est1 or Est3. [245]. Intriguingly, another alanine block 
mutation within the TEN domain, Est2ala4, has preliminarily shown a specific loss of Est3 
binding, while Est1 binding is maintained, albeit at a lower level than WT cells (K. 
Friedman and J. Talley, unpublished data). These results need to be repeated, but suggest 
that Est2TEN and Est3 may interact within or near the residues mutated in the Est2ala4 allele 
(amino acids 110-119).  It is important to note that the ala4 mutant protein is somewhat 
unstable and supports reduced in vitro telomerase activity, most likely explained by a 
concomitant reduction in TLC1 RNA binding.  These phenotypes are probably due to 
gross changes in protein structure, therefore generating less disruptive mutations is 
critical for analyzing what contribution the ala4 region of Est2 may have in binding Est3. 
 Our lab worked with the Center for Structural Biology at Vanderbilt to generate a 
3-dimensional model of the S. cerevisiae Est2 TEN domain based upon the crystal 
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structure of the Tetrahymena thermophila TEN domain [217]. Based on this model, there 
are three positively charged residues (lysine 111, lysine 116 and histidine 119) within 
Est2ala4 that are predicted to be surface-exposed and therefore, good candidates for sites 
of interaction with Est3. Additionally, there are three other alleles already available in the 
lab: glycine 112 to alanine, alanine 113 to aspartate and the tryptophan 115 to alanine. 
These mutations can be tested for complex assembly with TLC1 RNA, Est1 and Est3 in 
vivo and recombinant protein generated to test His6-Est3 binding in vitro. Alleles that 
retain assembly with TLC1 RNA and Est1 while losing Est3 binding in vivo would be 
great candidates to test in the in vitro binding assay. 
 Since it does appear that Est3 makes multiple contacts with telomerase 
components, the development of additional in vitro assays could aid the dissecting of this 
seemingly complex set of interactions. Full-length Est2 and Est1 can be expressed using 
rabbit reticulocyte lysate ([212, 224] and J. Ferguson, unpublished data). Therefore, the 
interaction of Est3 with Est2 and/or Est1 could be assessed using an in vitro 
transcription/translation system. The rabbit reticulocyte lysate system has several 
advantages: it allows more rapid protein production than expression and purification from 
E. coli (1 day  vs. 5-7 days) and the addition of radiolabel is facile (potentially 
eliminating the need for epitope tags). Single point mutations or large deletions within 
either Est2 or Est1 could be made and incubated with recombinant His6-Est3 from E. coli. 
The His-tagged Est3 could be isolated using affinity purification and Est2 or Est1 could 
be detected using a PhosphoImager. Alternatively, an epitope tag could be cloned on 
either EST2 or EST1 (negating the need for radioactivity) and the reciprocal purification 
could be attempted and detected using traditional Western blotting techniques. 
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 Another possible means of determining how Est3 is assembling with telomerase is 
using proteins purified from yeast extract. For example, to understand how Est3 and Est1 
might be interacting in an in vivo context, yeast protein extract could be made from yeast 
containing an epitope-tagged version of Est1. His6-Est3 could be added and then Est1 
could be immunopurified from the yeast extract. If recombinant Est3 is co-
immunoprecipitated then mutations in either protein could be assessed for their ability to 
interact with each other. Abigail Riddle, a graduate student in the lab is attempting this 
type of experiment and having variable success. The major caveat to this experiment is 
that since other telomerase complex components are present in the yeast extract, 
determining the specificity of this interaction is difficult. Additionally, because 
telomerase assembles Est3 in S phase and not earlier, it might be important to enrich for 
an Est3-competent complex by blocking cells in S or G2 phase. Alternatively, blocking 
cells in G1 phase using alpha factor and then releasing them to grow synchronously until 
they reach mid-late S phase and then harvesting them could also enrich for an Est3-
competent telomerase. 
   
Est3 as a TPP1 homologue 
 Though EST3 was discovered in a genetic screen in 1996 its function within the 
complex has remained unknown [210]. It has been suggested to unwind DNA/RNA 
duplexes in vitro in a non-sequence specific manner [228]. However, no mutation created 
within Est3 decreased or changed this function, suggesting that this activity could be due 
to a contaminant or an indirect mechanism [228]. Recently, it has been demonstrated with 
NMR that titration of DNA into an Est3 sample does not shift Est3 crosspeaks, 
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suggesting that Est3 from S. cerevisiae is unable to bind DNA directly (or at least Est3 
does not bind the DNA primers used in this experiment) [194]. Est3 in S. castelli and C. 
albicans influence telomerase activity in vitro, though no change in telomerase activity 
upon loss of the Est3 protein was previously documented in S. cerevisiae (the more 
widely studied yeast species) [194, 248].  
 When the amino acid sequence of Est3 from C. albicans and S. cerevisiae was 
queried against different structural prediction servers, the OB fold domain of TPP1 was 
the highest-ranking hit, suggesting that the mammalian shelterin protein, TPP1, could be 
a homologue of Est3 [226, 227]. TPP1 consists of at least three structural domains, one 
that binds to POT1, another that binds to TIN2, and an N-terminal domain that adopts an 
OB fold [37]. TPP1 has at least three important functions: (1) it “shelters” the telomere 
from nucleolytic degradation as a member of the shelterin complex [37]; (2) it works with 
POT1 to protect the telomere and increase telomerase processivity [33, 264] and (3) it 
helps localize telomerase to the telomere [252, 265]. Since TPP1 influences processivity 
and telomerase localization in mammalian cells and the Est3 protein from other yeast 
species affects telomerase activity, I was interested in determining if Est3 in S. cerevisiae 
influences telomerase function [194, 248, 253]. To address this possibility, I initiated a 
collaboration with Brian Freeman’s lab at the University of Illinois. Since all that is 
required to do Dr. Freeman’s telomerase assay is recombinant protein (such as the Est3 
protein I generated for in vitro binding assays), I felt that using his techniques could 
easily assess an influence, if any, Est3 might have on telomerase activity. Strikingly, 
addition of Est3 to partially purified telomerase from yeast extract caused a robust 
stimulation of overall telomerase activity in the primer extension assay (Chapter IV). It is 
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important to note that addition of Est3 did not increase the number of repeats added to the 
primer (called repeat addition processivity) or change the pattern of telomere addition. 
These data suggest that Est3 may act at an early step of telomerase activity, by 
influencing the probability that a primer will be elongated. For example, Est3 may 
influence appropriate positioning of telomerase on the DNA substrate or may increase 
telomerase’s affinity for the substrate through conformational changes. 
 Mutations within Est3 that reduced or completely disrupted binding to Est2TEN in 
vitro also negatively affected telomerase stimulation, supporting the idea that assembly of 
Est3 into the telomerase complex is a prerequisite for Est3 stimulation. Unfortunately, I 
was unable to identify Est3 variants that retain binding in vitro but disrupt stimulation. 
Identification of such alleles is critical to an understanding of the molecular basis for 
stimulation and to verify that the stimulatory function observed in vitro contributes to 
telomerase function in vivo. Although our lab is very interested in finding this type of 
mutation, it is possible that no such region or mutation exists within Est3. For example, if 
assembly of Est3 into the complex induces a conformational change within Est3 that is 
critical for its stimulation function, then complex assembly and telomerase activation 
cannot be separated. 
 I can envision two primary methods of defining the “stimulatory” region of Est3: 
(1) using available mutation information to generate a number of recombinant Est3 
mutants that are tested both for their ability to bind Est2TEN and to stimulate telomerase 
activity in vitro and (2) designing a genetic screen to determine a minimal stimulatory 
Est3 fragment. The former would require a considerable amount of time and energy and 
is dependent upon choosing the correct alleles to study. In contrast, the second approach 
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might allow a larger number of random mutants to be screened. An undergraduate, Leslie 
Maness, and I worked on the development of a genetic strategy to define a minimal 
stimulatory Est3 fragment by constitutively fusing Est3 to Est2. After considerable trial 
and error, we identified an Est2-Est3 protein fusion construct that restores nearly normal 
telomere length in an est3∆ est2∆ yeast strain, demonstrating that the fusion protein is 
functional (L. Maness, unpublished data). We reasoned that forced assembly of Est3 into 
the complex by fusion with Est2 would bypass mutations that specifically disrupt Est3 
assembly, while those that affect stimulation would not be bypassed. Laura Bechard, a 
post-doctoral fellow in the lab, is currently pursuing this idea by selecting functional 
alleles from a library of Est2-Est3 fusion proteins containing random deletions within the 
EST3 coding sequence. This approach should help determine if there is any region or 
domain of Est3 that is solely responsible for its stimulation activity. 
 
Implications 
 In 2009, Drs. Elizabeth Blackburn, Jack Szostak, and Carol Greider won the 
Nobel Prize in Medicine for their work in understanding how chromosomes are protected 
by telomeres and the discovery of the enzyme telomerase. Their initial discoveries of 
telomeres and telomerase have allowed researchers to gain greater insight into how this 
important and fundamental process of DNA maintenance works. Through the study of 
both mouse models and human genetics, it has become increasingly apparent that these 
dynamic DNA structures are critically important during cellular and organismal aging 
and during development and continued proliferation of cancer cells. [168]. Since 
telomeres and telomerase are highly conserved in most eukaryotic organisms, the study 
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of telomerase regulation in yeast has implications for the understanding of similar 
processes in human cells.  
 Prior to the work presented in this thesis, little was known regarding the assembly 
and function of the telomerase component Est3. While this work was in progress, TPP1 
was proposed to be an Est3 homologue in higher eukaryotes. However, there was little 
evidence, beyond structural modeling, that the proteins were functionally related. 
Through my work, I have determined that Est3 interacts with the catalytic protein subunit 
of telomerase through its N-terminal TEN domain and have demonstrated that Est3 can 
stimulate telomerase activity. Both of these functions may be analogous to those of TPP1: 
TPP1 and TERT (the Est2 homologue in humans) interact and this interaction stimulates 
the association of TERT with as well as telomerase processivity [252, 253, 265]. These 






1. Muller, H.J., The remaking of chromosomes. Collecting Net, 1938. 13: p. 181-
 198. 
 
2. McClintock, B., Cytological observations of deficiencies involving known genes, 
translocations and an inversion in Zea mays. Missouri Agricultural Experiment 
Research Station Research Bulletin, 1931. 163: p. 4-30. 
 
3. McClintock, B., The behavior in successive nuclear divisions of a chromosome 
broken at meiosis. Genetics, 1939. 25: p. 405-416. 
 
4. Olovnikov, A.M., Principle of marginotomy in template synthesis of 
polynucleotides. Dokl Akad Nauk SSSR, 1971. 201(6): p. 1496-9. 
 
5. Watson, J.D., Origin of concatemeric T7 DNA. Nat New Biol, 1972. 239(94): p. 
197-201. 
 
6. Hayflick, L. and P.S. Moorhead, The serial cultivation of human diploid cell 
strains. Exp Cell Res, 1961. 25: p. 585-621. 
 
7. Olovnikov, A.M., A theory of marginotomy. The incomplete copying of template 
margin in enzymic synthesis of polynucleotides and biological significance of the 
phenomenon. J Theor Biol, 1973. 41(1): p. 181-90. 
 
8. Cavalier-Smith, T., Palindromic base sequences and replication of eukaryote 
chromosome ends. Nature, 1974. 250(5466): p. 467-70. 
 
9. Hoffman, D.C., et al., Macronuclear gene-sized molecules of hypotrichs. Nucleic 
Acids Res, 1995. 23(8): p. 1279-83. 
 
10. Blackburn, E.H. and J.G. Gall, A tandemly repeated sequence at the termini of the 
extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol, 1978. 
120(1): p. 33-53. 
 
11. Price, C., Ciliate Telomeres. Second ed. Telomeres, ed. T. de Lange, V. 




12. Szostak, J.W. and E.H. Blackburn, Cloning yeast telomeres on linear plasmid 
vectors. Cell, 1982. 29(1): p. 245-55. 
 
13. Shampay, J., J.W. Szostak, and E.H. Blackburn, DNA sequences of telomeres 
maintained in yeast. Nature, 1984. 310(5973): p. 154-7. 
 
14. Blackburn, E.H., Telomeres and their synthesis. Harvey Lect, 1990. 86: p. 1-18. 
 
15. Blackburn, E., Appendix: A personal Account of the Discovery of Telomerase. 2 
ed. Telomeres, ed. T. de Lange, V. Lundblad, and E. Blackburn. 2006, Cold 
Spring Harbor, NY: Cold Spring Harbor Laboratories. 
 
16. Greider, C.W. and E.H. Blackburn, Identification of a specific telomere terminal 
transferase activity in Tetrahymena extracts. Cell, 1985. 43(2 Pt 1): p. 405-13. 
 
17. Gomes, N.M., J.W. Shay, and W.E. Wright, Telomere biology in Metazoa. FEBS 
Lett, 2010. 584(17): p. 3741-51. 
 
18. O'Sullivan, R.J. and J. Karlseder, Telomeres: protecting chromosomes against 
genome instability. Nat Rev Mol Cell Biol. 11(3): p. 171-81. 
 
19. Taddei, A., H. Schober, and S.M. Gasser, The budding yeast nucleus. Cold Spring 
Harb Perspect Biol. 2(8): p. a000612. 
 
20. Harley, C.B., Telomerase is not an oncogene. Oncogene, 2002. 21(4): p. 494-502. 
 
21. Ottaviani, A., E. Gilson, and F. Magdinier, Telomeric position effect: from the 
yeast paradigm to human pathologies? Biochimie, 2008. 90(1): p. 93-107. 
 
22. Shippen, D.E., Plant Telomeres. Second ed. Telomeres, ed. T. de Lange, V. 
Lundblad, and E.H. Blackburn. 2006, Cold Spring Harbor, NY: Cold Spring 
Harbor Laboratory Press. 
 
23. Wellinger, R.J., et al., Evidence for a new step in telomere maintenance. Cell, 
1996. 85(3): p. 423-33. 
 
24. Dionne, I. and R.J. Wellinger, Cell cycle-regulated generation of single-stranded 
G-rich DNA in the absence of telomerase. Proc Natl Acad Sci U S A, 1996. 
93(24): p. 13902-7. 
 
25. Larrivee, M., C. LeBel, and R.J. Wellinger, The generation of proper constitutive 
G-tails on yeast telomeres is dependent on the MRX complex. Genes Dev, 2004. 
18(12): p. 1391-6. 
 
26. Bonetti, D., et al., Multiple pathways regulate 3' overhang generation at S. 
cerevisiae telomeres. Mol Cell, 2009. 35(1): p. 70-81. 
 124 
 
27. Horvath, M.P., et al., Crystal structure of the Oxytricha nova telomere end 
binding protein complexed with single strand DNA. Cell, 1998. 95(7): p. 963-74. 
 
28. Gao, H., et al., RPA-like proteins mediate yeast telomere function. Nat Struct Mol 
Biol, 2007. 14(3): p. 208-14. 
 
29. Giraud-Panis, M.J., et al., CST meets shelterin to keep telomeres in check. Mol 
Cell, 2010. 39(5): p. 665-76. 
 
30. Raffa, G.D., et al., The Drosophila modigliani (moi) gene encodes a HOAP-
interacting protein required for telomere protection. Proc Natl Acad Sci U S A, 
2009. 106(7): p. 2271-6. 
 
31. Raffa, G.D., et al., Verrocchio, a Drosophila OB fold-containing protein, is a 
component of the terminin telomere-capping complex. Genes Dev, 2010. 24(15): 
p. 1596-601. 
 
32. Baumann, P. and T.R. Cech, Pot1, the putative telomere end-binding protein in 
fission yeast and humans. Science, 2001. 292(5519): p. 1171-5. 
 
33. Wang, F., et al., The POT1-TPP1 telomere complex is a telomerase processivity 
factor. Nature, 2007. 445(7127): p. 506-10. 
 
34. Kastan, M.B. and J. Bartek, Cell-cycle checkpoints and cancer. Nature, 2004. 
432(7015): p. 316-323. 
 
35. Broccoli, D., et al., Human telomeres contain two distinct Myb-related proteins, 
TRF1 and TRF2. Nat Genet, 1997. 17(2): p. 231-5. 
 
36. Griffith, J.D., et al., Mammalian telomeres end in a large duplex loop. Cell, 1999. 
97(4): p. 503-14. 
 
37. de Lange, T., Shelterin: the protein complex that shapes and safeguards human 
telomeres. Genes Dev, 2005. 19(18): p. 2100-10. 
 
38. Karlseder, J., et al., p53- and ATM-dependent apoptosis induced by telomeres 
lacking TRF2. Science, 1999. 283(5406): p. 1321-5. 
 
39. Celli, G.B. and T. de Lange, DNA processing is not required for ATM-mediated 
telomere damage response after TRF2 deletion. Nat Cell Biol, 2005. 7(7): p. 712-
8. 
 
40. Konishi, A. and T. de Lange, Cell cycle control of telomere protection and NHEJ 
revealed by a ts mutation in the DNA-binding domain of TRF2. Genes Dev, 2008. 
22(9): p. 1221-30. 
 125 
 
41. Chen, Y., et al., A conserved motif within RAP1 has diversified roles in telomere 
protection and regulation in different organisms. Nat Struct Mol Biol, 2011. 
18(2): p. 213-21. 
 
42. Sfeir, A., et al., Loss of Rap1 induces telomere recombination in the absence of 
NHEJ or a DNA damage signal. Science, 2010. 327(5973): p. 1657-61. 
 
43. Martinez, P., et al., Mammalian Rap1 controls telomere function and gene 
expression through binding to telomeric and extratelomeric sites. Nat Cell Biol, 
2010. 12(8): p. 768-80. 
 
44. Sfeir, A., et al., Mammalian telomeres resemble fragile sites and require TRF1 
for efficient replication. Cell, 2009. 138(1): p. 90-103. 
 
45. Wu, L., et al., Pot1 deficiency initiates DNA damage checkpoint activation and 
aberrant homologous recombination at telomeres. Cell, 2006. 126(1): p. 49-62. 
 
46. Denchi, E.L. and T. de Lange, Protection of telomeres through independent 
control of ATM and ATR by TRF2 and POT1. Nature, 2007. 448(7157): p. 1068-
71. 
 
47. Guo, X., et al., Dysfunctional telomeres activate an ATM-ATR-dependent DNA 
damage response to suppress tumorigenesis. Embo J, 2007. 26(22): p. 4709-19. 
 
48. Gong, Y. and T. de Lange, A Shld1-controlled POT1a provides support for 
repression of ATR signaling at telomeres through RPA exclusion. Mol Cell, 2010. 
40(3): p. 377-87. 
 
49. Flynn, R.L., et al., TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on 
telomeric single-stranded DNA. Nature, 2011. 471(7339): p. 532-6. 
 
50. Hockemeyer, D., et al., Recent expansion of the telomeric complex in rodents: 
Two distinct POT1 proteins protect mouse telomeres. Cell, 2006. 126(1): p. 63-
77. 
 
51. Platner, G., Ueber die Entstchung des Nebenkerns und seine Beziehung zur 
Kerntheilung. Archives of Microscopic Anatomy, 1885. 26(1): p. 343-396. 
 
52. Eisen, G., The spermatogenesis of Batrachoseps. Polymorphous spermatogonia, 
auxocytes, and spermatocytes. Journal of Morphology, 1900. 17(1): p. 1-117. 
 
53. Scherthan, H., Meiotic Telomeres. Second ed. Telomeres, ed. T. de Lange, V. 
Lundblad, and E.H. Blackburn. 2006, Cold Spring Harbor, NY: Cold Spring 
Harbor Laboratory Press. 
 
 126 
54. Naito, T., A. Matsuura, and F. Ishikawa, Circular chromosome formation in a 
fission yeast mutant defective in two ATM homologues. Nat Genet, 1998. 20(2): p. 
203-6. 
 
55. Liu, L., et al., Irregular telomeres impair meiotic synapsis and recombination in 
mice. Proc Natl Acad Sci U S A, 2004. 101(17): p. 6496-501. 
 
56. Maddar, H., N. Ratzkovsky, and A. Krauskopf, Role for telomere cap structure in 
meiosis. Mol Biol Cell, 2001. 12(10): p. 3191-203. 
 
57. Hemann, M.T., et al., Telomere dysfunction triggers developmentally regulated 
germ cell apoptosis. Mol Biol Cell, 2001. 12(7): p. 2023-30. 
 
58. Kanoh, J. and F. Ishikawa, spRap1 and spRif1, recruited to telomeres by Taz1, 
are essential for telomere function in fission yeast. Curr Biol, 2001. 11(20): p. 
1624-30. 
 
59. Chikashige, Y. and Y. Hiraoka, Telomere binding of the Rap1 protein is required 
for meiosis in fission yeast. Curr Biol, 2001. 11(20): p. 1618-23. 
 
60. Nimmo, E.R., et al., Defective meiosis in telomere-silencing mutants of 
Schizosaccharomyces pombe. Nature, 1998. 392(6678): p. 825-8. 
 
61. Cooper, J.P., Y. Watanabe, and P. Nurse, Fission yeast Taz1 protein is required 
for meiotic telomere clustering and recombination. Nature, 1998. 392(6678): p. 
828-31. 
 
62. Alexander, M.K. and V.A. Zakian, Rap1p telomere association is not required for 
mitotic stability of a C(3)TA(2) telomere in yeast. Embo J, 2003. 22(7): p. 1688-
96. 
 
63. Trelles-Sticken, E., M.E. Dresser, and H. Scherthan, Meiotic telomere protein 
Ndj1p is required for meiosis-specific telomere distribution, bouquet formation 
and efficient homologue pairing. J Cell Biol, 2000. 151(1): p. 95-106. 
 
64. Chua, P.R. and G.S. Roeder, Tam1, a telomere-associated meiotic protein, 
functions in chromosome synapsis and crossover interference. Genes Dev, 1997. 
11(14): p. 1786-800. 
 
65. Conrad, M.N., A.M. Dominguez, and M.E. Dresser, Ndj1p, a meiotic telomere 
protein required for normal chromosome synapsis and segregation in yeast. 
Science, 1997. 276(5316): p. 1252-5. 
 
66. Podgornaya, O.I., et al., Nuclear envelope associated protein that binds telomeric 
DNAs. Mol Reprod Dev, 2000. 57(1): p. 16-25. 
 
 127 
67. Ding, D.Q., et al., Dynamics of homologous chromosome pairing during meiotic 
prophase in fission yeast. Dev Cell, 2004. 6(3): p. 329-41. 
 
68. Loidl, J. and H. Scherthan, Organization and pairing of meiotic chromosomes in 
the ciliate Tetrahymena thermophila. J Cell Sci, 2004. 117(Pt 24): p. 5791-801. 
 
69. Mondoux, M.A. and V.A. Zakian, Telomere Position Effect: Silencing Near the 
End. Second ed. Telomeres, ed. T. de Lange, V. Lundblad, and E.H. Blackburn. 
2006, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 576. 
 
70. Luo, K., M.A. Vega-Palas, and M. Grunstein, Rap1-Sir4 binding independent of 
other Sir, yKu, or histone interactions initiates the assembly of telomeric 
heterochromatin in yeast. Genes Dev, 2002. 16(12): p. 1528-39. 
 
71. Hecht, A., S. Strahl-Bolsinger, and M. Grunstein, Spreading of transcriptional 
repressor SIR3 from telomeric heterochromatin. Nature, 1996. 383(6595): p. 92-
6. 
 
72. Gravel, S., et al., Yeast Ku as a regulator of chromosomal DNA end structure. 
Science, 1998. 280(5364): p. 741-4. 
 
73. Martin, S.G., et al., Relocalization of telomeric Ku and SIR proteins in response 
to DNA strand breaks in yeast. Cell, 1999. 97(5): p. 621-33. 
 
74. Buck, S.W., J.J. Sandmeier, and J.S. Smith, RNA polymerase I propagates 
unidirectional spreading of rDNA silent chromatin. Cell, 2002. 111(7): p. 1003-
14. 
 
75. Renauld, H., et al., Silent domains are assembled continuously from the telomere 
and are defined by promoter distance and strength, and by SIR3 dosage. Genes 
Dev, 1993. 7(7A): p. 1133-45. 
 
76. Gartenberg, M.R., et al., Sir-mediated repression can occur independently of 
chromosomal and subnuclear contexts. Cell, 2004. 119(7): p. 955-67. 
 
77. Taddei, A., et al., Separation of silencing from perinuclear anchoring functions in 
yeast Ku80, Sir4 and Esc1 proteins. Embo J, 2004. 23(6): p. 1301-12. 
 
78. Andrulis, E.D., et al., Perinuclear localization of chromatin facilitates 
transcriptional silencing. Nature, 1998. 394(6693): p. 592-5. 
 
79. Zappulla, D.C., R. Sternglanz, and J. Leatherwood, Control of replication timing 
by a transcriptional silencer. Curr Biol, 2002. 12(11): p. 869-75. 
 
80. Stevenson, J.B. and D.E. Gottschling, Telomeric chromatin modulates replication 
timing near chromosome ends. Genes Dev, 1999. 13(2): p. 146-51. 
 128 
 
81. Therizols, P., et al., Telomere tethering at the nuclear periphery is essential for 
efficient DNA double strand break repair in subtelomeric region. J Cell Biol, 
2006. 172(2): p. 189-99. 
 
82. Baudat, F. and A. Nicolas, Clustering of meiotic double-strand breaks on yeast 
chromosome III. Proc Natl Acad Sci U S A, 1997. 94(10): p. 5213-8. 
 
83. Baur, J.A., et al., Telomere position effect in human cells. Science, 2001. 
292(5524): p. 2075-7. 
 
84. Lingner, J., et al., Reverse transcriptase motifs in the catalytic subunit of 
telomerase. Science, 1997. 276(5312): p. 561-7. 
 
85. Gillis, A.J., A.P. Schuller, and E. Skordalakes, Structure of the Tribolium 
castaneum telomerase catalytic subunit TERT. Nature, 2008. 455(7213): p. 633-7. 
 
86. Greider, C.W. and E.H. Blackburn, A telomeric sequence in the RNA of 
Tetrahymena telomerase required for telomere repeat synthesis. Nature, 1989. 
337(6205): p. 331-7. 
 
87. Shippen-Lentz, D. and E.H. Blackburn, Functional evidence for an RNA template 
in telomerase. Science, 1990. 247(4942): p. 546-52. 
 
88. Blasco, M.A., et al., Functional characterization and developmental regulation of 
mouse telomerase RNA. Science, 1995. 269(5228): p. 1267-70. 
 
89. Feng, J., et al., The RNA component of human telomerase. Science, 1995. 
269(5228): p. 1236-41. 
 
90. Singer, M.S. and D.E. Gottschling, TLC1: template RNA component of 
Saccharomyces cerevisiae telomerase. Science, 1994. 266(5184): p. 404-9. 
 
91. Zappulla, D.C. and T.R. Cech, Yeast telomerase RNA: a flexible scaffold for 
protein subunits. Proc Natl Acad Sci U S A, 2004. 101(27): p. 10024-9. 
 
92. Bachand, F., G. Kukolj, and C. Autexier, Expression of hTERT and hTR in cis 
reconstitutes and active human telomerase ribonucleoprotein. Rna, 2000. 6(5): p. 
778-84. 
 
93. Lingner, J. and T.R. Cech, Purification of telomerase from Euplotes aediculatus: 




94. Hammond, P.W., T.N. Lively, and T.R. Cech, The anchor site of telomerase from 
Euplotes aediculatus revealed by photo-cross-linking to single- and double-
stranded DNA primers. Mol Cell Biol, 1997. 17(1): p. 296-308. 
 
95. Lue, N.F., A physical and functional constituent of telomerase anchor site. J Biol 
Chem, 2005. 280(28): p. 26586-91. 
 
96. Lue, N.F., Sequence-specific and conformation-dependent binding of yeast 
telomerase RNA to single-stranded telomeric DNA. Nucleic Acids Res, 1999. 
27(12): p. 2560-7. 
 
97. Chen, J.L. and C.W. Greider, Telomerase Biochemistry and Biogenesis. 
Telomeres, ed. T. de Lange, V. Lundblad, and E.H. Blackburn. 2006, Cold Spring 
Harbor, NY: Cold Spring Harbor Laboratory Press. 
 
98. Friedman, K.L. and T.R. Cech, Essential functions of amino-terminal domains in 
the yeast telomerase catalytic subunit revealed by selection for viable mutants. 
Genes Dev, 1999. 13(21): p. 2863-74. 
 
99. Nakamura, T.M., et al., Telomerase catalytic subunit homologs from fission yeast 
and human. Science, 1997. 277(5328): p. 955-9. 
 
100. Bryan, T.M., K.J. Goodrich, and T.R. Cech, Telomerase RNA bound by protein 
motifs specific to telomerase reverse transcriptase. Mol Cell, 2000. 6(2): p. 493-9. 
 
101. Beattie, T.L., et al., Polymerization defects within human telomerase are distinct 
from telomerase RNA and TEP1 binding. Mol Biol Cell, 2000. 11(10): p. 3329-
40. 
 
102. Armbruster, B.N., et al., N-terminal domains of the human telomerase catalytic 
subunit required for enzyme activity in vivo. Mol Cell Biol, 2001. 21(22): p. 7775-
86. 
 
103. Bachand, F. and C. Autexier, Functional regions of human telomerase reverse 
transcriptase and human telomerase RNA required for telomerase activity and 
RNA-protein interactions. Mol Cell Biol, 2001. 21(5): p. 1888-97. 
 
104. Lai, C.K., J.R. Mitchell, and K. Collins, RNA binding domain of telomerase 
reverse transcriptase. Mol Cell Biol, 2001. 21(4): p. 990-1000. 
 
105. Etheridge, K.T., et al., The nucleolar localization domain of the catalytic subunit 
of human telomerase. J Biol Chem, 2002. 277(27): p. 24764-70. 
 
106. Yang, Y., et al., Nucleolar localization of hTERT protein is associated with 
telomerase function. Exp Cell Res, 2002. 277(2): p. 201-9. 
 
 130 
107. Arai, K., et al., Two independent regions of human telomerase reverse 
transcriptase are important for its oligomerization and telomerase activity. J Biol 
Chem, 2002. 277(10): p. 8538-44. 
 
108. Armbruster, B.N., et al., Rescue of an hTERT mutant defective in telomere 
elongation by fusion with hPot1. Mol Cell Biol, 2004. 24(8): p. 3552-61. 
 
109. Nakamura, T.M. and T.R. Cech, Reversing time: origin of telomerase. Cell, 1998. 
92(5): p. 587-90. 
 
110. Counter, C.M., et al., The catalytic subunit of yeast telomerase. Proc Natl Acad 
Sci U S A, 1997. 94(17): p. 9202-7. 
 
111. Peng, Y., I.S. Mian, and N.F. Lue, Analysis of telomerase processivity: 
mechanistic similarity to HIV-1 reverse transcriptase and role in telomere 
maintenance. Mol Cell, 2001. 7(6): p. 1201-11. 
 
112. Beattie, T.L., et al., Functional multimerization of the human telomerase reverse 
transcriptase. Mol Cell Biol, 2001. 21(18): p. 6151-60. 
 
113. Banik, S.S., et al., C-terminal regions of the human telomerase catalytic subunit 
essential for in vivo enzyme activity. Mol Cell Biol, 2002. 22(17): p. 6234-46. 
 
114. Hossain, S., S. Singh, and N.F. Lue, Functional analysis of the C-terminal 
extension of telomerase reverse transcriptase. A putative "thumb" domain. J Biol 
Chem, 2002. 277(39): p. 36174-80. 
 
115. Huard, S., T.J. Moriarty, and C. Autexier, The C terminus of the human 
telomerase reverse transcriptase is a determinant of enzyme processivity. Nucleic 
Acids Res, 2003. 31(14): p. 4059-70. 
 
116. Seimiya, H., et al., Involvement of 14-3-3 proteins in nuclear localization of 
telomerase. Embo J, 2000. 19(11): p. 2652-61. 
 
117. Snow, B.E., et al., Functional conservation of the telomerase protein Est1 in 
humans. Curr Biol, 2003. 13(8): p. 698-704. 
 
118. Reichenbach, P., et al., A human homolog of yeast Est1 associates with 
telomerase and uncaps chromosome ends when overexpressed. Curr Biol, 2003. 
13(7): p. 568-74. 
 
119. Knight, S.W., et al., X-linked dyskeratosis congenita is predominantly caused by 
missense mutations in the DKC1 gene. Am J Hum Genet, 1999. 65(1): p. 50-8. 
 
 131 
120. Vulliamy, T., et al., Mutations in the telomerase component NHP2 cause the 
premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A, 
2008. 105(23): p. 8073-8. 
 
121. Venteicher, A.S., et al., A human telomerase holoenzyme protein required for 
Cajal body localization and telomere synthesis. Science, 2009. 323(5914): p. 644-
8. 
 
122. Harrington, L., et al., Human telomerase contains evolutionarily conserved 
catalytic and structural subunits. Genes Dev, 1997. 11(23): p. 3109-15. 
 
123. Meyerson, M., et al., hEST2, the putative human telomerase catalytic subunit 
gene, is up-regulated in tumor cells and during immortalization. Cell, 1997. 
90(4): p. 785-95. 
 
124. Lee, H., et al., Histone deacetylase 8 safeguards the human ever-shorter 
telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation. Mol Cell 
Biol, 2006. 26(14): p. 5259-69. 
 
125. Mitchell, J.R., J. Cheng, and K. Collins, A box H/ACA small nucleolar RNA-like 
domain at the human telomerase RNA 3' end. Mol Cell Biol, 1999. 19(1): p. 567-
76. 
 
126. Dragon, F., V. Pogacic, and W. Filipowicz, In vitro assembly of human H/ACA 
small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol 
Cell Biol, 2000. 20(9): p. 3037-48. 
 
127. Pogacic, V., F. Dragon, and W. Filipowicz, Human H/ACA small nucleolar RNPs 
and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol 
Cell Biol, 2000. 20(23): p. 9028-40. 
 
128. Fu, D. and K. Collins, Distinct biogenesis pathways for human telomerase RNA 
and H/ACA small nucleolar RNAs. Mol Cell, 2003. 11(5): p. 1361-72. 
 
129. Forsythe, H.L., et al., Stable association of hsp90 and p23, but Not hsp70, with 
active human telomerase. J Biol Chem, 2001. 276(19): p. 15571-4. 
 
130. Holt, S.E., et al., Functional requirement of p23 and Hsp90 in telomerase 
complexes. Genes Dev, 1999. 13(7): p. 817-26. 
 
131. Bachand, F., et al., The product of the survival of motor neuron (SMN) gene is a 
human telomerase-associated protein. Mol Biol Cell, 2002. 13(9): p. 3192-202. 
 
132. Khurts, S., et al., Nucleolin interacts with telomerase. J Biol Chem, 2004. 
279(49): p. 51508-15. 
 
 132 
133. Ting, N.S., et al., Human Ku70/80 interacts directly with hTR, the RNA 
component of human telomerase. Nucleic Acids Res, 2005. 33(7): p. 2090-8. 
 
134. Chai, W., et al., Human Ku70/80 associates physically with telomerase through 
interaction with hTERT. J Biol Chem, 2002. 277(49): p. 47242-7. 
 
135. Ford, L.P., J.W. Shay, and W.E. Wright, The La antigen associates with the 
human telomerase ribonucleoprotein and influences telomere length in vivo. Rna, 
2001. 7(8): p. 1068-75. 
 
136. Eversole, A. and N. Maizels, In vitro properties of the conserved mammalian 
protein hnRNP D suggest a role in telomere maintenance. Mol Cell Biol, 2000. 
20(15): p. 5425-32. 
 
137. Shay, J.W. and S. Bacchetti, A survey of telomerase activity in human cancer. Eur 
J Cancer, 1997. 33(5): p. 787-91. 
 
138. Cong, Y.S., J. Wen, and S. Bacchetti, The human telomerase catalytic subunit 
hTERT: organization of the gene and characterization of the promoter. Hum Mol 
Genet, 1999. 8(1): p. 137-42. 
 
139. Cong, Y.S., W.E. Wright, and J.W. Shay, Human telomerase and its regulation. 
Microbiol Mol Biol Rev, 2002. 66(3): p. 407-25, table of contents. 
 
140. Wu, K.J., et al., Direct activation of TERT transcription by c-MYC. Nat Genet, 
1999. 21(2): p. 220-4. 
 
141. Greenberg, R.A., et al., Telomerase reverse transcriptase gene is a direct target of 
c-Myc but is not functionally equivalent in cellular transformation. Oncogene, 
1999. 18(5): p. 1219-26. 
 
142. Kyo, S., et al., Sp1 cooperates with c-Myc to activate transcription of the human 
telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res, 2000. 28(3): 
p. 669-77. 
 
143. McMurray, H.R. and D.J. McCance, Human papillomavirus type 16 E6 activates 
TERT gene transcription through induction of c-Myc and release of USF-
mediated repression. J Virol, 2003. 77(18): p. 9852-61. 
 
144. Veldman, T., et al., Human papillomavirus E6 and Myc proteins associate in vivo 
and bind to and cooperatively activate the telomerase reverse transcriptase 
promoter. Proc Natl Acad Sci U S A, 2003. 100(14): p. 8211-6. 
 
145. Cerni, C., et al., Repression of in vivo growth of Myc/Ras transformed tumor cells 
by Mad1. Oncogene, 2002. 21(3): p. 447-59. 
 
 133 
146. Kanaya, T., et al., Adenoviral expression of p53 represses telomerase activity 
through down-regulation of human telomerase reverse transcriptase 
transcription. Clin Cancer Res, 2000. 6(4): p. 1239-47. 
 
147. Lin, S.Y. and S.J. Elledge, Multiple tumor suppressor pathways negatively 
regulate telomerase. Cell, 2003. 113(7): p. 881-9. 
 
148. Jenuwein, T. and C.D. Allis, Translating the histone code. Science, 2001. 
293(5532): p. 1074-80. 
 
149. Cong, Y.S. and S. Bacchetti, Histone deacetylation is involved in the 
transcriptional repression of hTERT in normal human cells. J Biol Chem, 2000. 
275(46): p. 35665-8. 
 
150. Li, J., et al., Specific targeting and constitutive association of histone deacetylase 
complexes during transcriptional repression. Genes Dev, 2002. 16(6): p. 687-92. 
 
151. Atkinson, S.P., et al., Lack of telomerase gene expression in alternative 
lengthening of telomere cells is associated with chromatin remodeling of the hTR 
and hTERT gene promoters. Cancer Res, 2005. 65(17): p. 7585-90. 
 
152. Liu, C., et al., The telomerase reverse transcriptase (hTERT) gene is a direct 
target of the histone methyltransferase SMYD3. Cancer Res, 2007. 67(6): p. 2626-
31. 
 
153. Zhu, Q., et al., Lysine-specific demethylase 1 (LSD1) Is required for the 
transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. 
PLoS One, 2008. 3(1): p. e1446. 
 
154. Zhu, J., Y. Zhao, and S. Wang, Chromatin and epigenetic regulation of the 
telomerase reverse transcriptase gene. Protein Cell, 2010. 1(1): p. 22-32. 
 
155. Kharbanda, S., et al., Regulation of the hTERT telomerase catalytic subunit by the 
c-Abl tyrosine kinase. Curr Biol, 2000. 10(10): p. 568-75. 
 
156. Kim, J.H., et al., Ubiquitin ligase MKRN1 modulates telomere length homeostasis 
through a proteolysis of hTERT. Genes Dev, 2005. 19(7): p. 776-81. 
 
157. Tomlinson, R.L., et al., Cell cycle-regulated trafficking of human telomerase to 
telomeres. Mol Biol Cell, 2006. 17(2): p. 955-65. 
 
158. Matera, A.G. and K.B. Shpargel, Pumping RNA: nuclear bodybuilding along the 
RNP pipeline. Curr Opin Cell Biol, 2006. 18(3): p. 317-24. 
 
159. Sirri, V., et al., Nucleolus: the fascinating nuclear body. Histochem Cell Biol, 
2008. 129(1): p. 13-31. 
 134 
 
160. Kimura, A., et al., Induction of hTERT expression and phosphorylation by 
estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene, 2004. 
23(26): p. 4505-15. 
 
161. Lukowiak, A.A., et al., The snoRNA domain of vertebrate telomerase RNA 
functions to localize the RNA within the nucleus. Rna, 2001. 7(12): p. 1833-44. 
 
162. Jady, B.E., et al., Cell cycle-dependent recruitment of telomerase RNA and Cajal 
bodies to human telomeres. Mol Biol Cell, 2006. 17(2): p. 944-54. 
 
163. Harley, C.B., A.B. Futcher, and C.W. Greider, Telomeres shorten during ageing 
of human fibroblasts. Nature, 1990. 345(6274): p. 458-60. 
 
164. Allsopp, R.C., et al., Telomere length predicts replicative capacity of human 
fibroblasts. Proc Natl Acad Sci U S A, 1992. 89(21): p. 10114-8. 
 
165. Osterhage, J.L. and K.L. Friedman, Chromosome end maintenance by telomerase. 
J Biol Chem, 2009. 284(24): p. 16061-5. 
 
166. Forsyth, N.R., W.E. Wright, and J.W. Shay, Telomerase and differentiation in 
multicellular organisms: turn it off, turn it on, and turn it off again. 
Differentiation, 2002. 69(4-5): p. 188-97. 
 
167. Shay, J.W. and W.E. Wright, Telomerase and Human Cancer. Telomeres, ed. T. 
de Lange, V. Lundblad, and E. Blackburn. 2006, Cold Spring Harbor, NY: Cold 
Spring Harbor Laboratory Press. 
 
168. Kappei, D. and J.A. Londono-Vallejo, Telomere length inheritance and aging. 
Mech Ageing Dev, 2008. 129(1-2): p. 17-26. 
 
169. Baird, D.M. and D. Kipling, The extent and significance of telomere loss with 
age. Ann N Y Acad Sci, 2004. 1019: p. 265-8. 
 
170. Hao, L.Y., et al., Short telomeres, even in the presence of telomerase, limit tissue 
renewal capacity. Cell, 2005. 123(6): p. 1121-31. 
 
171. Calado, R.T. and N.S. Young, Telomere diseases. N Engl J Med, 2009. 361(24): 
p. 2353-65. 
 
172. Yamaguchi, H., et al., Mutations in TERT, the gene for telomerase reverse 
transcriptase, in aplastic anemia. N Engl J Med, 2005. 352(14): p. 1413-24. 
 
173. Valdes, A.M., et al., Obesity, cigarette smoking, and telomere length in women. 
Lancet, 2005. 366(9486): p. 662-4. 
 
 135 
174. Epel, E.S., et al., Cell aging in relation to stress arousal and cardiovascular 
disease risk factors. Psychoneuroendocrinology, 2006. 31(3): p. 277-87. 
 
175. Epel, E.S., et al., Accelerated telomere shortening in response to life stress. Proc 
Natl Acad Sci U S A, 2004. 101(49): p. 17312-5. 
 
176. Lee, D.C., et al., Effect of long-term hormone therapy on telomere length in 
postmenopausal women. Yonsei Med J, 2005. 46(4): p. 471-9. 
 
177. Mainous, A.G., 3rd, et al., Leukocyte telomere length and marital status among 
middle-aged adults. Age Ageing. 40(1): p. 73-8. 
 
178. Puterman, E., et al., The power of exercise: buffering the effect of chronic stress 
on telomere length. PLoS One. 5(5): p. e10837. 
 
179. Kiefer, A., et al., Dietary restraint and telomere length in pre- and 
postmenopausal women. Psychosom Med, 2008. 70(8): p. 845-9. 
 
180. Diede, S.J. and D.E. Gottschling, Telomerase-mediated telomere addition in vivo 
requires DNA primase and DNA polymerases alpha and delta. Cell, 1999. 99(7): 
p. 723-33. 
 
181. Marcand, S., et al., Cell cycle restriction of telomere elongation. Curr Biol, 2000. 
10(8): p. 487-90. 
 
182. Wellinger, R.J., A.J. Wolf, and V.A. Zakian, Saccharomyces telomeres acquire 
single-strand TG1-3 tails late in S phase. Cell, 1993. 72(1): p. 51-60. 
 
183. Shore, D. and A. Bianchi, Telomere length regulation: coupling DNA end 
processing to feedback regulation of telomerase. Embo J, 2009. 28(16): p. 2309-
22. 
 
184. Vodenicharov, M.D. and R.J. Wellinger, DNA degradation at unprotected 
telomeres in yeast is regulated by the CDK1 (Cdc28/Clb) cell-cycle kinase. Mol 
Cell, 2006. 24(1): p. 127-37. 
 
185. Vodenicharov, M.D., N. Laterreur, and R.J. Wellinger, Telomere capping in non-
dividing yeast cells requires Yku and Rap1. Embo J, 2010. 29(17): p. 3007-19. 
 
186. Pennock, E., K. Buckley, and V. Lundblad, Cdc13 delivers separate complexes to 
the telomere for end protection and replication. Cell, 2001. 104(3): p. 387-96. 
 
187. Chandra, A., et al., Cdc13 both positively and negatively regulates telomere 
replication. Genes Dev, 2001. 15(4): p. 404-14. 
 
 136 
188. Evans, S.K. and V. Lundblad, Est1 and Cdc13 as comediators of telomerase 
access. Science, 1999. 286(5437): p. 117-20. 
 
189. Garvik, B., M. Carson, and L. Hartwell, Single-stranded DNA arising at 
telomeres in cdc13 mutants may constitute a specific signal for the RAD9 
checkpoint. Mol Cell Biol, 1995. 15(11): p. 6128-38. 
 
190. Taggart, A.K., S.C. Teng, and V.A. Zakian, Est1 as a cell cycle-regulated 
activator of telomere-bound telomerase. Science, 2002. 297(5583): p. 1023-6. 
 
191. Fisher, T.S., A.K. Taggart, and V.A. Zakian, Cell cycle-dependent regulation of 
yeast telomerase by Ku. Nat Struct Mol Biol, 2004. 11(12): p. 1198-205. 
 
192. Osterhage, J.L., J.M. Talley, and K.L. Friedman, Proteasome-dependent 
degradation of Est1 regulates the cell cycle-restricted assembly of telomerase in 
Saccharomyces cerevisiae. Nat Struct Mol Biol, 2006. 13(8): p. 720-8. 
 
193. Tuzon, C.T., et al., The Saccharomyces cerevisiae Telomerase Subunit Est3 Binds 
Telomeres in a Cell Cycle- and Est1-Dependent Manner and Interacts Directly 
with Est1 In Vitro. PLoS Genet, 2011. 7(5): p. e1002060. 
 
194. Lee, J., et al., Investigating the role of the Est3 protein in yeast telomere 
replication. Nucleic Acids Res, 2010. 38(7): p. 2279-90. 
 
195. Yen, W.-F., et al., Telomerase regulatory subunit Est3 in two Candida species 
physically interacts with the TEN domain of TERT and telomeric DNA. 
Proceedings of the National Academy of Sciences, 2011. 
 
196. Teixeira, M.T., et al., Telomere length homeostasis is achieved via a switch 
between telomerase- extendible and -nonextendible states. Cell, 2004. 117(3): p. 
323-35. 
 
197. Marcand, S., E. Gilson, and D. Shore, A protein-counting mechanism for telomere 
length regulation in yeast. Science, 1997. 275(5302): p. 986-90. 
 
198. Dionne, I. and R.J. Wellinger, Processing of telomeric DNA ends requires the 
passage of a replication fork. Nucleic Acids Res, 1998. 26(23): p. 5365-71. 
 
199. Bianchi, A. and D. Shore, Early replication of short telomeres in budding yeast. 
Cell, 2007. 128(6): p. 1051-62. 
 
200. Gao, H., et al., Telomerase recruitment in Saccharomyces cerevisiae is not 




201. Maringele, L. and D. Lydall, EXO1-dependent single-stranded DNA at telomeres 
activates subsets of DNA damage and spindle checkpoint pathways in budding 
yeast yku70Delta mutants. Genes Dev, 2002. 16(15): p. 1919-33. 
 
202. Diede, S.J. and D.E. Gottschling, Exonuclease activity is required for sequence 
addition and Cdc13p loading at a de novo telomere. Curr Biol, 2001. 11(17): p. 
1336-40. 
 
203. Prescott, J. and E.H. Blackburn, Telomerase RNA mutations in Saccharomyces 
cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. 
Genes Dev, 1997. 11(4): p. 528-40. 
 
204. Puglisi, A., et al., Distinct roles for yeast Stn1 in telomere capping and telomerase 
inhibition. Embo J, 2008. 27(17): p. 2328-39. 
 
205. Qi, H. and V.A. Zakian, The Saccharomyces telomere-binding protein Cdc13p 
interacts with both the catalytic subunit of DNA polymerase alpha and the 
telomerase-associated est1 protein. Genes Dev, 2000. 14(14): p. 1777-88. 
 
206. McGee, J.S., et al., Reduced Rif2 and lack of Mec1 target short telomeres for 
elongation rather than double-strand break repair. Nat Struct Mol Biol, 2010. 
17(12): p. 1438-45. 
 
207. Hirano, Y., K. Fukunaga, and K. Sugimoto, Rif1 and rif2 inhibit localization of 
tel1 to DNA ends. Mol Cell, 2009. 33(3): p. 312-22. 
 
208. Sabourin, M., C.T. Tuzon, and V.A. Zakian, Telomerase and Tel1p preferentially 
associate with short telomeres in S. cerevisiae. Mol Cell, 2007. 27(4): p. 550-61. 
 
209. Lundblad, V. and J.W. Szostak, A mutant with a defect in telomere elongation 
leads to senescence in yeast. Cell, 1989. 57(4): p. 633-43. 
 
210. Lendvay, T.S., et al., Senescence mutants of Saccharomyces cerevisiae with a 
defect in telomere replication identify three additional EST genes. Genetics, 1996. 
144(4): p. 1399-412. 
 
211. Lingner, J., et al., Three Ever Shorter Telomere (EST) genes are dispensable for 
in vitro yeast telomerase activity. Proc Natl Acad Sci U S A, 1997. 94(21): p. 
11190-5. 
 
212. Zappulla, D.C., K. Goodrich, and T.R. Cech, A miniature yeast telomerase RNA 
functions in vivo and reconstitutes activity in vitro. Nat Struct Mol Biol, 2005. 
12(12): p. 1072-7. 
 
213. Hughes, T.R., et al., The Est3 protein is a subunit of yeast telomerase. Curr Biol, 
2000. 10(13): p. 809-12. 
 138 
 
214. Nugent, C.I., et al., Cdc13p: a single-strand telomeric DNA-binding protein with 
a dual role in yeast telomere maintenance. Science, 1996. 274(5285): p. 249-52. 
 
215. Lin, J.J. and V.A. Zakian, The Saccharomyces CDC13 protein is a single-strand 
TG1-3 telomeric DNA-binding protein in vitro that affects telomere behavior in 
vivo. Proc Natl Acad Sci U S A, 1996. 93(24): p. 13760-5. 
 
216. Lue, N.F. and Y. Peng, Negative regulation of yeast telomerase activity through 
an interaction with an upstream region of the DNA primer. Nucleic Acids Res, 
1998. 26(6): p. 1487-94. 
 
217. Jacobs, S.A., E.R. Podell, and T.R. Cech, Crystal structure of the essential N-
terminal domain of telomerase reverse transcriptase. Nat Struct Mol Biol, 2006. 
13(3): p. 218-25. 
 
218. Ji, H., et al., Regulation of telomere length by an N-terminal region of the yeast 
telomerase reverse transcriptase. Mol Cell Biol, 2005. 25(20): p. 9103-14. 
 
219. Seto, A.G., et al., Saccharomyces cerevisiae telomerase is an Sm small nuclear 
ribonucleoprotein particle. Nature, 1999. 401(6749): p. 177-80. 
 
220. Livengood, A.J., A.J. Zaug, and T.R. Cech, Essential regions of Saccharomyces 
cerevisiae telomerase RNA: separate elements for Est1 and Est2 interaction. Mol 
Cell Biol, 2002. 22(7): p. 2366-74. 
 
221. Peterson, S.E., et al., The function of a stem-loop in telomerase RNA is linked to 
the DNA repair protein Ku. Nat Genet, 2001. 27(1): p. 64-7. 
 
222. Seto, A.G., et al., A bulged stem tethers Est1 to telomerase RNA in budding yeast. 
Genes Dev, 2002. 16(21): p. 2800-12. 
 
223. Virta-Pearlman, V., D.K. Morris, and V. Lundblad, Est1 has the properties of a 
single-stranded telomere end-binding protein. Genes Dev, 1996. 10(24): p. 3094-
104. 
 
224. Dezwaan, D.C. and B.C. Freeman, The conserved Est1 protein stimulates 
telomerase DNA extension activity. Proc Natl Acad Sci U S A, 2009. 
 
225. Zhang, M.L., et al., Yeast telomerase subunit Est1 has guanine quadruplex-
promoting activity that is required for telomere elongation. Nat Struct Mol Biol, 
2010. 17(2): p. 202-9. 
 
226. Young Yu, E., et al., A proposed OB-fold with a protein-interaction surface in 




227. Lee, J., et al., The Est3 protein associates with yeast telomerase through an OB-
fold domain. Nat Struct Mol Biol, 2008. 15(9): p. 990-997. 
 
228. Sharanov, Y.S., M.I. Zvereva, and O.A. Dontsova, Saccharomyces cerevisiae 
telomerase subunit Est3 binds DNA and RNA and stimulates unwinding of 
RNA/DNA heteroduplexes. FEBS Lett, 2006. 580(19): p. 4683-90. 
 
229. Sharanov, Y.S., et al., Isolation of Active Yeast Telomerase Protein Est3 and 
Investigation of Its Dimerization in vitro. Biochemistry (Mosc), 2007. 72(7): p. 
702-6. 
 
230. Yang, C.P., et al., Saccharomyces cerevisiae Est3 dimerizes in vitro and 
dimerization contributes to efficient telomere replication in vivo. Nucleic Acids 
Res, 2006. 34(2): p. 407-16. 
 
231. Malyavko, A.G., et al., In vitro dimerization of telomerase protein Est3 is 
stimulated by magnesium cations. Dokl Biochem Biophys. 433: p. 152-4. 
 
232. Morris, D.K. and V. Lundblad, Programmed translational frameshifting in a gene 
required for yeast telomere replication. Curr Biol, 1997. 7(12): p. 969-76. 
 
233. Pramila, T., et al., The Forkhead transcription factor Hcm1 regulates 
chromosome segregation genes and fills the S-phase gap in the transcriptional 
circuitry of the cell cycle. Genes Dev, 2006. 20(16): p. 2266-78. 
 
234. Larose, S., et al., RNase III-dependent regulation of yeast telomerase. J Biol 
Chem, 2007. 282(7): p. 4373-81. 
 
235. King, R.W., et al., How proteolysis drives the cell cycle. Science, 1996. 
274(5293): p. 1652-9. 
 
236. Elsasser, S. and D. Finley, Delivery of ubiquitinated substrates to protein-
unfolding machines. Nat Cell Biol, 2005. 7(8): p. 742-9. 
 
237. Grabbe, C., K. Husnjak, and I. Dikic, The spatial and temporal organization of 
ubiquitin networks. Nat Rev Mol Cell Biol, 2011. 12(5): p. 295-307. 
 
238. Glotzer, M., A.W. Murray, and M.W. Kirschner, Cyclin is degraded by the 
ubiquitin pathway. Nature, 1991. 349(6305): p. 132-8. 
 
239. Vodermaier, H.C., APC/C and SCF: controlling each other and the cell cycle. 
Curr Biol, 2004. 14(18): p. R787-96. 
 
240. Lee, D.H. and A.L. Goldberg, Proteasome inhibitors: valuable new tools for cell 
biologists. Trends Cell Biol, 1998. 8(10): p. 397-403. 
 140 
 
241. Baker, D.J., et al., Mitotic regulation of the anaphase-promoting complex. Cell 
Mol Life Sci, 2007. 64(5): p. 589-600. 
 
242. Talley, J.M., et al., Stimulation of yeast telomerase activity by the Ever Shorter 
Telomeres 3 (Est3) subunit is dependent on direct interaction with the catalytic 
protein Est2. J Biol Chem, 2011. In Press. 
 
243. Chappell, A.S. and V. Lundblad, Structural elements required for association of 
the Saccharomyces cerevisiae telomerase RNA with the Est2 reverse 
transcriptase. Mol Cell Biol, 2004. 24(17): p. 7720-36. 
 
244. Bianchi, A., S. Negrini, and D. Shore, Delivery of yeast telomerase to a DNA 
break depends on the recruitment functions of Cdc13 and Est1. Mol Cell, 2004. 
16(1): p. 139-46. 
 
245. Friedman, K.L., et al., N-terminal domain of yeast telomerase reverse 
transcriptase: recruitment of Est3 to the telomerase complex. Mol Biol Cell, 
2003. 14(1): p. 1-13. 
 
246. Lee, J.S., et. al., Investigating the role of the Est3 protein in yeast telomere 
replication. Nucleic Acids Research, 2010(1): p. 1-12. 
 
247. Chan, C. and B. Tye, Organization of DNA sequences and replication origins at 
yeast telomeres. Cell, 1983. 33(2): p. 563-73. 
 
248. Hsu, M., et al., Mutual Dependence of Candida albicans Est1 and Est3 in 
Telomerase Assembly and Activation. Eukaryot Cell, 2007. 6(8): p. 1330-8. 
 
249. DeZwaan, D.C., et al., The Hsp82 molecular chaperone promotes a switch 
between unextendable and extendable telomere states. Nat Struct Mol Biol, 2009. 
16(7): p. 711-6. 
 
250. Toogun, O.A., D.C. Dezwaan, and B.C. Freeman, The hsp90 molecular 
chaperone modulates multiple telomerase activities. Mol Cell Biol, 2008. 28(1): 
p. 457-67. 
 
251. Toogun, O.A., W. Zeiger, and B.C. Freeman, The p23 molecular chaperone 
promotes functional telomerase complexes through DNA dissociation. Proc Natl 
Acad Sci U S A, 2007. 104(14): p. 5765-70. 
 
252. Abreu, E., et al., TIN2-Tethered TPP1 Recruits Human Telomerase to Telomeres 
In Vivo. Mol. Cell. Biol., 2010. 30(12): p. 2971-2982. 
 
253. Zaug, A.J., et al., Functional interaction between telomere protein TPP1 and 
telomerase. Genes and Development, 2010. 24: p. 613-622. 
 141 
 
254. Landt, O., H.P. Grunert, and U. Hahn, A general method for rapid site-directed 
mutagenesis using the polymerase chain reaction. Gene, 1990. 96(1): p. 125-128. 
 
255. Sikorski, R.S. and P. Hieter, A stystem of Shuttle Vectors and Yeast Host Strains 
Designed for Efficient Manipulation of DNA in Saccharomyces cerevisiae. 
Genetics, 1989. 122: p. 19-27. 
 
256. Christianson, T.W., et al., Multifunctional yeast high-copy-number shuttle 
vectors. Gene, 1992. 110: p. 119-122. 
 
257. Wright, A.P., M. Bruns, and B.S. Hartley, Extraction and rapid inactivation of 
proteins from Saccharomyces cerevisiae by trichloroacetic acid precipitation. 
Yeast, 1989. 5: p. 51-53. 
 
258. Chapon, C., T.R. Cech, and A.J. Zaug, Polyadenylation of telomerase RNA in 
budding yeast. Rna, 1997. 3(11): p. 1337-51. 
 
259. Friedman, K.L. and T.R. Cech, Essential functions of N-terminal domains in the 
yeast telomerase catalytic subunit revealed by selection for viable mutants. Genes 
Dev., 1999. 13: p. 2863-2874. 
 
260. Truong, L.N. and X. Wu, Prevention of DNA re-replication in eukaryotic cells. J 
Mol Cell Biol. 3(1): p. 13-22. 
 
261. Zegerman, P. and J.F. Diffley, Phosphorylation of Sld2 and Sld3 by cyclin-
dependent kinases promotes DNA replication in budding yeast. Nature, 2007. 
445(7125): p. 281-5. 
 
262. Paques, F. and J.E. Haber, Multiple pathways of recombination induced by 
double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev, 
1999. 63(2): p. 349-404. 
 
263. Weinert, T., DNA damage and checkpoint pathways: molecular anatomy and 
interactions with repair. Cell, 1998. 94(5): p. 555-8. 
 
264. Kibe, T., et al., Telomere protection by TPP1 is mediated by POT1a and POT1b. 
Mol Cell Biol. 30(4): p. 1059-66. 
 
265. Tejera, A.M., et al., TPP1 is required for TERT recruitment, telomere elongation 
during nuclear reprogramming, and normal skin development in mice. Dev Cell, 
2010. 18(5): p. 775-89. 
 
 
